<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Part Fibre Toxicol</journal-id>
<journal-id journal-id-type="iso-abbrev">Part Fibre Toxicol</journal-id>
<journal-title-group>
<journal-title>Particle and Fibre Toxicology</journal-title>
</journal-title-group>
<issn pub-type="epub">1743-8977</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32487227</article-id>
<article-id pub-id-type="pmc">7268708</article-id>
<article-id pub-id-type="publisher-id">349</article-id>
<article-id pub-id-type="doi">10.1186/s12989-020-00349-z</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Impacts of foodborne inorganic nanoparticles on the gut microbiota-immune axis: potential consequences for host health</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7777-2127</contrib-id>
<name>
<surname>Lamas</surname>
<given-names>Bruno</given-names>
</name>
<address>
<email>bruno.lamas@inrae.fr</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martins Breyner</surname>
<given-names>Natalia</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Houdeau</surname>
<given-names>Eric</given-names>
</name>
<address>
<email>eric.houdeau@inrae.fr</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.11417.32</institution-id><institution-id institution-id-type="ISNI">0000 0001 2353 1689</institution-id><institution>INRAE Toxalim UMR 1331 (Research Center in Food Toxicology), Team Endocrinology and Toxicology of the Intestinal Barrier, INRAE, </institution><institution>Toulouse University, </institution></institution-wrap>ENVT, INP-Purpan, UPS, 180 Chemin de Tournefeuille, 31027 Toulouse cedex 3, France </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>1</day>
<month>6</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>6</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>17</volume>
<elocation-id>19</elocation-id>
<history>
<date date-type="received">
<day>5</day>
<month>9</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>5</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2020</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">In food toxicology, there is growing interest in studying the impacts of foodborne nanoparticles (NPs, originating from food additives, food supplements or food packaging) on the intestinal microbiome due to the important and complex physiological roles of these microbial communities in host health. Biocidal activities, as described over recent years for most inorganic and metal NPs, could favour chronic changes in the composition and/or metabolic activities of commensal bacteria (namely, intestinal dysbiosis) with consequences on immune functions. Reciprocally, direct interactions of NPs with the immune system (e.g., inflammatory responses, adjuvant or immunosuppressive properties) may in turn have effects on the gut microbiota. Many chronic diseases in humans are associated with alterations along the microbiota-immune system axis, such as inflammatory bowel diseases (IBD) (Crohn’s disease and ulcerative colitis), metabolic disorders (e.g., obesity) or colorectal cancer (CRC). This raises the question of whether chronic dietary exposure to inorganic NPs may be viewed as a risk factor facilitating disease onset and/or progression. Deciphering the variety of effects along the microbiota-immune axis may aid the understanding of how daily exposure to inorganic NPs through various foodstuffs may potentially disturb the intricate dialogue between gut commensals and immunity, hence increasing the vulnerability of the host. In animal studies, dose levels and durations of oral treatment are key factors for mimicking exposure conditions to which humans are or may be exposed through the diet on a daily basis, and are needed for hazard identification and risk assessment of foodborne NPs. This review summarizes relevant studies to support the development of predictive toxicological models that account for the gut microbiota-immune axis.</p>
</sec>
<sec>
<title>Conclusions</title>
<p id="Par2">The literature indicates that, in addition to evoking immune dysfunctions in the gut, inorganic NPs exhibit a moderate to extensive impact on intestinal microbiota composition and activity, highlighting a recurrent signature that favours colonization of the intestine by pathobionts at the expense of beneficial bacterial strains, as observed in IBD, CRC and obesity. Considering the long-term exposure via food, the effects of NPs on the gut microbiome should be considered in human health risk assessment, especially when a nanomaterial exhibits antimicrobial properties.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Intestinal microbiota</kwd>
<kwd>Gut dysbiosis</kwd>
<kwd>Nanoparticles</kwd>
<kwd>Silver</kwd>
<kwd>Titanium dioxide</kwd>
<kwd>Zinc oxide</kwd>
<kwd>Silicon dioxide</kwd>
<kwd>Gut inflammation</kwd>
<kwd>Obesity</kwd>
<kwd>Colorectal cancer</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par46">Nanomaterials are widely used in various industrial manufacturing processes and have applications in everyday consumer products such as foodstuffs, healthcare, clothing, sunscreens and cosmetics. Particles with sizes in the nanoscale range, namely, nanoparticles (NPs; with one dimension between 1 and 100 nm), present unique physical and chemical properties due to their high surface area to volume ratio (e.g., in photocatalysis, mechanical, optical properties), and these properties differ from those of corresponding bulk forms [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR3">3</xref>]. Due to the wide-ranging applications of nanotechnology in everyday products, concerns have been raised regarding the potential health consequences for humans exposed to NPs from different sources and routes (oral, dermal, inhalation). However, the human risk assessment of the oral uptake of NPs is poorly documented compared to that of other routes, although NPs are commonly found in food additives and in food supplements for improving organoleptic properties, shelf life and texture, until used for the nanoencapsulation of specific functional ingredients [<xref ref-type="bibr" rid="CR4">4</xref>–<xref ref-type="bibr" rid="CR6">6</xref>].</p>
<p id="Par47">Among inorganic NPs, titanium dioxide (TiO<sub>2</sub>), silver (Ag) and silicon dioxide (SiO<sub>2</sub>) are commonly used as food colouring or anti-caking agents, while others are added as food supplements, such as zinc oxide (ZnO), given that zinc is an essential trace element. Most of these NPs are also used to develop antimicrobial active food packaging or are incorporated into bio-based materials that come in contact with food to act as oxygen, moisture and carbon dioxide barriers. Oral uptake is thought to be one of the major routes of exposure to NPs for the general population, and studies focused on the fate and effects of foodborne NPs have recently gained considerable attention for the assessment of health risks and for regulatory purposes. Following ingestion, NPs interact with a complex gastrointestinal (GI) environment. The non-absorbed fractions of foodborne mineral NPs (or their ionic forms for soluble compounds, such as Ag and ZnO) are accumulated in the intestinal lumen as a result of daily consumption, and can directly interact with the intestinal microbiota colonizing the gut lumen as well as the mucus layer lining the epithelial surface [<xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR9">9</xref>]. A portion of the NPs then translocate through the epithelial barrier and are possibly captured by the intestinal immune cells (e.g., macrophages and dendritic cells), before reaching systemic circulation. Notably, the gut microbiota (formerly called the intestinal flora) plays important roles in a number of physiological functions as an indispensable substrate for host health. Indeed, the commensal microbial community not only contributes to digestion of dietary fibres leading to the production of key metabolites for host physiology, but also strongly interacts with epithelial cells to maintain an effective gut barrier separating the body from the external environment [<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR12">12</xref>]. Intestinal microorganisms also communicate with local immune cells to shape specific responses by balancing tolerance and effector immune functions to various antigens [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Beyond the gut, there is also unique coordination between the intestinal microbiota and liver functions, as well as the brain. Indeed, alteration in the microbiota (namely, dysbiosis), in its ecology (microbial population) and/or metabolic functions (production of bacterial metabolites), has been implicated in various chronic GI and metabolic diseases and even neurodevelopmental disorders [<xref ref-type="bibr" rid="CR15">15</xref>–<xref ref-type="bibr" rid="CR21">21</xref>]. For general homeostasis of organisms, immune cells of the gut-associated lymphoid tissue (GALT) shape the microbiota from birth to adulthood in terms of composition, quality and activity and allow these microorganisms to be tolerated by the host for its lifetime. In this context, little attention has been paid to the occurrence of intestinal dysbiosis after daily uptake of nanosized and biocidal particles. Consequences of chronic oral exposure to foodborne NPs on GI functions require scrutiny, taking into account all intestinal compartments that are in close contact with the ingested NPs. This includes direct effects on microbiota composition and/or activity and indirect dysbiosis due to NP-mediated immune system dysfunctions, both leading to potential disruption of intestinal homeostasis, affecting the functions of a number of systemic organs, with long-term effects on health.</p>
<p id="Par48">Here, we review data from in vivo and in vitro studies on the impacts of Ag, TiO<sub>2</sub>, SiO<sub>2</sub> and ZnO along the gut microbiota-immune system axis and examine whether these reports are relevant for health risk assessment in humans in terms of dose levels and effects. Silver (referenced as E174 in the EU) is used to colour the surfaces of some products, such as cakes, ice creams, frozen desserts and chocolates, with exposure levels from children to adults ranging from 0.03 to 2.6 μg/kg of body weight (bw)/day (d) [<xref ref-type="bibr" rid="CR22">22</xref>]. Food-grade TiO<sub>2</sub> (E171) is a white pigment and brightening agent that is used in large amounts in confectionery items, white sauces and icing [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. Depending on the exposure scenario, the European Food Safety Authority (EFSA) estimated that the daily exposure levels to E171 range from 0.2 to 1.9 mg/kg bw/d in infants, 0.9 to 10.4 mg/kg bw/d in children, and 0.3 to 6.8 mg/kg bw/d in adults [<xref ref-type="bibr" rid="CR25">25</xref>]. Food-grade SiO<sub>2</sub> (E551) is commonly added to powdered food as an anticaking agent, such as in salt, icing sugar, spices, dried milk and dry mixes [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. The EFSA estimated that daily exposure to E551 ranges between 0.8 and 74.2 mg/kg bw/d in infants, 2.7 and 31.2 mg/kg bw/d in children and 0.9 and 13.2 mg/kg bw/d in adults [<xref ref-type="bibr" rid="CR28">28</xref>]. In addition, because zinc is important for human health, ZnO-NPs may be found as a nutrient source in supplements and functional foods [<xref ref-type="bibr" rid="CR29">29</xref>]. To date, the majority of studies evaluating the toxicity of TiO<sub>2</sub>, SiO<sub>2</sub>, Ag and ZnO NPs used nanomodels, i.e., composed of strictly nanosized particles and often coated with different compounds to improve their stability and dispersability. Within the scope of food additives, exhibiting size mix in the nano- and submicron range, with particles as aggregates or agglomerates and batch to batch variation, studies should mainly consider oral exposure to food grade NPs originating from E171, E174 and E551 for human health risk assessment, that remains poorly documented. As most animal studies focused on Ag, TiO<sub>2</sub>, SiO<sub>2</sub> and ZnO NPs do not address the potential impacts of these materials on the gut microbiota-immune axis, this review will focus on effects susceptible to affect the delicate balance between these microorganisms and their hosts. In addition, we compared the effect of NPs on the gut microbiome to the intestinal dysbiosis characteristics reported in chronic diseases such as colorectal cancer (CRC), obesity and inflammatory bowel diseases (IBD), where microbiota alteration play important pathogenic roles [<xref ref-type="bibr" rid="CR15">15</xref>–<xref ref-type="bibr" rid="CR19">19</xref>]. Understanding the impact of NPs on the crosstalk between the microbiota and the immune system will improve the understanding of the potential effects of chronic exposure to foodborne NPs on host physiology. These effects could lead to a favourable environment for the onset and progression of chronic diseases and/or disruption of the gut-liver and gut-brain axes under the influence of bacterial metabolites.</p>
</sec>
<sec id="Sec2">
<title>Main text</title>
<sec id="Sec3">
<title>The intestinal microbiota-immune axis in host physiology</title>
<p id="Par49">The human intestinal microbiota is a complex ecosystem mainly composed of bacteria, as well as archaea, viruses, fungi and protozoa. Colonized at birth, the adult human GI tract harbours 100 trillions of bacteria, including at least several hundred species and more than 7000 strains. A majority of these bacteria belong to the phyla Firmicutes and Bacteroidetes, representing approximately 90% of the microbial population, while other species are members of the phyla Proteobacteria, Verrucomicrobia, Actinobacteria, Fusobacteria and Cyanobacteria [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. The density of these bacterial populations increases from the proximal to the distal end of the intestine, with ~ 10<sup>2–3</sup> colony forming units (cfu) per gram in the proximal ileum and jejunum, ~ 10<sup>7–8</sup> cfu in the distal ileum, and ~ 10<sup>11–12</sup> cfu in the ascending colon [<xref ref-type="bibr" rid="CR32">32</xref>]. The biomass of these gut microbes is approximately 1–2 kg, which is similar to the weight of the human brain [<xref ref-type="bibr" rid="CR33">33</xref>]. The whole genome of intestinal microorganisms (known as the gut microbiome) is 150 times larger than the human genome, providing a diverse range of biochemical and metabolic activities, allowing the microbiota to complement host physiology [<xref ref-type="bibr" rid="CR31">31</xref>]. Indeed, the gut microbiota and the liver exhibit equal metabolic capacities [<xref ref-type="bibr" rid="CR34">34</xref>] and due to its beneficial effects for human health, the gut microbiome is now being considered an hidden and indispensable organ of the human body, of which activities need to be integrated as the missing link into host physiology and the development of diseases [<xref ref-type="bibr" rid="CR35">35</xref>–<xref ref-type="bibr" rid="CR39">39</xref>].</p>
<sec id="Sec4">
<title>Local and distant roles of the gut microbiome</title>
<p id="Par50">The intestinal microbiota plays essential roles in GI functions: these microbes i) facilitate the digestion and fermentation of indigestible polysaccharides and produce vitamins, ii) are essential for the development and differentiation of the intestinal epithelium as well as of the GALT, iii) are involved in host immune defence against pathogens in the luminal content, and, finally, iv) contribute greatly to lifelong maintenance of intestinal homeostasis [<xref ref-type="bibr" rid="CR40">40</xref>–<xref ref-type="bibr" rid="CR43">43</xref>]. One of the major biological approaches to examine the importance of the gut microbiota for host physiology is the use of germ-free (GF) mice, which are raised in the absence of any microorganisms [<xref ref-type="bibr" rid="CR44">44</xref>]. GF mice present an underdeveloped intestinal epithelium, which is consistent with the important role of the microbiota in the maintenance of a functional epithelial surface to prevent the passage of harmful intraluminal entities, including foreign antigens, microorganisms and microbial toxins [<xref ref-type="bibr" rid="CR45">45</xref>–<xref ref-type="bibr" rid="CR47">47</xref>]. Specifically, GF mice exhibit decreased brush border differentiation [<xref ref-type="bibr" rid="CR48">48</xref>] and villus thickness [<xref ref-type="bibr" rid="CR49">49</xref>] due to reduced cell regeneration [<xref ref-type="bibr" rid="CR50">50</xref>] and increased cell cycle time [<xref ref-type="bibr" rid="CR51">51</xref>]. Similar to GF mice, GF piglets show aberrant epithelial surface, notably lengthened villi and shortened crypts, and these effects are reversed by intestinal colonization with faecal microbiota or commensal <italic>Escherichia coli</italic> strain [<xref ref-type="bibr" rid="CR52">52</xref>–<xref ref-type="bibr" rid="CR55">55</xref>]. Studies in <italic>Drosophila</italic> and mice showed that commensal bacteria promote epithelial development and wound closure through mechanisms that involve reactive oxygen species (ROS) [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. The intestinal flora also regulates intestinal epithelial cell growth and differentiation indirectly by the production of metabolites such as short-chain fatty acids (SCFAs), and aryl hydrocarbon receptor (AhR) ligands [<xref ref-type="bibr" rid="CR58">58</xref>–<xref ref-type="bibr" rid="CR61">61</xref>]. SCFAs (i.e., butyrate, propionate and acetate) are by-products of the fermentation of non-digestible dietary fibres through the action of intestinal bacteria, while AhR ligands are mostly derived from tryptophan metabolism. Moreover, these two metabolite groups are involved in the preservation of intercellular tight junction integrity in the intestinal epithelium, thereby establishing the link between gut microbial activity and the maintenance of effective intestinal barrier function.</p>
<p id="Par51">Beyond the gut, it is well recognized that the gut microbiome can also modulate the function and/or development of systemic organs, such as the liver and brain, an ongoing dialogue that is enabled by a large variety of bacterial metabolites (SCFAs, polyamines, retinoic acid, AhR ligands). These metabolites can affect distant organs either directly through the bloodstream or indirectly by signalling via nerves or hormones from the gut [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR62">62</xref>–<xref ref-type="bibr" rid="CR64">64</xref>]. Both microbiota composition and activity play key roles in such interactions, and dietary alterations may have a significant impact on the gut-liver and gut-brain axes. Consistent with these findings, brain development and social behaviour are impaired in GF mice, and colonization of these mice with a complex microbiota or specific bacterial strains alleviates most of these effects [<xref ref-type="bibr" rid="CR65">65</xref>–<xref ref-type="bibr" rid="CR72">72</xref>]. Moreover, GF mice showed an elevated stress response, which was decreased after colonization with wild-type (WT) microbiota or <italic>Bifidobacterium infantis</italic>, a SCFA producer, whereas colonization with the enteropathogenic proteobacteria <italic>E. coli</italic> aggravated the stress response [<xref ref-type="bibr" rid="CR71">71</xref>]. Intestinal microbiota supplementation with <italic>Lactobacillus reuteri</italic> also restores social behaviours in young mice born to mothers fed a high-fat diet that is known to alter microbiota composition [<xref ref-type="bibr" rid="CR72">72</xref>]. The social deficit observed in these young mice was not rescued after <italic>Lactobacillus johnsonii</italic> supplementation, indicating that a specific metabolite produced by <italic>L. reuteri</italic> is required [<xref ref-type="bibr" rid="CR72">72</xref>]. This metabolite remains to be determined, but <italic>L. reuteri</italic> (among other commensals) is able to metabolize the essential amino acid tryptophan to AhR ligands [<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>] that are known to protect the brain from inflammation [<xref ref-type="bibr" rid="CR75">75</xref>]. Regarding other bacterial products, the increased blood-brain barrier permeability commonly reported in GF mice was reversed after colonization with the SCFA-producing <italic>Clostridium tyrobutyricum</italic> or <italic>Bacteroides thetaiotaomicron</italic> [<xref ref-type="bibr" rid="CR69">69</xref>]. SCFAs are also involved in the maturation of microglia, which are responsible for immune defence in the brain [<xref ref-type="bibr" rid="CR70">70</xref>]. Along the gut-liver axis, AhR ligands such as indole are also able to alleviate liver inflammation in mice [<xref ref-type="bibr" rid="CR76">76</xref>]. Moreover, SCFA administration in animal models of obesity decreases the accumulation of fat in the liver and improves insulin resistance through mechanisms involving liver glycogenesis and lipogenesis [<xref ref-type="bibr" rid="CR77">77</xref>]. Again, administration of SCFA-producing bacteria in rats helped prevent non-alcoholic fatty liver disease and lower triglyceride levels [<xref ref-type="bibr" rid="CR78">78</xref>], reinforcing the idea that the SCFA production level is crucial for liver homeostasis and susceptibility to metabolic diseases.</p>
</sec>
<sec id="Sec5">
<title>Microbiota and the gut-associated lymphoid tissue</title>
<p id="Par52">The intestinal mucosa, encompassing the surface epithelium and the GALT, represents a complex interface participating in the homeostatic relationships between the gut microbiota and the host immune system in response to the environment and diet [<xref ref-type="bibr" rid="CR79">79</xref>–<xref ref-type="bibr" rid="CR82">82</xref>]. A balanced dialogue at this interface requires collaboration between mucosal immune cells (macrophages, dendritic cells (DCs), B and T lymphocytes) and epithelial cells producing antimicrobial peptides (e.g., defensins, cathelicidins and histatins) and enzymes such as lysozyme produced by the secretory Paneth cells (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). Moreover, GALT also consists of isolated or aggregated lymphoid follicles that form Peyer’s patches (PPs) in the small intestine. PPs exhibit a strong ability to sample luminal antigens and bacteria through microfold (M) cells, a class of antigen-presenting cells and immune sensors of the gut located in the follicle-associated epithelium overlying PP domes (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). M cells transport bacteria and macromolecules to the underlying immune cells where they play a critical role in gut-oriented immune responses, triggering the induction of immune tolerance to innocuous antigens derived from food and microbiota or activation of immune defence against pathogens (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). In the <italic>lamina propria</italic> (LP), DCs complement these surveillance systems in linking innate immune sensing of the environment to the initiation of adaptive immune responses. By extending transepithelial dendrites into the gut lumen, DCs sample antigens and subsequently migrate to mesenteric lymph nodes (MLNs), where they initiate T-cell responses with an intestinal tropism. Under homeostatic conditions, DCs preferentially promote regulatory T-cell (Treg) responses for oral tolerance [<xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR84">84</xref>] while they can also initiate the immunity to pathogens [<xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR85">85</xref>] (Fig. <xref ref-type="fig" rid="Fig1">1</xref>).
<fig id="Fig1"><label>Fig. 1</label><caption><p>The gut microbiota modulates the intestinal immune response. The gut microbiota influences the development of T cell subsets, intraepithelial lymphocytes (IELs) and are critical for the induction of plasma cells which produce immunoglobulin A (IgA). Dendritic cells (DCs) sample microbial antigens that pass through the epithelial barrier via microfold (M) cells or capture antigens from the lumen directly by extending dendrites between the intestinal epithelial cells. Some of these DCs migrate to the mesenteric lymph nodes and induce naïve T cells differentiation into regulatory T-cell (Treg) by production of transforming growth factor β (TGF-β) and retinoic acid. Segmented filamentous bacteria (SFB) exhibit pro-inflammatory effects by inducing IL-17 and IgA production, whereas <italic>Bacteroides fragilis</italic>, <italic>Faecalibacterium prausnitzii</italic> and short-chain fatty acids (SCFAs) exhibit anti-inflammatory effects via recruitment of Treg that produce the immunosuppressive cytokine IL-10. The intestinal flora also regulates immune response by the production of aryl hydrocarbon receptor (AhR) ligands able to activate AhR, highly expressed on IELs, Th17, Th22, innate lymphoid cells group 3 (ILC3) that produce IL-17 and/or IL-22. These cytokines induce secretion of antimicrobial peptides (AMPs) from Paneth cells and intestinal epithelial cells. AMPs shape the microbiota and are also involved in colonization resistance against pathogens</p></caption><graphic id="MO1" xlink:href="12989_2020_349_Fig1_HTML"></graphic></fig></p>
<p id="Par53">The intestinal microbiota is essential for GALT maturation and development, as proven by GF mice exhibiting highly immature immune system. The intestine of these mice exhibit small MLNs and PPs and decreased numbers of immune cells, such as immunoglobulin A (IgA)-producing plasma cells and T lymphocytes, for example, LP CD4<sup>+</sup> T cells and intraepithelial αβ CD8<sup>+</sup> T cells, leading to a reduced capacity to combat pathogens [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR86">86</xref>]. All these immune alterations are microbiota dependent and can be reversed by faecal microbiota colonization [<xref ref-type="bibr" rid="CR87">87</xref>]. Notably, recent studies highlighted the existence of anti- or pro-inflammatory microorganisms in the gut. In mice, segmented filamentous bacteria (SFB) direct the accumulation of pro-inflammatory T helper 17 (Th17) cells in the LP [<xref ref-type="bibr" rid="CR88">88</xref>, <xref ref-type="bibr" rid="CR89">89</xref>] (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). This finding is in contrast with the results for other bacteria, such as <italic>Bacteroides fragilis</italic> [<xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR91">91</xref>] and <italic>Faecalibacterium prausnitzii</italic> [<xref ref-type="bibr" rid="CR92">92</xref>–<xref ref-type="bibr" rid="CR94">94</xref>], which exhibit anti-inflammatory activity via metabolite production and/or the recruitment of Treg-producing interleukin (IL)-10, a potent immunosuppressive cytokine (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). Indeed, most metabolites derived from commensal bacteria, such as SCFAs and AhR ligands, may regulate immune cell functions via indirect and direct mechanisms [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR95">95</xref>] (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). In the intestine, butyrate is a key regulator of host energy, and the butyrate level in the lumen is correlated with the abundance of <italic>Lactobacillus</italic>, <italic>Allobacterium</italic>, <italic>Bifidobacterium</italic>, <italic>Dorea</italic> and <italic>Blautia</italic>. Many cells are affected by SCFAs, such as intestinal epithelial cells (IECs), DCs and T cells, leading to modulation of different aspects of cell development, survival and function and to modulation of enzymes and transcription factors [<xref ref-type="bibr" rid="CR96">96</xref>, <xref ref-type="bibr" rid="CR97">97</xref>]. Gurav and colleagues demonstrated that SCFAs modulate T cell activation and effector response by inducing a tolerogenic profile [<xref ref-type="bibr" rid="CR98">98</xref>]. This study also showed that DCs stimulated with SCFAs in vitro exhibited increased expression of indoleamine 2,3-dioxygenase 1 [<xref ref-type="bibr" rid="CR98">98</xref>], the role of which in inflammation is to attenuate the immune response through an immunosuppressive effect on T cell proliferation and activation. On the other hand, AhR ligands produced by the gut microbiota induce AhR activation, with endogenous downstream functions on the cell cycle, immune response, and cell differentiation [<xref ref-type="bibr" rid="CR99">99</xref>–<xref ref-type="bibr" rid="CR101">101</xref>] (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). IECs have a role in the regulation of AhR ligands availability to GALT, including macrophages, DCs, innate lymphoid cells (ILCs), Th17/Th22 cells and intraepithelial lymphocytes (IELs). All of these immune cell types express AhR, activation of which by microbiota-derived appropriate ligands being pivotal in the regulation of mucosal immune responses in the gut [<xref ref-type="bibr" rid="CR99">99</xref>].</p>
</sec>
</sec>
<sec id="Sec6">
<title>Interactions of inorganic NPs with the gut microbiome</title>
<p id="Par54">Despite several studies highlighting the deleterious effects of nanomaterials in soil [<xref ref-type="bibr" rid="CR102">102</xref>] or plant [<xref ref-type="bibr" rid="CR103">103</xref>] microbial communities, the impact of inorganic NPs on bacteria that colonize the gut remain poorly documented. Tables <xref ref-type="table" rid="Tab1">1</xref> and <xref ref-type="table" rid="Tab2">2</xref> provides a detailed description of data on NPs that exhibit biocidal effects on intestinal bacteria, mainly metal NPs such as Ag, ZnO and TiO<sub>2</sub>, with additional information for SiO<sub>2</sub>. Given the very limited information on nanostructured food additives (namely, E174, E171, E551 in EU for food-grade formulations of nano-Ag, TiO<sub>2</sub> and SiO<sub>2</sub>, respectively), it should be noted that this review mostly provides data obtained with NP models. The in vivo studies are categorized according to the duration of treatment and dose levels (Table <xref ref-type="table" rid="Tab1">1</xref>), followed by classification of in vitro data on the human microbiota (Table <xref ref-type="table" rid="Tab2">2</xref>), to provide information relevant for risk assessment of NP exposure through food.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Studies using animal models to determine the impact of NPs on the gut microbiota</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th colspan="2">Ag-NP</th><th colspan="2">TiO<sub>2</sub>-NP</th><th>SiO<sub>2</sub>-NP</th><th colspan="2">ZnO-NP</th></tr><tr><th>Duration (days)</th><th>≤14</th><th>≥28</th><th>7</th><th>≥28</th><th>7</th><th>≤14</th><th>≥28</th></tr></thead><tbody><tr><td>Actinobacteria</td><td></td><td></td><td></td><td>↗[<xref ref-type="bibr" rid="CR104">104</xref>]</td><td></td><td></td><td></td></tr><tr><td><italic>Bifidobacterium (g)</italic></td><td></td><td>↙[<xref ref-type="bibr" rid="CR105">105</xref>]</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><italic>Corynebacterium (g)</italic></td><td>↙[<xref ref-type="bibr" rid="CR106">106</xref>]</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><italic>Rhodococcus (g)</italic></td><td></td><td></td><td></td><td>↙[<xref ref-type="bibr" rid="CR104">104</xref>]</td><td></td><td></td><td></td></tr><tr><td>Bacteroidetes</td><td>↗[<xref ref-type="bibr" rid="CR107">107</xref>]</td><td>↗[<xref ref-type="bibr" rid="CR105">105</xref>] or ↙[<xref ref-type="bibr" rid="CR108">108</xref>]<sup>♦</sup></td><td>↙[<xref ref-type="bibr" rid="CR107">107</xref>]<sup>♦</sup></td><td>↙[<xref ref-type="bibr" rid="CR104">104</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR107">107</xref>]<sup>♦</sup></td><td>↙[<xref ref-type="bibr" rid="CR109">109</xref>]</td><td>↗[<xref ref-type="bibr" rid="CR110">110</xref>]</td></tr><tr><td><italic>Bacteroidaceae (f)</italic></td><td></td><td>↙[<xref ref-type="bibr" rid="CR108">108</xref>]<sup>♦</sup></td><td></td><td></td><td></td><td></td><td>↗[<xref ref-type="bibr" rid="CR110">110</xref>]</td></tr><tr><td><italic>Bacteroides (g)</italic></td><td></td><td>↗[<xref ref-type="bibr" rid="CR105">105</xref>] or ↙[<xref ref-type="bibr" rid="CR108">108</xref>]<sup>♦</sup></td><td>↙[<xref ref-type="bibr" rid="CR107">107</xref>]<sup>♦</sup></td><td></td><td>↙[<xref ref-type="bibr" rid="CR107">107</xref>]<sup>♦</sup></td><td></td><td>↗[<xref ref-type="bibr" rid="CR110">110</xref>]</td></tr><tr><td><italic>Bacteroides uniformis</italic></td><td>↙[<xref ref-type="bibr" rid="CR106">106</xref>]</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><italic>Odoribacteraceae (f)</italic></td><td></td><td>↙[<xref ref-type="bibr" rid="CR108">108</xref>]<sup>♦</sup></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><italic>Prevotellaceae (f)</italic></td><td></td><td></td><td></td><td></td><td></td><td>↙[<xref ref-type="bibr" rid="CR109">109</xref>]</td><td></td></tr><tr><td><italic>Prevotella (g)</italic></td><td>↗[<xref ref-type="bibr" rid="CR107">107</xref>]</td><td></td><td></td><td>↙[<xref ref-type="bibr" rid="CR104">104</xref>]</td><td>↗[<xref ref-type="bibr" rid="CR107">107</xref>]<sup>♦</sup></td><td>↙[<xref ref-type="bibr" rid="CR109">109</xref>]</td><td></td></tr><tr><td><italic>Rikenellaceae (f)</italic></td><td></td><td>↗[<xref ref-type="bibr" rid="CR108">108</xref>]<sup>♦</sup></td><td></td><td></td><td></td><td></td><td>↙[<xref ref-type="bibr" rid="CR110">110</xref>]</td></tr><tr><td><italic>Alistipes (g)</italic></td><td>↗[<xref ref-type="bibr" rid="CR107">107</xref>]</td><td></td><td></td><td></td><td>↗[<xref ref-type="bibr" rid="CR107">107</xref>]<sup>♦</sup></td><td></td><td>↙[<xref ref-type="bibr" rid="CR110">110</xref>]</td></tr><tr><td><italic>S24–7 (f)</italic></td><td></td><td>↙[<xref ref-type="bibr" rid="CR108">108</xref>]<sup>♦</sup></td><td></td><td></td><td></td><td>↙[<xref ref-type="bibr" rid="CR109">109</xref>]</td><td></td></tr><tr><td><italic>Barnesiella (g)</italic></td><td></td><td></td><td></td><td>↙[<xref ref-type="bibr" rid="CR104">104</xref>]</td><td></td><td></td><td></td></tr><tr><td>Firmicutes</td><td>↙[<xref ref-type="bibr" rid="CR107">107</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR105">105</xref>] or ↗[<xref ref-type="bibr" rid="CR108">108</xref>]<sup>♦</sup></td><td></td><td>↙[<xref ref-type="bibr" rid="CR104">104</xref>]</td><td>↗[<xref ref-type="bibr" rid="CR107">107</xref>]<sup>♦</sup></td><td>↗colon, ↙ileum [<xref ref-type="bibr" rid="CR109">109</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR110">110</xref>]</td></tr><tr><td><italic>Bacillaceae (f)</italic></td><td></td><td></td><td></td><td></td><td></td><td>↗[<xref ref-type="bibr" rid="CR109">109</xref>]</td><td></td></tr><tr><td><italic>Bacillus (g)</italic></td><td></td><td></td><td></td><td></td><td></td><td>↗[<xref ref-type="bibr" rid="CR109">109</xref>]</td><td></td></tr><tr><td><italic>Christensenellaceae (f)</italic></td><td>↙[<xref ref-type="bibr" rid="CR106">106</xref>]</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><italic>Erysipelotrichaceae (f)</italic></td><td></td><td></td><td></td><td>↙[<xref ref-type="bibr" rid="CR104">104</xref>]</td><td></td><td></td><td></td></tr><tr><td><italic>Turicibacter (g)</italic></td><td></td><td></td><td></td><td>↙[<xref ref-type="bibr" rid="CR104">104</xref>]</td><td></td><td></td><td>↗[<xref ref-type="bibr" rid="CR111">111</xref>]</td></tr><tr><td><italic>Lachnospiraceae (f)</italic></td><td>↙[<xref ref-type="bibr" rid="CR107">107</xref>]</td><td>↗[<xref ref-type="bibr" rid="CR108">108</xref>]<sup>♦</sup></td><td></td><td></td><td>↗[<xref ref-type="bibr" rid="CR107">107</xref>]<sup>♦</sup></td><td></td><td></td></tr><tr><td><italic>Blautia (g)</italic></td><td></td><td>↗[<xref ref-type="bibr" rid="CR108">108</xref>]<sup>♦</sup></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><italic>Coprococcus (g)</italic></td><td></td><td>↗[<xref ref-type="bibr" rid="CR108">108</xref>]<sup>♦</sup></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><italic>Coprococcus eutatus</italic></td><td>↙[<xref ref-type="bibr" rid="CR106">106</xref>]</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><italic>Lactobacillaceae (f)</italic></td><td></td><td>↗[<xref ref-type="bibr" rid="CR108">108</xref>]<sup>♦</sup></td><td></td><td></td><td></td><td>↗colon, ↙ileum [<xref ref-type="bibr" rid="CR109">109</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR110">110</xref>, <xref ref-type="bibr" rid="CR111">111</xref>]</td></tr><tr><td><italic>Lactobacillus (g)</italic></td><td>↙[<xref ref-type="bibr" rid="CR107">107</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR105">105</xref>] or ↗[<xref ref-type="bibr" rid="CR108">108</xref>]<sup>♦</sup></td><td></td><td>↙[<xref ref-type="bibr" rid="CR104">104</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR107">107</xref>]<sup>♦</sup></td><td>↗colon, ↙ileum [<xref ref-type="bibr" rid="CR109">109</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR110">110</xref>, <xref ref-type="bibr" rid="CR111">111</xref>]</td></tr><tr><td><italic>Peptococcaceae (f)</italic></td><td>↙[<xref ref-type="bibr" rid="CR106">106</xref>]</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><italic>Ruminococcaceae (f)</italic></td><td></td><td></td><td></td><td></td><td>↗[<xref ref-type="bibr" rid="CR107">107</xref>]<sup>♦</sup></td><td></td><td></td></tr><tr><td><italic>Oscillospira (g)</italic></td><td>↙[<xref ref-type="bibr" rid="CR106">106</xref>]</td><td></td><td></td><td></td><td></td><td>↙[<xref ref-type="bibr" rid="CR109">109</xref>]</td><td></td></tr><tr><td><italic>Streptococcaceae (f)</italic></td><td></td><td></td><td></td><td></td><td></td><td>↗[<xref ref-type="bibr" rid="CR109">109</xref>]</td><td></td></tr><tr><td><italic>Streptococcus (g)</italic></td><td></td><td></td><td></td><td></td><td></td><td>↗[<xref ref-type="bibr" rid="CR109">109</xref>]</td><td></td></tr><tr><td><italic>Clostridium (g)</italic></td><td>↙[<xref ref-type="bibr" rid="CR106">106</xref>]</td><td></td><td></td><td></td><td></td><td></td><td>↗[<xref ref-type="bibr" rid="CR111">111</xref>]</td></tr><tr><td><italic>Dehalobacterium (g)</italic></td><td>↙[<xref ref-type="bibr" rid="CR106">106</xref>]</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><italic>Oscillibacter (g)</italic></td><td></td><td></td><td></td><td></td><td>↗[<xref ref-type="bibr" rid="CR107">107</xref>]<sup>♦</sup></td><td></td><td></td></tr><tr><td><italic>SMB53 (g)</italic></td><td></td><td></td><td></td><td></td><td></td><td></td><td>↗[<xref ref-type="bibr" rid="CR111">111</xref>]</td></tr><tr><td>Proteobacteria</td><td></td><td></td><td></td><td>↗[<xref ref-type="bibr" rid="CR104">104</xref>]</td><td>↗[<xref ref-type="bibr" rid="CR107">107</xref>]<sup>♦</sup></td><td>↗[<xref ref-type="bibr" rid="CR109">109</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR111">111</xref>]</td></tr><tr><td><italic>Enterobacteriaceae (f)</italic></td><td></td><td>↗[<xref ref-type="bibr" rid="CR105">105</xref>]</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><italic>Escherichia/Shigella (g)</italic></td><td></td><td></td><td></td><td>↗[<xref ref-type="bibr" rid="CR104">104</xref>]</td><td></td><td></td><td></td></tr><tr><td><italic>Halomonadaceae (f)</italic></td><td></td><td></td><td></td><td></td><td></td><td>↗[<xref ref-type="bibr" rid="CR109">109</xref>]</td><td></td></tr><tr><td><italic>Halomonas (g)</italic></td><td></td><td></td><td></td><td></td><td></td><td>↗[<xref ref-type="bibr" rid="CR109">109</xref>]</td><td></td></tr><tr><td><italic>Aggregatibacter pneumotropica</italic></td><td>↙[<xref ref-type="bibr" rid="CR106">106</xref>]</td><td></td><td></td><td></td><td></td><td></td><td></td></tr></tbody></table><table-wrap-foot><p><sup>♦</sup> Studies using NPs at human relevant doses</p></table-wrap-foot></table-wrap><table-wrap id="Tab2"><label>Table 2</label><caption><p>In vitro studies exploring the impact of NPs on human microbiota</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th>Ag-NP</th><th>TiO<sub>2</sub>-NP</th></tr></thead><tbody><tr><td>Duration (days)</td><td>2</td><td>2</td></tr><tr><td colspan="3">Bacteroidetes</td></tr><tr><td><italic>Bacteroides ovatus</italic></td><td>↙[<xref ref-type="bibr" rid="CR112">112</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR113">113</xref>]</td></tr><tr><td colspan="3">Firmicutes</td></tr><tr><td><italic>Acidaminococcus intestini</italic></td><td></td><td>↗[<xref ref-type="bibr" rid="CR113">113</xref>]</td></tr><tr><td><italic>Clostridium cocleatum</italic></td><td></td><td>↗[<xref ref-type="bibr" rid="CR113">113</xref>]</td></tr><tr><td><italic>Eubacterium rectale</italic></td><td>↙[<xref ref-type="bibr" rid="CR112">112</xref>]</td><td>↗[<xref ref-type="bibr" rid="CR113">113</xref>]</td></tr><tr><td><italic>Eubacterium ventriosum</italic></td><td></td><td>↗[<xref ref-type="bibr" rid="CR113">113</xref>]</td></tr><tr><td><italic>Faecalibacterium prausnitzii</italic></td><td>↙[<xref ref-type="bibr" rid="CR112">112</xref>]</td><td></td></tr><tr><td><italic>Roseburia faecalis</italic></td><td>↙[<xref ref-type="bibr" rid="CR112">112</xref>]</td><td></td></tr><tr><td><italic>Roseburia intestinalis</italic></td><td>↙[<xref ref-type="bibr" rid="CR112">112</xref>]</td><td></td></tr><tr><td><italic>Ruminococcus torques</italic></td><td>↙[<xref ref-type="bibr" rid="CR112">112</xref>]</td><td></td></tr><tr><td colspan="3">Proteobacteria</td></tr><tr><td><italic>Escherichia coli</italic></td><td>↗[<xref ref-type="bibr" rid="CR112">112</xref>]</td><td></td></tr><tr><td><italic>Raoultella (sp)</italic></td><td>↗[<xref ref-type="bibr" rid="CR112">112</xref>]</td><td></td></tr></tbody></table></table-wrap></p>
<sec id="Sec7">
<title>Impacts of nano-silver and titanium dioxide</title>
<p id="Par55">Regarding Ag-NPs, several studies were first performed in rats or mice using high concentrations (up to 36 mg/kg bw/d) compared to human dietary levels (0.03 to 0.65 μg/kg bw/d [<xref ref-type="bibr" rid="CR22">22</xref>]) and with different methods of administration (gavage, addition to drinking water or incorporation into food pellets) and/or exposure times (between 7 and 90 days). Contradictory results were reported, with some studies showing no impact on microbiota ecology and activity and, others revealing profound alterations. Indeed, two studies in rats and mice (9 and 10 mg/kg bw/d, respectively) showed non-significant alterations in the caecal microbiota composition following 28 days of oral exposure to Ag-NPs (stabilized with polyvinylpyrolidone or citrate), regardless of particle size (14, 20 and 110 nm) [<xref ref-type="bibr" rid="CR114">114</xref>, <xref ref-type="bibr" rid="CR115">115</xref>]. In contrast, rats chronically exposed for 13 weeks to Ag-NPs (10, 75 and 110 nm at 9, 18 and 36 mg/kg bw/d) showed a shift in their ileal microbial populations towards increased proportions of Bacteroidetes and pathogenic gram-negative bacteria, and decreased proportions of Firmicutes, <italic>Lactobacillus</italic> and <italic>Bifidobacterium</italic> [<xref ref-type="bibr" rid="CR105">105</xref>]. These effects on <italic>Lactobacillus</italic> and Bacteroidetes appeared to be more prominent in males than in females, whereas the increased proportion of Enterobacteria was higher in female rats [<xref ref-type="bibr" rid="CR105">105</xref>]. In addition to the dose of exposure, authors considered NP size as an influencing factor on host gene expression, but the heterogeneity of the results does not allow to fully conclude on a size and/or dose effect of Ag-NPs [<xref ref-type="bibr" rid="CR105">105</xref>]. The shift in the Firmicutes/Bacteroidetes (F/B) ratio has been confirmed in the faecal microbiota of rats and mice orally given Ag-NPs at 2.5 or 3.6 mg/kg bw/d for 7 days or 2 weeks, respectively [<xref ref-type="bibr" rid="CR106">106</xref>, <xref ref-type="bibr" rid="CR107">107</xref>]. Notably, these authors concluded that microbiota alterations depend on the shapes of Ag-NPs [<xref ref-type="bibr" rid="CR106">106</xref>], suggesting that NPs structure (which affects the surface-to-volume ratio) could determine the reactivity with gut bacteria. Finally, a shift in the F/B ratio in the faecal microbiota has been reported in mice orally exposed for 28 days to food supplemented with relevant doses of Ag-NPs for human intake [<xref ref-type="bibr" rid="CR108">108</xref>]. The authors noted that these gut microbiota alterations did not occur when mice were fed aged food pellets due to sulfidation of Ag-NPs in contact with the sulfur-containing food matrix [<xref ref-type="bibr" rid="CR108">108</xref>]. Because Ag sulfidation limits the release of the toxic Ag<sup>+</sup> ions responsible for antimicrobial effects, one may hypothesize that this ageing mechanism could contribute to the aforementioned discrepancies in rodent studies. Some differences in terms of gut microbiota alterations might also be due to differences in NP doses, durations of treatment, microbiota sampling sites along the rodent intestine (i.e., small bowel or more distal regions in the caecum or colon), and the methods and analysis techniques used to determine bacterial composition. Regarding the sampling site, the faecal samples from the distal colon should remain the predominant material for microbial community analysis in toxicity testings with NPs, because this region is characterized by a low transit time making reservoir for NP accumulation after chronic exposure, as reported in rats daily treated with E171 [<xref ref-type="bibr" rid="CR116">116</xref>], with expected stable impacts on the microbiome.</p>
<p id="Par56">Although the impacts of Ag-NP ingestion on the rodent microbiota are well documented, their effects on the human microbiota remain to be fully characterized. Only one study has determined, in vitro, the short-term impacts of Ag-NPs on a defined human bacterial community called microbial ecosystem therapeutic-1 (MET-1, consisting of 33 bacterial strains, established from stool obtained from a healthy donor) [<xref ref-type="bibr" rid="CR112">112</xref>]. The authors observed a reduction in culture-generated gas production and changes in fatty acid methyl ester profiles after 48 h of exposure to several concentrations of Ag-NPs (0–200 mg/L) [<xref ref-type="bibr" rid="CR112">112</xref>]. Microbiota sequencing confirmed alterations in bacterial composition, characterized by decreased abundances of <italic>Bacteroides ovatus</italic>, <italic>F. prausnitzii</italic>, <italic>Roseburia faecalis</italic>, <italic>Roseburia intestinalis</italic>, <italic>Eubacterium rectale</italic> and <italic>Ruminococcus torques</italic>, and increased proportions of <italic>Raoultella</italic> sp. and of <italic>E. coli</italic>, i.e., a negative shift in the microbial community that favours the growth of pathogenic bacteria [<xref ref-type="bibr" rid="CR112">112</xref>].</p>
<p id="Par57">The same bacterial community, MET-1, has also been used in a custom colon reactor to determine the impact on the human microbiota of TiO<sub>2</sub>-NPs and different food-grade TiO<sub>2</sub> formulations (the E171 food additive in EU) [<xref ref-type="bibr" rid="CR113">113</xref>]. A minor effect on bacterial ecology, restricted to a decrease in <italic>B. ovatus</italic> in favour of <italic>Clostridium cocleatum</italic>, was reported after 48 h of TiO<sub>2</sub> treatment [<xref ref-type="bibr" rid="CR113">113</xref>]. However, using long exposure times in vitro (5 days) at environmentally relevant concentrations, significant changes in bacterial metabolites were observed in the human colon microbiome, including in SCFA production [<xref ref-type="bibr" rid="CR117">117</xref>]. To date, whether the effect of TiO<sub>2</sub> (on phyla, strains and/or metabolic activity) could occur in vivo at dietary levels for humans has remained poorly studied. Nevertheless, oral bioavailability studies in rodents and humans clearly showed very limited systemic absorption of TiO<sub>2</sub> (0.1 to 0.6% of the initial dose, respectively) [<xref ref-type="bibr" rid="CR118">118</xref>, <xref ref-type="bibr" rid="CR119">119</xref>]. This finding indicates that at least 99% of the ingested TiO<sub>2</sub> matter accumulates in the lumen of the gut with the commensals in permanent contact with the particles, especially due to repeated exposure, with the potential for alterations in the growth profiles of bacteria as shown in vitro for E171 [<xref ref-type="bibr" rid="CR8">8</xref>]. Mice exposed for one week to TiO<sub>2</sub>-NPs at a relevant dose for humans (2.5 mg/kg bw/d) did not reveal any changes in the faecal microbiota composition [<xref ref-type="bibr" rid="CR107">107</xref>]. However, an increased proportion of potentially harmful Actinobacteria and Proteobacteria and a decrease in the abundance of beneficial Firmicutes and Bacteroidetes were observed in the same region after 28 days of oral treatment, but at higher dosage (100 mg/kg bw/d) [<xref ref-type="bibr" rid="CR104">104</xref>]. Currently, due to the absence of specific tests for assessing NP-related changes in the composition and activity of the gut microbiota, it is important to elucidate the potential induction of dysbiosis by TiO<sub>2</sub>-NPs to perform these examinations at appropriate doses and over long periods for relevant dietary exposure models.</p>
</sec>
<sec id="Sec8">
<title>Impacts of zinc oxide and silicon dioxide</title>
<p id="Par58">Zinc oxide NPs exhibit potent antimicrobial activity on various non-intestinal microorganisms. ZnO is currently listed as a generally recognized as safe (GRAS) material by the Food and Drug Administration and is commonly used as food supplement or in food packaging. Due to a widespread use to enhance the bioavailability of zinc in the body, these metal particles are good candidates for NP-induced intestinal dysbiosis, but this aspect has been poorly explored to date. Most of the available studies have been conducted using the microbiota from piglets and hens due to efficient functioning of ZnO to promote growth and relieve diarrhoea in livestock animals [<xref ref-type="bibr" rid="CR120">120</xref>]. The ingestion of ZnO-NPs at 600 mg/kg for 14 days increased the bacterial richness and diversity in the ileum of piglets, while these parameters decreased in both caecum and colon [<xref ref-type="bibr" rid="CR109">109</xref>]. Nevertheless, the authors observed different effects on microbiota composition according to the collection sites along the GI tract. An increased abundance of <italic>Streptococcus</italic> concomitant with a decreased proportion of <italic>Lactobacillus</italic> was observed in the ileum, while the abundance of <italic>Lactobacillus</italic> increased and the abundance of <italic>Oscillospira</italic> and <italic>Prevotella</italic> decreased in the colon [<xref ref-type="bibr" rid="CR109">109</xref>]. In hens, gene-sequencing analysis of the 16S rRNA of the ileal digesta microbiota showed that the richness of the bacterial community decreased in a dose-dependent manner (25, 50 and 100 mg/kg for 9 weeks), with increased populations of Bacteroidetes, Fusobacteria and Bacilli and decreased populations of Proteobacteria and <italic>Lactobacillus</italic> [<xref ref-type="bibr" rid="CR111">111</xref>]. Moreover, blood metabolite analysis clearly indicated a positive correlation between the richness of the microbiota and choline, lactate and methionine metabolism, suggesting an impact of ZnO-NPs on bacterial metabolic activity [<xref ref-type="bibr" rid="CR111">111</xref>]<italic>.</italic> These observations are consistent with those of another study that showed decreased abundance of the SCFA-producing <italic>Lactobacillus</italic> in the caecum of broiler chickens fed ZnO-NPs at 5 mg/kg of feed for 42 days [<xref ref-type="bibr" rid="CR110">110</xref>]. One study focused on the human faecal microbiota isolated from a healthy donor confirmed the impacts of ZnO-NPs on the metabolic activity of the gut microbiota, impairing the production capacity of SCFAs as well as extracellular polymeric substances (i.e., polysaccharides, proteins, lipids, and extracellular DNA secreted by bacteria in protective biofilms) [<xref ref-type="bibr" rid="CR117">117</xref>]. Overall, these studies showed that oral ingestion of ZnO-NPs can lead to changes in both the composition and metabolic activity of the intestinal microbiota, the main feature being decreased abundance of the genus <italic>Lactobacillus</italic> regardless of the animal model. Finally, with regard to non-metal NPs without well-known biocidal properties, one study in mice exposed to SiO<sub>2</sub>-NPs for one week at relevant dose for humans (2.5 mg/kg bw/d) reported enrichment and increased diversity of microbial species, with increased populations of Firmicutes and Proteobacteria and decreased proportion of Bacteroidetes and <italic>Lactobacillus</italic> [<xref ref-type="bibr" rid="CR107">107</xref>]. Such an unexpected effect should be taken into consideration for risk assessment in the context of the low absorption rate in the human GI tract for precipitated or fumed (amorphous) silicate (E551) [<xref ref-type="bibr" rid="CR28">28</xref>], leading to gut lumen accumulation.</p>
</sec>
</sec>
<sec id="Sec9">
<title>Microbiota-immune system dysfunction in chronic diseases: could inorganic NPs favour host vulnerability?</title>
<sec id="Sec10">
<title>NP-related GALT dysfunctions as possible inducers of disease development</title>
<p id="Par59">Despite several in vitro studies highlighting the variety of immunotoxic effects of TiO<sub>2</sub>-NPs, SiO<sub>2</sub>-NPs, Ag-NPs and ZnO-NPs (Table <xref ref-type="table" rid="Tab3">3</xref>) on bone marrow-derived cells and systemic and pulmonary immune cells [<xref ref-type="bibr" rid="CR121">121</xref>–<xref ref-type="bibr" rid="CR151">151</xref>], the potential impact of these NPs on GALT functions and consequences for the host remain poorly documented. From a risk perspective, current challenges include the determination of whether NP-related dysbiosis and immune dysfunction may increase the susceptibility to chronic diseases in humans where disruption of the microbiota-GALT crosstalk is central to pathogenesis, such as in CRC, obesity and IBD [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR152">152</xref>, <xref ref-type="bibr" rid="CR153">153</xref>]. IBD, namely Crohn’s disease and ulcerative colitis, are chronic relapsing disorders of multifactorial aetiology characterized by intestinal dysbiosis and severe mucosal inflammation with epithelial injuries. In addition, gut dysbiosis and low-grade inflammation of the intestinal mucosa are often viewed as contributors to CRC and obesity [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR152">152</xref>, <xref ref-type="bibr" rid="CR153">153</xref>]. Notably, micro- and nano-particles have been found in colon biopsies of patients with IBD and CRC, whereas the absence of these particles is consistently reported in the colon of healthy subjects [<xref ref-type="bibr" rid="CR154">154</xref>]. Again, blood titanium (Ti) levels are high in IBD patients [<xref ref-type="bibr" rid="CR155">155</xref>], and TiO<sub>2</sub> particles of dietary origin were shown to be accumulated in PPs of IBD patients [<xref ref-type="bibr" rid="CR156">156</xref>], including infants [<xref ref-type="bibr" rid="CR157">157</xref>]. Such localization is consistent with data from studies in rats and mice that commonly report bioaccumulation of Ti, Ag or silicon (Si) in the ileum (including PPs) and the colon as a result of repeated oral treatment with TiO<sub>2</sub>-NPs (or E171) [<xref ref-type="bibr" rid="CR107">107</xref>, <xref ref-type="bibr" rid="CR116">116</xref>, <xref ref-type="bibr" rid="CR158">158</xref>, <xref ref-type="bibr" rid="CR159">159</xref>], nano-Ag [<xref ref-type="bibr" rid="CR160">160</xref>] or SiO<sub>2</sub>-NPs [<xref ref-type="bibr" rid="CR107">107</xref>], respectively. In the colon of rats chronically exposed for 100 days to food-grade TiO<sub>2</sub> (E171) at a relevant dose for humans (i.e., 10 mg/kg bw/d), a micro-inflammatory state of the mucosa has been demonstrated [<xref ref-type="bibr" rid="CR116">116</xref>]. Using a ten-fold higher dosage, another study in mice exposed to TiO<sub>2</sub> particle models (nano- and microsized) found increased production of Th1 pro-inflammatory cytokines (tumour necrosis factor alpha (TNF-α), interferon-gamma (IFN-γ), IL-12) and of the Th2 cytokine IL-4 in the mucosa of the small intestine after 10 days of exposure [<xref ref-type="bibr" rid="CR161">161</xref>]. Inflammation associated with other immune system disturbances has also been observed following the ingestion of SiO<sub>2</sub>-NPs [<xref ref-type="bibr" rid="CR107">107</xref>, <xref ref-type="bibr" rid="CR162">162</xref>] and Ag-NPs [<xref ref-type="bibr" rid="CR107">107</xref>, <xref ref-type="bibr" rid="CR163">163</xref>], including impairment of oral tolerance mechanisms to food proteins and bacterial antigens present in the gut lumen [<xref ref-type="bibr" rid="CR162">162</xref>, <xref ref-type="bibr" rid="CR163">163</xref>]. Furthermore, IBD-like symptoms, including intestinal upregulation of pro-inflammatory cytokines, were notably induced in mice treated with Ag-NPs at 2.5 mg/kg bw/d for 7 days [<xref ref-type="bibr" rid="CR107">107</xref>]. Again, oral administration of TiO<sub>2</sub>-NPs worsened existing gut inflammation in a mouse model of acute colitis through activation of the inflammasome [<xref ref-type="bibr" rid="CR155">155</xref>]. As an exception, the intestinal expression of pro-inflammatory genes was decreased in piglets exposed orally to ZnO-NPs for 2 weeks [<xref ref-type="bibr" rid="CR109">109</xref>], which is consistent with ZnO-NPs exhibiting markedly dose-dependent effects on the remission of experimental colitis in mice [<xref ref-type="bibr" rid="CR164">164</xref>].
<table-wrap id="Tab3"><label>Table 3</label><caption><p>In vitro studies on immunological properties of NPs</p></caption><table frame="hsides" rules="groups"><thead><tr><th>NPs</th><th>cell response</th><th>cell frequence/activity</th><th>Potential effect</th></tr></thead><tbody><tr><td rowspan="9">TiO2 (6-48 h)</td><td><bold>↗</bold> oxidative stress (ROS) [<xref ref-type="bibr" rid="CR121">121</xref>–<xref ref-type="bibr" rid="CR125">125</xref>]</td><td><bold>↗</bold> DC, μɸ, lymphocytes [<xref ref-type="bibr" rid="CR121">121</xref>, <xref ref-type="bibr" rid="CR122">122</xref>, <xref ref-type="bibr" rid="CR126">126</xref>]</td><td>Innate inflammatory response [<xref ref-type="bibr" rid="CR122">122</xref>, <xref ref-type="bibr" rid="CR126">126</xref>–<xref ref-type="bibr" rid="CR128">128</xref>]</td></tr><tr><td><bold>↗</bold> expression of TLR (TLR3, TLR4, TLR7 and TLR10) [<xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR128">128</xref>]</td><td><bold>↗</bold> naïve T cells [<xref ref-type="bibr" rid="CR122">122</xref>]</td><td>Cytotoxicity and inflammation [<xref ref-type="bibr" rid="CR122">122</xref>, <xref ref-type="bibr" rid="CR123">123</xref>, <xref ref-type="bibr" rid="CR125">125</xref>, <xref ref-type="bibr" rid="CR129">129</xref>]</td></tr><tr><td><bold>↗</bold> pro-inflammatory cytokines (IL-6, TNF-α, IL1-β) [<xref ref-type="bibr" rid="CR121">121</xref>–<xref ref-type="bibr" rid="CR123">123</xref>, <xref ref-type="bibr" rid="CR127">127</xref>, <xref ref-type="bibr" rid="CR130">130</xref>–<xref ref-type="bibr" rid="CR132">132</xref>]</td><td><bold>↗</bold> mature DC [<xref ref-type="bibr" rid="CR122">122</xref>, <xref ref-type="bibr" rid="CR131">131</xref>, <xref ref-type="bibr" rid="CR132">132</xref>]</td><td>Adjuvant [<xref ref-type="bibr" rid="CR121">121</xref>, <xref ref-type="bibr" rid="CR130">130</xref>–<xref ref-type="bibr" rid="CR132">132</xref>]</td></tr><tr><td><bold>↗</bold> chemokines secretion (IL-8 and CXCL1) <bold>↙</bold> activity (IL-8) [<xref ref-type="bibr" rid="CR122">122</xref>, <xref ref-type="bibr" rid="CR133">133</xref>]</td><td><bold>↗</bold> mast cell activation [<xref ref-type="bibr" rid="CR134">134</xref>]</td><td>Allergic response [<xref ref-type="bibr" rid="CR134">134</xref>, <xref ref-type="bibr" rid="CR135">135</xref>]</td></tr><tr><td><bold>↗</bold> co-stimulatory molecules (CD80 and CD86) [<xref ref-type="bibr" rid="CR122">122</xref>, <xref ref-type="bibr" rid="CR123">123</xref>, <xref ref-type="bibr" rid="CR131">131</xref>, <xref ref-type="bibr" rid="CR132">132</xref>]</td><td><bold>↙</bold> neutrophil and μɸ mobility [<xref ref-type="bibr" rid="CR133">133</xref>]</td><td>Tissue damage [<xref ref-type="bibr" rid="CR124">124</xref>, <xref ref-type="bibr" rid="CR133">133</xref>]</td></tr><tr><td><bold>↗</bold> MPO, MMP-9 and NET [<xref ref-type="bibr" rid="CR124">124</xref>, <xref ref-type="bibr" rid="CR136">136</xref>]</td><td><bold>↗</bold> neutrophil activity [<xref ref-type="bibr" rid="CR124">124</xref>, <xref ref-type="bibr" rid="CR136">136</xref>]</td><td>NETosis: inflammation, necrosis and apoptosis [<xref ref-type="bibr" rid="CR124">124</xref>]</td></tr><tr><td><bold>↗</bold> β-hexosaminidase release [<xref ref-type="bibr" rid="CR134">134</xref>]</td><td></td><td></td></tr><tr><td>inflammasome activation [<xref ref-type="bibr" rid="CR123">123</xref>]</td><td></td><td></td></tr><tr><td>activation of NFkB pathway [<xref ref-type="bibr" rid="CR128">128</xref>, <xref ref-type="bibr" rid="CR131">131</xref>]</td><td></td><td></td></tr><tr><td rowspan="8">SiO2 (6-48 h)</td><td><bold>↗</bold> apoptose [<xref ref-type="bibr" rid="CR123">123</xref>, <xref ref-type="bibr" rid="CR125">125</xref>, <xref ref-type="bibr" rid="CR137">137</xref>, <xref ref-type="bibr" rid="CR138">138</xref>]</td><td><bold>↙</bold> DC and lymphocytes [<xref ref-type="bibr" rid="CR123">123</xref>, <xref ref-type="bibr" rid="CR137">137</xref>, <xref ref-type="bibr" rid="CR138">138</xref>]</td><td>Imbalance of immune response [<xref ref-type="bibr" rid="CR125">125</xref>, <xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR137">137</xref>–<xref ref-type="bibr" rid="CR140">140</xref>]</td></tr><tr><td><bold>↗</bold> pro inflammatory cytokines (IL1-β, IL-2, TNF-α) [<xref ref-type="bibr" rid="CR121">121</xref>, <xref ref-type="bibr" rid="CR123">123</xref>, <xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR138">138</xref>, <xref ref-type="bibr" rid="CR139">139</xref>, <xref ref-type="bibr" rid="CR141">141</xref>]</td><td><bold>↗</bold> DC maturation [<xref ref-type="bibr" rid="CR123">123</xref>, <xref ref-type="bibr" rid="CR139">139</xref>]</td><td>Immunogenic or adjuvant potential [<xref ref-type="bibr" rid="CR121">121</xref>, <xref ref-type="bibr" rid="CR123">123</xref>, <xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR140">140</xref>, <xref ref-type="bibr" rid="CR141">141</xref>]</td></tr><tr><td><bold>↗</bold> CD80, CD86 and MHCII [<xref ref-type="bibr" rid="CR123">123</xref>, <xref ref-type="bibr" rid="CR138">138</xref>, <xref ref-type="bibr" rid="CR139">139</xref>]</td><td><bold>↗</bold> M1 μɸ polarization [<xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR140">140</xref>]</td><td>Inflammation [<xref ref-type="bibr" rid="CR121">121</xref>, <xref ref-type="bibr" rid="CR123">123</xref>, <xref ref-type="bibr" rid="CR125">125</xref>, <xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR137">137</xref>–<xref ref-type="bibr" rid="CR141">141</xref>]</td></tr><tr><td><bold>↙</bold> TLR9 expression [<xref ref-type="bibr" rid="CR126">126</xref>]</td><td><bold>↗</bold> neutrophil activity [<xref ref-type="bibr" rid="CR142">142</xref>]</td><td><bold>↗</bold> Susceptibility IBD [<xref ref-type="bibr" rid="CR123">123</xref>, <xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR140">140</xref>], autoimmune diseases [<xref ref-type="bibr" rid="CR139">139</xref>, <xref ref-type="bibr" rid="CR140">140</xref>]</td></tr><tr><td><bold>↗</bold> oxidative stress (ROS) [<xref ref-type="bibr" rid="CR125">125</xref>]</td><td><bold>↗</bold> cross-presentation [<xref ref-type="bibr" rid="CR141">141</xref>]</td><td>NETosis: inflammation, necrosis and apoptosis [<xref ref-type="bibr" rid="CR142">142</xref>]</td></tr><tr><td>inflammasome activation [<xref ref-type="bibr" rid="CR123">123</xref>]</td><td></td><td>Cytotoxic effect [<xref ref-type="bibr" rid="CR121">121</xref>, <xref ref-type="bibr" rid="CR123">123</xref>, <xref ref-type="bibr" rid="CR125">125</xref>, <xref ref-type="bibr" rid="CR137">137</xref>, <xref ref-type="bibr" rid="CR138">138</xref>, <xref ref-type="bibr" rid="CR140">140</xref>]</td></tr><tr><td>NFkB activation [<xref ref-type="bibr" rid="CR138">138</xref>]</td><td></td><td>Susceptibility to infection [<xref ref-type="bibr" rid="CR126">126</xref>]</td></tr><tr><td><bold>↗</bold> DNA release – NET [<xref ref-type="bibr" rid="CR142">142</xref>]</td><td></td><td>Allergic response [<xref ref-type="bibr" rid="CR135">135</xref>]</td></tr><tr><td rowspan="7">ZnO (6-48 h)</td><td><bold>↗</bold> pro inflammatory cytokines (IL-1β, TNF-α, IL-6, IFN-ɣ) [<xref ref-type="bibr" rid="CR125">125</xref>, <xref ref-type="bibr" rid="CR130">130</xref>, <xref ref-type="bibr" rid="CR143">143</xref>, <xref ref-type="bibr" rid="CR144">144</xref>]</td><td><bold>↗</bold> DC activity [<xref ref-type="bibr" rid="CR130">130</xref>, <xref ref-type="bibr" rid="CR145">145</xref>]</td><td>Cytotoxicity and inflammation [<xref ref-type="bibr" rid="CR125">125</xref>, <xref ref-type="bibr" rid="CR129">129</xref>, <xref ref-type="bibr" rid="CR130">130</xref>, <xref ref-type="bibr" rid="CR134">134</xref>, <xref ref-type="bibr" rid="CR143">143</xref>, <xref ref-type="bibr" rid="CR146">146</xref>]</td></tr><tr><td><bold>↗</bold> chemokines secretion (IL-8, CXCL9) [<xref ref-type="bibr" rid="CR130">130</xref>, <xref ref-type="bibr" rid="CR144">144</xref>]</td><td><bold>↙</bold> Lymphocytes [<xref ref-type="bibr" rid="CR146">146</xref>]</td><td>Imbalance of immune response [<xref ref-type="bibr" rid="CR125">125</xref>, <xref ref-type="bibr" rid="CR129">129</xref>, <xref ref-type="bibr" rid="CR130">130</xref>, <xref ref-type="bibr" rid="CR143">143</xref>, <xref ref-type="bibr" rid="CR144">144</xref>]</td></tr><tr><td><bold>↗</bold> oxidative stress (ROS) [<xref ref-type="bibr" rid="CR125">125</xref>, <xref ref-type="bibr" rid="CR145">145</xref>]</td><td><bold>↗</bold> neutrophil functions [<xref ref-type="bibr" rid="CR136">136</xref>]</td><td>Chronic pathologies [<xref ref-type="bibr" rid="CR143">143</xref>]</td></tr><tr><td>induces neo-synthesis of polypeptides [<xref ref-type="bibr" rid="CR144">144</xref>]</td><td><bold>↙</bold> mast cell activation [<xref ref-type="bibr" rid="CR134">134</xref>]</td><td>Allergenic response [<xref ref-type="bibr" rid="CR134">134</xref>, <xref ref-type="bibr" rid="CR135">135</xref>]</td></tr><tr><td><bold>↙</bold> or <bold>↗</bold> apoptose [<xref ref-type="bibr" rid="CR125">125</xref>, <xref ref-type="bibr" rid="CR129">129</xref>, <xref ref-type="bibr" rid="CR130">130</xref>, <xref ref-type="bibr" rid="CR144">144</xref>]</td><td><bold>↗</bold> eosinophils [<xref ref-type="bibr" rid="CR144">144</xref>]</td><td>Protective effect [<xref ref-type="bibr" rid="CR134">134</xref>, <xref ref-type="bibr" rid="CR144">144</xref>]</td></tr><tr><td><bold>↗</bold> DNA damage [<xref ref-type="bibr" rid="CR125">125</xref>, <xref ref-type="bibr" rid="CR129">129</xref>, <xref ref-type="bibr" rid="CR146">146</xref>]</td><td></td><td>Genomic instability [<xref ref-type="bibr" rid="CR146">146</xref>]</td></tr><tr><td><bold>↙</bold> β-hexosaminidase and histamine release [<xref ref-type="bibr" rid="CR134">134</xref>]</td><td></td><td>Cell cycle imbalanced [<xref ref-type="bibr" rid="CR125">125</xref>]</td></tr><tr><td rowspan="5">Ag (6-48 h)</td><td><bold>↗</bold> oxidative stress (ROS) [<xref ref-type="bibr" rid="CR147">147</xref>–<xref ref-type="bibr" rid="CR149">149</xref>]</td><td><bold>↙</bold> μɸ, lymphocyte [<xref ref-type="bibr" rid="CR147">147</xref>–<xref ref-type="bibr" rid="CR149">149</xref>]</td><td>Apoptosis and cytotoxicity [<xref ref-type="bibr" rid="CR147">147</xref>–<xref ref-type="bibr" rid="CR149">149</xref>]</td></tr><tr><td><bold>↗</bold> DNA damage [<xref ref-type="bibr" rid="CR148">148</xref>]</td><td><bold>↗</bold> mast cell activation [<xref ref-type="bibr" rid="CR135">135</xref>, <xref ref-type="bibr" rid="CR150">150</xref>, <xref ref-type="bibr" rid="CR151">151</xref>]</td><td>Inflammation/imbalance of immune response [<xref ref-type="bibr" rid="CR147">147</xref>–<xref ref-type="bibr" rid="CR149">149</xref>]</td></tr><tr><td><bold>↗</bold> pro inflammatory cytokines (IL-1β, TNF-α) [<xref ref-type="bibr" rid="CR147">147</xref>, <xref ref-type="bibr" rid="CR149">149</xref>]</td><td></td><td>Allergic response [<xref ref-type="bibr" rid="CR135">135</xref>, <xref ref-type="bibr" rid="CR150">150</xref>, <xref ref-type="bibr" rid="CR151">151</xref>]</td></tr><tr><td>inflammasome activation [<xref ref-type="bibr" rid="CR147">147</xref>]</td><td></td><td></td></tr><tr><td><bold>↗</bold> β-hexosaminidase release [<xref ref-type="bibr" rid="CR135">135</xref>, <xref ref-type="bibr" rid="CR150">150</xref>, <xref ref-type="bibr" rid="CR151">151</xref>]</td><td></td><td></td></tr></tbody></table><table-wrap-foot><p><italic>CD</italic> Cluster of differentiation, <italic>CXCL1</italic> chemokine ligand 1, <italic>DC</italic> dendritic cell, <italic>IBD</italic> Inflammatory bowel disease, <italic>Ig</italic> immunoglobulin, <italic>IL</italic> interleukin, <italic>μɸ</italic> macrophage, <italic>MHCII</italic> major histocompatibility complex II, <italic>MMP-9</italic> matrix metalloproteinase 9, <italic>MPO</italic> myeloperoxidase, <italic>NET</italic> Neutrophil extracellular trap, <italic>NFkB</italic> nuclear factor-kappa B, <italic>ROS</italic> reactive oxygen species, <italic>TLR</italic> Toll-like receptor</p></table-wrap-foot></table-wrap></p>
<p id="Par60">Taken together, these data highlight the considerable impact of TiO<sub>2</sub>-NPs, Ag-NPs and SiO<sub>2</sub>-NPs on the modulation of the immune response in vivo (Table <xref ref-type="table" rid="Tab4">4</xref>) [<xref ref-type="bibr" rid="CR105">105</xref>, <xref ref-type="bibr" rid="CR116">116</xref>, <xref ref-type="bibr" rid="CR161">161</xref>–<xref ref-type="bibr" rid="CR163">163</xref>, <xref ref-type="bibr" rid="CR165">165</xref>–<xref ref-type="bibr" rid="CR170">170</xref>], which may in turn modulate the microbiota. Indeed, recent studies in mice have shown a number of immune deficiencies evoking intestinal dysbiosis in ways that predispose to disease. For example, mice lacking the caspase recruitment domain 9 (<italic>Card9</italic><sup>−/−</sup>, a key adapter protein for innate immunity against a wide range of microorganisms) developed colitis in a microbiota-dependent manner [<xref ref-type="bibr" rid="CR74">74</xref>]. Remarkably, this colitis phenotype was transmissible to WT mice via transfer of the <italic>Card9</italic><sup>−/−</sup> microbiota and was rescued after inoculation with <italic>Lactobacillus</italic> strains [<xref ref-type="bibr" rid="CR74">74</xref>]. Similarly, immune-driven dysbiosis was demonstrated in mice lacking Toll-like receptor 5 (<italic>Tlr5</italic><sup>−/−</sup>), which detects bacterial flagellin. The mice exhibit an altered microbiota associated with metabolic disorders characterized by insulin resistance, hyperlipidaemia and increased fat deposition, and all these markers were also observed in WT mice colonized with the gut microbiota of Tlr5-deficient mice [<xref ref-type="bibr" rid="CR171">171</xref>]. By describing the key role of the local immune system in controlling the composition and activity of the microbiota, these data support the idea that the strong interactions between NPs and GALT can also shape the microbiota of exposed individuals (Fig. <xref ref-type="fig" rid="Fig2">2</xref>).
<table-wrap id="Tab4"><label>Table 4</label><caption><p><italic>In vivo</italic> studies on immunological properties of NPs</p></caption><table frame="hsides" rules="groups"><thead><tr><th>NPs</th><th>Time</th><th>Cell response</th><th>Cell frequency/activity</th><th>Dose range</th><th>Potential effect</th><th>Ref</th></tr></thead><tbody><tr><td rowspan="10">TiO<sub>2</sub></td><td rowspan="5">1 -14 d</td><td rowspan="3">↗ IFN-ɣ and IL-17 in spleen</td><td>↗ Th17 and Th1 in spleen</td><td rowspan="3"><bold>10</bold> mg/kg bw/d</td><td>inflammation</td><td rowspan="3">[<xref ref-type="bibr" rid="CR116">116</xref>]</td></tr><tr><td>↗ DC frequency in PP</td><td>imbalance immune response</td></tr><tr><td>↙ Treg and T helper cells in PP</td><td>immunossuppression</td></tr><tr><td><p>↗ inflammatory cytokines in ileum</p><p>(IL-12, IL-4, IL-23, TNF-α, IFN-γ)</p></td><td>↗ T cells CD4<sup>+</sup> in small intestin</td><td>100 mg/kg bw/d</td><td>inflammation</td><td>[<xref ref-type="bibr" rid="CR161">161</xref>]</td></tr><tr><td></td><td></td><td>5 g/kg bw (single oral gavage)</td><td>no toxic effects</td><td>[<xref ref-type="bibr" rid="CR165">165</xref>]</td></tr><tr><td rowspan="5">&gt; 28 d</td><td>↗ TNF-α, IL-10 and IL-8 in colon</td><td>↙ Treg and T helper cells in PP</td><td><bold>10</bold> mg/kg bw/d</td><td>risk of preneoplasic lesions in colon</td><td>[<xref ref-type="bibr" rid="CR116">116</xref>]</td></tr><tr><td rowspan="2"><p>↗ IL-6, TNF-α, IL1-β in ovary</p><p>(expression and production)</p></td><td rowspan="2">↙ white cells and lymphocytes in blood</td><td rowspan="2"><bold>2.5; 5; 10</bold> mg/kg bw/d</td><td>inflammation and follicule atresia</td><td rowspan="2">[<xref ref-type="bibr" rid="CR166">166</xref>]</td></tr><tr><td>fertility reduction</td></tr><tr><td rowspan="2">↗ glucose in blood of young rats</td><td rowspan="2">↗ mast cells activation in stomach</td><td rowspan="2"><bold>10</bold>, 50, 200 mg/kg bw/d</td><td>alteration of gastrointestinal functions</td><td rowspan="2">[<xref ref-type="bibr" rid="CR167">167</xref>]</td></tr><tr><td>Heart, Liver and Kidney injuries</td></tr><tr><td rowspan="6">SiO<sub>2</sub></td><td rowspan="5">7 -14 d</td><td rowspan="3"><p>↙ inflammatory cytokines in blood</p><p>(IL1-β, TNF-α, IL-12p70, IL-6 and IFN-ɣ)</p></td><td>↙ Natural Killer acitivity in spleen</td><td rowspan="3">750 mg/kg bw/d</td><td>immunossuppression</td><td rowspan="3">[<xref ref-type="bibr" rid="CR168">168</xref>]</td></tr><tr><td>↙ T cells and B cells proliferation in spleen</td><td>dysregulation of immune response</td></tr><tr><td>↙ Lymphocytes population in blood</td><td></td></tr><tr><td>↗ IgG and IgE in blood</td><td rowspan="2">↗ splenocyte proliferation</td><td rowspan="2"><bold>0.1</bold>; 1; 10 mg/mouse/d</td><td>imbalance immune response (dose dependent)</td><td rowspan="2">[<xref ref-type="bibr" rid="CR162">162</xref>]</td></tr><tr><td><p>↗ inflammatory cytokines in spleen</p><p>(INF-ɣ, IL-4, IL-5 and IL-17)</p></td><td>risk of food allergy development</td></tr><tr><td>≥ 28 d</td><td></td><td>slight ↗ lymphocytes in blood</td><td>2.5 mg/mouse/d</td><td>no effect</td><td>[<xref ref-type="bibr" rid="CR169">169</xref>]</td></tr><tr><td rowspan="6">Ag</td><td rowspan="2">7-14 d</td><td>↗ TGF-β in blood</td><td><p>↗ B and Natural Killer cells in blood</p><p>↗ T CD8<sup>+</sup> population in blood</p></td><td>1 mg/kg bw/d</td><td>imbalance immune response</td><td>[<xref ref-type="bibr" rid="CR170">170</xref>]</td></tr><tr><td><p>↗ IgG in blood,</p><p>↗ TGF-β and IFN-ɣ in spleen</p></td><td>↗ splenocyte proliferation</td><td>0.01; 0.1; 1; 10 mg/kg bw/d</td><td>imbalance immune response</td><td>[<xref ref-type="bibr" rid="CR163">163</xref>]</td></tr><tr><td rowspan="4">≥ 28 d</td><td><p>↗ inflammatory cytokines in blood</p><p>(IL1-β, IL-6, IL-4, IL-10, IL-12 and TGF-β)</p></td><td>↗ T CD8<sup>+</sup> population in blood</td><td rowspan="2">0.25; 0.50; 1 mg/kg bw/d</td><td>inflammation</td><td rowspan="2">[<xref ref-type="bibr" rid="CR170">170</xref>]</td></tr><tr><td>↗ IgE in blood</td><td>↗ B cell in blood</td><td>risk of food allergy development</td></tr><tr><td><p>↙ gene expression in ileum</p><p>(MUC3, TLR2, TLR4, FOXP3, IL-10, TGF-β)</p></td><td></td><td>9 mg/kg bw/d</td><td>immunossuppression</td><td rowspan="2">[<xref ref-type="bibr" rid="CR105">105</xref>]</td></tr><tr><td></td><td></td><td></td><td>sexual dimorphism response</td></tr></tbody></table><table-wrap-foot><p>The relevant doses for humans are indicated in bold. <italic>DC</italic> dendritic cell, <italic>FOXP3</italic> forkhead box P3, <italic>GPR43</italic> G-protein coupled receptor 43, <italic>IFN-γ</italic> interferon-gamma, <italic>Ig</italic> immunoglobulin, <italic>IL</italic> interleukin, <italic>MUC3</italic> mucin 3, <italic>NOD2</italic> nucleotide-binding oligomerization domain 2, <italic>TGF-β</italic> transforming growth factor beta, <italic>Th</italic> T helper, <italic>TLR</italic> Toll-like receptor, <italic>TNF-α</italic> tumor necrosis factor alpha, <italic>Treg</italic> regulatory T-cell</p></table-wrap-foot></table-wrap><fig id="Fig2"><label>Fig. 2</label><caption><p>Potential impact of NP ingestion on the crosstalk between the microbiota and the immune system. After ingestion, NPs interact with the gastrointestinal environment and can alter the gut microbiota, characterized by an alteration of the F/B ratio, a depletion of <italic>Lactobacillus</italic> strains and an increase in the abundance of Proteobacteria. NPs exhibit also deleterious effects on the epithelial barrier and the intestinal immune response, which can amplifies the dysbiosis in a vicious circle favouring intestinal inflammation in susceptible individuals</p></caption><graphic id="MO2" xlink:href="12989_2020_349_Fig2_HTML"></graphic></fig></p>
</sec>
<sec id="Sec11">
<title>The NP-induced gut microbiota signature resembles that of dysbiosis-associated human diseases</title>
<p id="Par61">Despite some contradictory studies, the majority of observations (Table <xref ref-type="table" rid="Tab1">1</xref>) [<xref ref-type="bibr" rid="CR104">104</xref>–<xref ref-type="bibr" rid="CR113">113</xref>] reveals a microbiota signature for nano-Ag, TiO<sub>2</sub>, ZnO and SiO<sub>2</sub> characterized by alteration of the F/B ratio together with depletion of <italic>Lactobacillus</italic> and enrichment of Proteobacteria. The F/B ratio is often considered an informative parameter for the general state of the intestinal microbiota. Alteration of the F/B ratio has been observed in diseases associated with dysbiosis [<xref ref-type="bibr" rid="CR172">172</xref>–<xref ref-type="bibr" rid="CR175">175</xref>], and helps to predict the decrease in the relative abundance of SCFAs [<xref ref-type="bibr" rid="CR176">176</xref>, <xref ref-type="bibr" rid="CR177">177</xref>]. Furthermore, <italic>Lactobacillus</italic> confers a health benefit on the host, notably via SCFAs and AhR ligand production [<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR99">99</xref>, <xref ref-type="bibr" rid="CR178">178</xref>–<xref ref-type="bibr" rid="CR180">180</xref>], while pathogenic Proteobacteria (<italic>E. coli</italic>, <italic>Shigella</italic>, <italic>Listeria</italic>, etc.,) are often overrepresented in several intestinal and extra-intestinal diseases with an inflammatory phenotype [<xref ref-type="bibr" rid="CR181">181</xref>, <xref ref-type="bibr" rid="CR182">182</xref>]. Altogether, these data emphasize a negative shift in the microbial community in response to NP exposure, favouring the growth of pathogenic bacteria at the expense of beneficial strains such as <italic>Lactobacillus</italic> (Fig. <xref ref-type="fig" rid="Fig2">2</xref>). Importantly, these reported effects were very similar to those observed in patients suffering from IBD, CRC or chronic metabolic disorders such as obesity (Table <xref ref-type="table" rid="Tab5">5</xref>) [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR92">92</xref>, <xref ref-type="bibr" rid="CR173">173</xref>, <xref ref-type="bibr" rid="CR183">183</xref>–<xref ref-type="bibr" rid="CR222">222</xref>].
<table-wrap id="Tab5"><label>Table 5</label><caption><p>Microbiota alteration observed in IBD, CRC and obesity compared to those induced after NP ingestion</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th>IBD</th><th>CRC</th><th>Obesity</th><th>NPs effects on microbiota</th></tr></thead><tbody><tr><td>Actinobacteria</td><td>↗[<xref ref-type="bibr" rid="CR183">183</xref>–<xref ref-type="bibr" rid="CR185">185</xref>]</td><td>↗[<xref ref-type="bibr" rid="CR186">186</xref>]</td><td>↗[<xref ref-type="bibr" rid="CR187">187</xref>]</td><td>↗TiO<sub>2</sub> [<xref ref-type="bibr" rid="CR104">104</xref>]</td></tr><tr><td><italic>Acidimicrobidae ellin</italic> 7143</td><td>↗[<xref ref-type="bibr" rid="CR184">184</xref>]</td><td></td><td></td><td></td></tr><tr><td><italic>Actinobacterium</italic> GWS-BW-H99</td><td>↗[<xref ref-type="bibr" rid="CR184">184</xref>]</td><td></td><td></td><td></td></tr><tr><td><italic>Actinomycinaeae (o)</italic></td><td>↗[<xref ref-type="bibr" rid="CR184">184</xref>]</td><td></td><td></td><td></td></tr><tr><td><italic>Actinomyces (g)</italic></td><td>↗[<xref ref-type="bibr" rid="CR188">188</xref>]</td><td></td><td></td><td></td></tr><tr><td><italic>Actinomyces oxydans</italic></td><td>↗[<xref ref-type="bibr" rid="CR184">184</xref>]</td><td></td><td></td><td></td></tr><tr><td><italic>Bifidobacteriales (o)</italic></td><td></td><td>↗[<xref ref-type="bibr" rid="CR186">186</xref>]</td><td></td><td></td></tr><tr><td><italic>Bifidobacterium (g)</italic></td><td>↙[<xref ref-type="bibr" rid="CR189">189</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR190">190</xref>, <xref ref-type="bibr" rid="CR191">191</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR192">192</xref>, <xref ref-type="bibr" rid="CR193">193</xref>]</td><td>↙Ag [<xref ref-type="bibr" rid="CR105">105</xref>]</td></tr><tr><td><italic>Bifidobacterium adolescentis</italic></td><td>↙[<xref ref-type="bibr" rid="CR194">194</xref>, <xref ref-type="bibr" rid="CR195">195</xref>]</td><td></td><td></td><td></td></tr><tr><td><italic>Corynebacteriaceae (f)</italic></td><td>↗[<xref ref-type="bibr" rid="CR184">184</xref>]</td><td></td><td>↗[<xref ref-type="bibr" rid="CR196">196</xref>]</td><td></td></tr><tr><td><italic>Nocardioides</italic> NS/27</td><td>↗[<xref ref-type="bibr" rid="CR184">184</xref>]</td><td></td><td></td><td></td></tr><tr><td>Bacteroidetes</td><td>↙[<xref ref-type="bibr" rid="CR183">183</xref>, <xref ref-type="bibr" rid="CR184">184</xref>, <xref ref-type="bibr" rid="CR188">188</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR197">197</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR173">173</xref>, <xref ref-type="bibr" rid="CR187">187</xref>, <xref ref-type="bibr" rid="CR198">198</xref>–<xref ref-type="bibr" rid="CR200">200</xref>]</td><td>↙Ag, TiO<sub>2</sub>, SiO<sub>2</sub>, ZnO [<xref ref-type="bibr" rid="CR104">104</xref>, <xref ref-type="bibr" rid="CR107">107</xref>–<xref ref-type="bibr" rid="CR109">109</xref>]; ↗Ag, ZnO [<xref ref-type="bibr" rid="CR105">105</xref>, <xref ref-type="bibr" rid="CR107">107</xref>, <xref ref-type="bibr" rid="CR110">110</xref>]</td></tr><tr><td><italic>Bacteroides (g)</italic></td><td>↙[<xref ref-type="bibr" rid="CR183">183</xref>, <xref ref-type="bibr" rid="CR194">194</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR186">186</xref>, <xref ref-type="bibr" rid="CR197">197</xref>, <xref ref-type="bibr" rid="CR201">201</xref>]</td><td>↗[<xref ref-type="bibr" rid="CR202">202</xref>, <xref ref-type="bibr" rid="CR203">203</xref>]</td><td>↙Ag, TiO<sub>2</sub>, SiO<sub>2</sub> [<xref ref-type="bibr" rid="CR107">107</xref>, <xref ref-type="bibr" rid="CR108">108</xref>]; ↗Ag, ZnO [<xref ref-type="bibr" rid="CR105">105</xref>, <xref ref-type="bibr" rid="CR110">110</xref>]</td></tr><tr><td><italic>Bacteroides ovatus</italic></td><td>↙[<xref ref-type="bibr" rid="CR204">204</xref>, <xref ref-type="bibr" rid="CR205">205</xref>]</td><td></td><td>↙[<xref ref-type="bibr" rid="CR206">206</xref>]</td><td>↙Ag, TiO<sub>2</sub> [<xref ref-type="bibr" rid="CR112">112</xref>, <xref ref-type="bibr" rid="CR113">113</xref>]</td></tr><tr><td><italic>Bacteroides uniformis</italic></td><td>↙[<xref ref-type="bibr" rid="CR183">183</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR186">186</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR206">206</xref>]</td><td>↙Ag [<xref ref-type="bibr" rid="CR106">106</xref>]</td></tr><tr><td><italic>Prevotellaceae (f)</italic></td><td></td><td></td><td>↗[<xref ref-type="bibr" rid="CR196">196</xref>, <xref ref-type="bibr" rid="CR207">207</xref>]</td><td>↙ZnO [<xref ref-type="bibr" rid="CR109">109</xref>]</td></tr><tr><td><italic>Prevotella</italic></td><td>↙[<xref ref-type="bibr" rid="CR183">183</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR201">201</xref>]</td><td>↗[<xref ref-type="bibr" rid="CR207">207</xref>, <xref ref-type="bibr" rid="CR208">208</xref>]</td><td>↙TiO<sub>2</sub>, ZnO [<xref ref-type="bibr" rid="CR104">104</xref>, <xref ref-type="bibr" rid="CR109">109</xref>]; ↗Ag, SiO<sub>2</sub> [<xref ref-type="bibr" rid="CR107">107</xref>]</td></tr><tr><td><italic>Rikenellaceae (f)</italic></td><td>↙[<xref ref-type="bibr" rid="CR209">209</xref>]</td><td></td><td>↙[<xref ref-type="bibr" rid="CR200">200</xref>, <xref ref-type="bibr" rid="CR207">207</xref>]</td><td>↙ZnO [<xref ref-type="bibr" rid="CR110">110</xref>]; ↗Ag [<xref ref-type="bibr" rid="CR108">108</xref>]</td></tr><tr><td><italic>Alistipes (g)</italic></td><td>↙[<xref ref-type="bibr" rid="CR184">184</xref>, <xref ref-type="bibr" rid="CR185">185</xref>, <xref ref-type="bibr" rid="CR188">188</xref>]</td><td>↗[<xref ref-type="bibr" rid="CR210">210</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR193">193</xref>, <xref ref-type="bibr" rid="CR206">206</xref>]</td><td>↙ZnO [<xref ref-type="bibr" rid="CR110">110</xref>]; ↗Ag, SiO<sub>2</sub> [<xref ref-type="bibr" rid="CR107">107</xref>]</td></tr><tr><td>Firmicutes</td><td>↙[<xref ref-type="bibr" rid="CR92">92</xref>, <xref ref-type="bibr" rid="CR184">184</xref>, <xref ref-type="bibr" rid="CR211">211</xref>, <xref ref-type="bibr" rid="CR212">212</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR197">197</xref>]</td><td>↗[<xref ref-type="bibr" rid="CR173">173</xref>, <xref ref-type="bibr" rid="CR199">199</xref>, <xref ref-type="bibr" rid="CR200">200</xref>]</td><td>↙Ag, TiO<sub>2</sub>, ZnO [<xref ref-type="bibr" rid="CR104">104</xref>, <xref ref-type="bibr" rid="CR105">105</xref>, <xref ref-type="bibr" rid="CR107">107</xref>, <xref ref-type="bibr" rid="CR109">109</xref>, <xref ref-type="bibr" rid="CR110">110</xref>]; ↗Ag, SiO<sub>2</sub>, ZnO [<xref ref-type="bibr" rid="CR107">107</xref>–<xref ref-type="bibr" rid="CR109">109</xref>]</td></tr><tr><td><italic>Erysipelotrichaceae (f)</italic></td><td>↙[<xref ref-type="bibr" rid="CR194">194</xref>]</td><td>↗[<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR190">190</xref>]</td><td>↗[<xref ref-type="bibr" rid="CR196">196</xref>]</td><td>↙TiO<sub>2</sub> [<xref ref-type="bibr" rid="CR104">104</xref>]</td></tr><tr><td><italic>Turicibacter (g)</italic></td><td>↙[<xref ref-type="bibr" rid="CR183">183</xref>]</td><td></td><td></td><td>↙TiO<sub>2</sub> [<xref ref-type="bibr" rid="CR104">104</xref>]</td></tr><tr><td><italic>Lachnospiraceae (f)</italic></td><td>↙[<xref ref-type="bibr" rid="CR194">194</xref>, <xref ref-type="bibr" rid="CR209">209</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR197">197</xref>, <xref ref-type="bibr" rid="CR201">201</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR207">207</xref>]</td><td>↙Ag [<xref ref-type="bibr" rid="CR107">107</xref>]; ↗Ag, SiO<sub>2</sub> [<xref ref-type="bibr" rid="CR104">104</xref>, <xref ref-type="bibr" rid="CR107">107</xref>]</td></tr><tr><td><italic>Blautia (g)</italic></td><td>↙[<xref ref-type="bibr" rid="CR209">209</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR17">17</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR207">207</xref>]</td><td>↗Ag [<xref ref-type="bibr" rid="CR108">108</xref>]</td></tr><tr><td><italic>Blautia faecis</italic></td><td>↙[<xref ref-type="bibr" rid="CR183">183</xref>]</td><td></td><td></td><td></td></tr><tr><td><italic>Coprococcus (g)</italic></td><td>↙[<xref ref-type="bibr" rid="CR209">209</xref>]</td><td></td><td>↙[<xref ref-type="bibr" rid="CR193">193</xref>, <xref ref-type="bibr" rid="CR207">207</xref>]</td><td>↗Ag [<xref ref-type="bibr" rid="CR108">108</xref>]</td></tr><tr><td><italic>Roseburia (g)</italic></td><td>↙[<xref ref-type="bibr" rid="CR185">185</xref>, <xref ref-type="bibr" rid="CR209">209</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR186">186</xref>, <xref ref-type="bibr" rid="CR210">210</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR207">207</xref>]</td><td></td></tr><tr><td><italic>Roseburia intestinalis</italic></td><td>↙[<xref ref-type="bibr" rid="CR183">183</xref>, <xref ref-type="bibr" rid="CR194">194</xref>]</td><td></td><td>↗[<xref ref-type="bibr" rid="CR206">206</xref>, <xref ref-type="bibr" rid="CR213">213</xref>]</td><td>↙Ag [<xref ref-type="bibr" rid="CR112">112</xref>]</td></tr><tr><td><italic>Roseburia inulinivorans</italic></td><td>↙[<xref ref-type="bibr" rid="CR183">183</xref>]</td><td></td><td></td><td></td></tr><tr><td><italic>Clostridium XIVa</italic> and <italic>IV</italic> groups</td><td>↙[<xref ref-type="bibr" rid="CR92">92</xref>, <xref ref-type="bibr" rid="CR184">184</xref>]</td><td></td><td>↗[<xref ref-type="bibr" rid="CR206">206</xref>]</td><td></td></tr><tr><td><italic>Clostridium lavalense</italic></td><td>↙[<xref ref-type="bibr" rid="CR183">183</xref>]</td><td></td><td></td><td></td></tr><tr><td><italic>Dialister invisus</italic></td><td>↙[<xref ref-type="bibr" rid="CR195">195</xref>]</td><td></td><td></td><td></td></tr><tr><td><italic>Enterococcus (g)</italic></td><td></td><td>↗[<xref ref-type="bibr" rid="CR186">186</xref>]</td><td></td><td></td></tr><tr><td><italic>Eubacterium (g)</italic></td><td></td><td>↙[<xref ref-type="bibr" rid="CR186">186</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR207">207</xref>]</td><td></td></tr><tr><td><italic>Eubacterium rectale</italic></td><td>↙[<xref ref-type="bibr" rid="CR194">194</xref>, <xref ref-type="bibr" rid="CR211">211</xref>]</td><td></td><td>↗[<xref ref-type="bibr" rid="CR213">213</xref>]</td><td>↙Ag [<xref ref-type="bibr" rid="CR112">112</xref>]; ↗TiO<sub>2</sub> [<xref ref-type="bibr" rid="CR113">113</xref>]</td></tr><tr><td><italic>Eubacterium ventriosum</italic></td><td>↙[<xref ref-type="bibr" rid="CR183">183</xref>]</td><td></td><td>↗[<xref ref-type="bibr" rid="CR198">198</xref>, <xref ref-type="bibr" rid="CR213">213</xref>]</td><td>↗TiO<sub>2</sub> [<xref ref-type="bibr" rid="CR113">113</xref>]</td></tr><tr><td><italic>Faecalibacterium (g)</italic></td><td>↙[<xref ref-type="bibr" rid="CR185">185</xref>, <xref ref-type="bibr" rid="CR209">209</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR190">190</xref>, <xref ref-type="bibr" rid="CR197">197</xref>, <xref ref-type="bibr" rid="CR210">210</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR193">193</xref>]</td><td></td></tr><tr><td><italic>Faecalibacterium prausnitzii</italic></td><td>↙[<xref ref-type="bibr" rid="CR92">92</xref>, <xref ref-type="bibr" rid="CR183">183</xref>, <xref ref-type="bibr" rid="CR194">194</xref>, <xref ref-type="bibr" rid="CR211">211</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR191">191</xref>, <xref ref-type="bibr" rid="CR210">210</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR206">206</xref>, <xref ref-type="bibr" rid="CR214">214</xref>]</td><td>↙Ag [<xref ref-type="bibr" rid="CR112">112</xref>]</td></tr><tr><td><italic>Lactobacillus (sp)</italic></td><td>↙[<xref ref-type="bibr" rid="CR183">183</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR191">191</xref>, <xref ref-type="bibr" rid="CR215">215</xref>]</td><td>↙[<xref ref-type="bibr" rid="CR193">193</xref>, <xref ref-type="bibr" rid="CR216">216</xref>]</td><td>↙Ag, TiO<sub>2</sub>, SiO<sub>2</sub>, ZnO [<xref ref-type="bibr" rid="CR104">104</xref>, <xref ref-type="bibr" rid="CR105">105</xref>, <xref ref-type="bibr" rid="CR107">107</xref>, <xref ref-type="bibr" rid="CR109">109</xref>–<xref ref-type="bibr" rid="CR111">111</xref>]; ↗Ag, ZnO [<xref ref-type="bibr" rid="CR108">108</xref>, <xref ref-type="bibr" rid="CR109">109</xref>]</td></tr><tr><td><italic>Oscillospira (g)</italic></td><td></td><td></td><td>↙[<xref ref-type="bibr" rid="CR207">207</xref>, <xref ref-type="bibr" rid="CR213">213</xref>]</td><td>↙Ag, ZnO [<xref ref-type="bibr" rid="CR106">106</xref>, <xref ref-type="bibr" rid="CR109">109</xref>]</td></tr><tr><td><italic>Ruminococcus gnavus</italic></td><td>↗[<xref ref-type="bibr" rid="CR195">195</xref>, <xref ref-type="bibr" rid="CR209">209</xref>, <xref ref-type="bibr" rid="CR217">217</xref>]</td><td></td><td></td><td></td></tr><tr><td><italic>Ruminococcus torques</italic></td><td>↙[<xref ref-type="bibr" rid="CR183">183</xref>, <xref ref-type="bibr" rid="CR194">194</xref>]</td><td></td><td></td><td>↙Ag [<xref ref-type="bibr" rid="CR112">112</xref>]</td></tr><tr><td><italic>Streptococcus (g)</italic></td><td></td><td>↗[<xref ref-type="bibr" rid="CR186">186</xref>, <xref ref-type="bibr" rid="CR218">218</xref>]</td><td></td><td>↗ZnO [<xref ref-type="bibr" rid="CR109">109</xref>]</td></tr><tr><td>Proteobacteria</td><td>↗[<xref ref-type="bibr" rid="CR184">184</xref>, <xref ref-type="bibr" rid="CR185">185</xref>]</td><td>↗[<xref ref-type="bibr" rid="CR186">186</xref>]</td><td>↗[<xref ref-type="bibr" rid="CR200">200</xref>, <xref ref-type="bibr" rid="CR206">206</xref>, <xref ref-type="bibr" rid="CR216">216</xref>]</td><td>↗TiO<sub>2</sub>, SiO<sub>2</sub>, ZnO [<xref ref-type="bibr" rid="CR104">104</xref>, <xref ref-type="bibr" rid="CR107">107</xref>, <xref ref-type="bibr" rid="CR109">109</xref>]; ↙ZnO [<xref ref-type="bibr" rid="CR111">111</xref>]</td></tr><tr><td><italic>Enterobacteriaceae (f)</italic></td><td>↗[<xref ref-type="bibr" rid="CR209">209</xref>, <xref ref-type="bibr" rid="CR219">219</xref>]</td><td>↗[<xref ref-type="bibr" rid="CR191">191</xref>, <xref ref-type="bibr" rid="CR218">218</xref>]</td><td>↗[<xref ref-type="bibr" rid="CR207">207</xref>]</td><td>↗Ag [<xref ref-type="bibr" rid="CR105">105</xref>]</td></tr><tr><td><italic>Escherichia coli</italic></td><td>↗[<xref ref-type="bibr" rid="CR194">194</xref>, <xref ref-type="bibr" rid="CR211">211</xref>, <xref ref-type="bibr" rid="CR220">220</xref>–<xref ref-type="bibr" rid="CR222">222</xref>]</td><td>↗[<xref ref-type="bibr" rid="CR186">186</xref>, <xref ref-type="bibr" rid="CR210">210</xref>]</td><td></td><td>↗ Ag, TiO<sub>2</sub> [<xref ref-type="bibr" rid="CR104">104</xref>, <xref ref-type="bibr" rid="CR112">112</xref>]</td></tr><tr><td><italic>Shigella (sp)</italic></td><td>↗[<xref ref-type="bibr" rid="CR185">185</xref>, <xref ref-type="bibr" rid="CR211">211</xref>]</td><td>↗[<xref ref-type="bibr" rid="CR186">186</xref>, <xref ref-type="bibr" rid="CR210">210</xref>]</td><td></td><td>↗ TiO<sub>2</sub> [<xref ref-type="bibr" rid="CR104">104</xref>]</td></tr><tr><td><italic>Sutterella (g)</italic></td><td></td><td></td><td>↗[<xref ref-type="bibr" rid="CR216">216</xref>]</td><td></td></tr><tr><td><italic>Listeria (sp)</italic></td><td>↗[<xref ref-type="bibr" rid="CR211">211</xref>]</td><td></td><td></td><td></td></tr></tbody></table></table-wrap></p>
<p id="Par62">A deficiency in AhR ligand production by the microbiota was reported in IBD and obese patients compared to healthy subjects [<xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR178">178</xref>]. Some commensal bacteria are able to metabolize the essential amino acid tryptophan in AhR ligands such as indole, indole-3-acetic acid, tryptamine, and indole-3-aldehyde. This ability is mainly exhibited by <italic>Lactobacillus</italic> [<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR99">99</xref>, <xref ref-type="bibr" rid="CR178">178</xref>], the abundance of which is decreased in the microbiota of IBD and obese patients [<xref ref-type="bibr" rid="CR183">183</xref>, <xref ref-type="bibr" rid="CR193">193</xref>, <xref ref-type="bibr" rid="CR216">216</xref>]. Recent studies in mice demonstrated that the reduced capacity of the microbiota to produce AhR ligands is involved in the pathogenesis of IBD and obesity through a mechanism that involves decreased IL-22 production by intestinal immune cells [<xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR178">178</xref>]. In the intestine, IL-22 is involved in mucosal wound healing [<xref ref-type="bibr" rid="CR223">223</xref>] and production of antimicrobial peptides (AMPs) by IECs, such as regenerating islet-derived 3 gamma (Reg3γ) and Reg3β [<xref ref-type="bibr" rid="CR224">224</xref>, <xref ref-type="bibr" rid="CR225">225</xref>], which can modulate the microbiota composition. Interestingly, defective intestinal production of IL-22 was observed in mice fed a high-fat diet, while administration of exogenous IL-22 reversed many metabolic symptoms, including hyperglycaemia and insulin resistance [<xref ref-type="bibr" rid="CR226">226</xref>]. IL-22 shows diverse metabolic benefits, as it improves insulin sensitivity, preserves the gut mucosal barrier and endocrine functions, decreases endotoxaemia and chronic inflammation, and regulates lipid metabolism in liver and adipose tissues [<xref ref-type="bibr" rid="CR226">226</xref>]. Similarly, mice treated with an AhR agonist or with <italic>Lactobacillus</italic> strains with high AhR-ligand production capacity exhibited improvement in symptoms of colitis and metabolic syndrome [<xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR178">178</xref>]. These treatments alleviate inflammatory insults in mice subjected to experimental colitis [<xref ref-type="bibr" rid="CR74">74</xref>] and reduce glucose dysmetabolism and liver steatosis in both dietary and genetic animal models of metabolic syndrome [<xref ref-type="bibr" rid="CR178">178</xref>]. Mechanistically, metabolic improvement is linked to the restoration of intestinal barrier function and the production of the intestinal hormone incretin [<xref ref-type="bibr" rid="CR178">178</xref>].</p>
<p id="Par63">The proportion of <italic>Lactobacillus</italic> is also decreased in the microbiota of CRC patients [<xref ref-type="bibr" rid="CR191">191</xref>, <xref ref-type="bibr" rid="CR215">215</xref>], while a number of <italic>Lactobacillus</italic> species exhibited notable anti-carcinogenic effects via the inactivation of microbial enzymes with procarcinogenic activities, such as β-glucuronidase and nitroreductase [<xref ref-type="bibr" rid="CR227">227</xref>]. To date, no studies have shown that the ability of some <italic>Lactobacillus</italic> species to produce AhR ligands contributes to the anti-carcinogenic potential of these bacteria. However, this mechanism cannot be excluded because AhR is an important node for the development of cancer. Indeed, in comparison to APC<sup>Min/+</sup> mice that spontaneously developed intestinal tumours, APC<sup>Min/+</sup>/AhR<sup>+/−</sup> mice exhibited increased tumour incidence, suggesting a tumour suppressor role for AhR. Moreover, a diet rich in AhR ligands can prevent or decrease CRC in mice: first, by inhibiting the Wnt-β-catenin pathway, which is known to be crucial for the proliferation of intestinal stem cells [<xref ref-type="bibr" rid="CR228">228</xref>], and second, by regulating components of the DNA damage response (DDR) in epithelial stem cells through a mechanism that involves IL-22 production by intestinal immune cells [<xref ref-type="bibr" rid="CR229">229</xref>]. DDR culminates in either transient cell-cycle arrest and DNA repair or elimination of damaged cells by apoptosis, thereby inhibiting the development of mutations that can lead to CRC [<xref ref-type="bibr" rid="CR229">229</xref>].</p>
<p id="Par64">Collectively, these data strongly support the AhR/IL-22 axis a key regulator of intestinal homeostasis. Hence, whether an NP-induced imbalance in this signalling pathway along the microbiota-immune axis could be a first cause of disease development and/or maintenance needs to be further examined in future studies. As noted above, because an NP-induced depletion in AhR-producing bacterial strains is commonly reported (Tables <xref ref-type="table" rid="Tab1">1</xref> and <xref ref-type="table" rid="Tab5">5</xref>), one may hypothesize that this change represents the missing mechanistic link for colon cancer development in rodents after long-term treatment with a food-grade form of TiO<sub>2</sub> (i.e., the food additive E171). Cancer evolves through a sequential process from normal cells to preneoplastic lesions before tumour development. Among rats exposed for 100 days to a commercial E171 vial (≈45% of TiO<sub>2</sub>-NPs by number) at a relevant dose for humans, nearly 40% of the animals developed spontaneously preneoplastic lesions in the colon (i.e., initiation of premalignant colorectal lesions), and a steady, low level of inflammation was reported in the colon mucosa [<xref ref-type="bibr" rid="CR116">116</xref>]. Furthermore, the same study showed increased severity of preneoplastic lesions in E171-treated rats pretreated with dimethylhydrazine to initiate colon carcinogenesis, suggesting the promotion of disease development by TiO<sub>2</sub> [<xref ref-type="bibr" rid="CR116">116</xref>]. This effect was confirmed in mice by using a similar E171 batch and showing exacerbated tumour formation (i.e., colorectal adenoma) in a chemical colitis-associated cancer model [<xref ref-type="bibr" rid="CR230">230</xref>]. These TiO<sub>2</sub> initiator and promoter effects of preneoplastic lesions in the colon could be due to intestinal micro-inflammation [<xref ref-type="bibr" rid="CR116">116</xref>] and defective expression of genes involved in oxidative stress, immune response and cancer [<xref ref-type="bibr" rid="CR231">231</xref>, <xref ref-type="bibr" rid="CR232">232</xref>] as well as due to alteration of the intestinal microbiota, as reviewed herein.</p>
<p id="Par65">In the context of dysbiosis as a susceptibility factor for CRC development, a review of human data clearly shows a reduction in the levels of SCFA-producing bacteria in the microbiota of patients, namely, <italic>Faecalibacterium</italic>, <italic>Roseburia</italic> and <italic>Bifidobacterium,</italic> as well as <italic>Lactobacillus</italic> (Table <xref ref-type="table" rid="Tab5">5</xref>). Decreased abundances of these specific strains was observed in IBD and obese patients, while similar depletion appears in rodents orally exposed to TiO<sub>2</sub>, Ag, SiO<sub>2</sub> and ZnO NPs, as indicated in Tables <xref ref-type="table" rid="Tab1">1</xref> and <xref ref-type="table" rid="Tab5">5</xref>. The SCFAs, mainly acetate, propionate and butyrate, are absorbed in the intestine. First, butyrate serves as a major source of energy for colonocytes and for epithelial renewal [<xref ref-type="bibr" rid="CR233">233</xref>–<xref ref-type="bibr" rid="CR235">235</xref>], whereas propionate and acetate reach the liver via portal circulation. Propionate is primarily used in gluconeogenesis [<xref ref-type="bibr" rid="CR233">233</xref>, <xref ref-type="bibr" rid="CR234">234</xref>, <xref ref-type="bibr" rid="CR236">236</xref>], while in the case of acetate, this organic product enters systemic circulation to reach peripheral tissues, where it serves as a substrate for cholesterol synthesis [<xref ref-type="bibr" rid="CR233">233</xref>, <xref ref-type="bibr" rid="CR236">236</xref>]. As previously detailed, SCFAs exhibit anti-inflammatory effects but are also involved in different physiological processes. Acetate participates in the de novo synthesis of lipids in colonic epithelial cells [<xref ref-type="bibr" rid="CR237">237</xref>], and similar to propionate, butyrate reduces food intake and stimulates the formation of the anorexigenic hormone leptin [<xref ref-type="bibr" rid="CR234">234</xref>, <xref ref-type="bibr" rid="CR236">236</xref>, <xref ref-type="bibr" rid="CR238">238</xref>]. Butyrate has been shown to enhance intestinal barrier function and regulate cellular apoptosis, cell proliferation and differentiation [<xref ref-type="bibr" rid="CR239">239</xref>]. Moreover, in mice, treatment with butyrate improves insulin sensitivity and increases energy expenditure, leading to reduced obesity [<xref ref-type="bibr" rid="CR240">240</xref>]. In addition to these anti-obesogenic properties, both butyrate and propionate play a protective role against IBD [<xref ref-type="bibr" rid="CR241">241</xref>–<xref ref-type="bibr" rid="CR244">244</xref>] and colon carcinogenesis [<xref ref-type="bibr" rid="CR245">245</xref>–<xref ref-type="bibr" rid="CR248">248</xref>]. Altogether, these observations suggest that NP-related depletion of bacteria responsible for SCFA production could be viewed as an additional risk factor for the development of these diseases.</p>
<p id="Par66">Finally, it should be noted that the inflammatory state induced by the absence of a healthy butyrate-producing microbiota leads to increased expression of the gene encoding nitric oxide synthase, <italic>Nos2</italic>, as well as of nitrate production by the host, a substrate favouring the growth of Enterobacteriaceae belonging to the Proteobacteria [<xref ref-type="bibr" rid="CR249">249</xref>]. The proportion of Proteobacteria is increased in the gut microbiota of patients suffering from IBD, obesity or CRC (Table <xref ref-type="table" rid="Tab5">5</xref>), and some authors have proposed that the abundance of Proteobacteria as a “microbial signature” of disease progression [<xref ref-type="bibr" rid="CR182">182</xref>]. The role of Proteobacteria in inflammation has been revealed in various mouse models of obesity, colitis and colitis-associated colorectal cancer. For example, the resistance of GF mice to the development of an obesity phenotype after being fed a high-fat diet was overcome by inoculation of these mice with an <italic>Enterobacter</italic> population isolated from the obese human gut, highlighting the obesogenic potential of Proteobacteria [<xref ref-type="bibr" rid="CR250">250</xref>]. In mice that exhibit spontaneous development of colitis, such as those lacking Toll-like receptors-5 (<italic>Tlr5</italic><sup>−/−</sup>), IL-10 (<italic>Il-10</italic><sup>−/−</sup>) or the transcription factor T-bet and the recombinase activating gene Rag (<italic>T-bet</italic><sup>−/−</sup> x <italic>Rag2</italic><sup>−/−</sup>), an increased intestinal level of Proteobacteria was reported [<xref ref-type="bibr" rid="CR251">251</xref>–<xref ref-type="bibr" rid="CR255">255</xref>]. Inoculation of WT mice with two <italic>Enterobacteriaceae</italic> species isolated from faeces of <italic>T-bet</italic><sup>−/−</sup> x <italic>Rag2</italic><sup>−/−</sup> mice induced intestinal inflammation leading to colitis [<xref ref-type="bibr" rid="CR253">253</xref>]. In addition, monocolonization with the commensal <italic>E. coli</italic> NC101 of GF <italic>Il-10</italic><sup>−/−</sup> mice treated with the colon-specific carcinogen azoxymethane promoted the development of invasive carcinoma [<xref ref-type="bibr" rid="CR256">256</xref>, <xref ref-type="bibr" rid="CR257">257</xref>]. These data indicate that some Proteobacteria are able to induce intestinal inflammation that may promote IBD and/or CRC development. Notably, in recent studies, microbiota composition analysis concluded on a Proteobacteria bloom in mice orally exposed to inorganic NPs (Tables <xref ref-type="table" rid="Tab1">1</xref> and <xref ref-type="table" rid="Tab3">3</xref>). However, the shift towards pathogenic bacterial colonization is not specific to NP exposure because such a shift was also observed with other xenobiotics. For example, mice exposed to artificial sweeteners and emulsifiers added to many processed foods or to chlorpyrifos (an organophosphorus pesticide frequently detected in the diet) exhibit a high abundance of Proteobacteria, a scenario that predisposes mice to obesity [<xref ref-type="bibr" rid="CR258">258</xref>–<xref ref-type="bibr" rid="CR260">260</xref>], colitis [<xref ref-type="bibr" rid="CR259">259</xref>, <xref ref-type="bibr" rid="CR261">261</xref>] and colon cancer [<xref ref-type="bibr" rid="CR262">262</xref>]. Despite in vivo studies demonstrating that oral exposure to NP induces inflammatory [<xref ref-type="bibr" rid="CR107">107</xref>, <xref ref-type="bibr" rid="CR116">116</xref>, <xref ref-type="bibr" rid="CR155">155</xref>, <xref ref-type="bibr" rid="CR161">161</xref>, <xref ref-type="bibr" rid="CR230">230</xref>] or metabolic [<xref ref-type="bibr" rid="CR263">263</xref>–<xref ref-type="bibr" rid="CR265">265</xref>] effects which could be related to IBD, CRC and obesity, it is not known whether the NP-induced bloom of the pathogenic phylum Proteobacteria may also promote the development of one or more of these diseases. In such a context, it should also be investigated whether NP-related GALT dysfunctions could be a cause or consequence of intestinal dysbiosis and whether specific NPs, alone or in mixture, are associated with different disease phenotypes, rendering the host highly vulnerable to IBD, CRC or metabolic disorders (Fig. <xref ref-type="fig" rid="Fig2">2</xref>).</p>
</sec>
</sec>
</sec>
<sec id="Sec12">
<title>Conclusions</title>
<p id="Par67">The increasing use of NPs in the food chain, as additives or incorporated into food packaging, has led to concerns regarding the daily exposure of consumers. On the basis of reports presented in this review, one may suggest that the antimicrobial and/or immunotoxic properties of inorganic NPs have the potential to alter the intestinal microbiota and GALT functions, interactions of which are important for many physiological processes in the organism (Fig. <xref ref-type="fig" rid="Fig2">2</xref>). This review has summarized the impacts on the gut microbiota-immune axis of the four most common NPs found in the food sector. The existing data highlight a recurrent microbiota signature for nano-Ag, TiO<sub>2</sub>, ZnO and SiO<sub>2</sub>, characterized by an alteration of the F/B ratio, a depletion of <italic>Lactobacillus</italic> strains (SCFA and AhR ligand producers) and an increase in the abundance of Proteobacteria, which may resemble the microbiome shift in IBD, CRC or obesity where gut dysbiosis play a key pathogenic role. These observations raise the need for additional studies for the re-evaluation of NP-containing food additives used for decades in foodstuffs, especially given the uncertainties associated with the long-term effects of these NPs on the gut microbiome as described in this review. In Europe, the new guidance document by EFSA on risk assessment for the application of nanotechnologies in food and the feed chain highlights the need for studies on the composition of the microbiome for nanomaterials, especially for those with antimicrobial properties [<xref ref-type="bibr" rid="CR266">266</xref>]. This caution appears to be of particular importance given the limited absorption of insoluble particles from the intestine (e.g., TiO<sub>2</sub>, SiO<sub>2</sub>), meaning that the non-absorbed fraction of NPs remains in direct contact with the resident bacteria before being excreted. In this context and based on available data, the NP-microbiota interactions appeared to be localization dependent along the gut, probably due to differences in microbial composition and density from the small intestine to the colon. Changes in the physicochemical properties of NPs during gut transit (i.e., differences in pH and influence of the food matrices and biliary acids) or the extent of particle dissolution for soluble materials (i.e., Ag, ZnO), could modify their long term impact on the microbiome. Except for few studies, the effects of foodborne NPs on the metabolic activity of the microbiota remain largely unexplored; however, this parameter is crucial for evaluating biological consequences for the host and potential hazards. Moreover, most studies have been conducted using pure nanoparticulate matter as NP models instead of the food additives that often exhibit mixed submicron- and nanosized particles, and at high doses, i.e., far above human dietary levels for the equivalent food-grade forms; these aspects could elicit different effects on the gut microbiome. It also appears that interpretations of findings from animals to humans are very limited due to differences in gut microbiota composition and activity. However, as 85% of the 16S rRNA sequence dataset for the mouse microbiota represents genera that are not present in humans [<xref ref-type="bibr" rid="CR199">199</xref>], the use of GF mice inoculated with the human microbiota seems to be a good model for investigation of the chronic impact of foodborne NPs on bacteria that colonize the human intestine. Some studies used a custom colon reactor in this way, but the exposure time of the microbiota to the NPs was short [<xref ref-type="bibr" rid="CR113">113</xref>, <xref ref-type="bibr" rid="CR117">117</xref>] and hence was not representative of chronic exposure conditions. Furthermore, available data are often limited to the impact of NP models/food additives exclusively on the intestinal flora, bypassing the importance of the microbiota-immune system axis for the host health that would require more integrated approaches as microbiota transfer in GF mice.</p>
<p id="Par68">Another area that requires detailed investigation is the ability of the gut microbiota to recover after the end of NP exposure; such an investigation would help determine whether NP-induced dysbiosis is permanent and has long-lasting consequences for the host. Notably, the period of exposure to NPs during life is rarely taken into account, while exposure when the microbiota and immune system begin to interact, such as the perinatal period, could induce higher alteration of microbiota-GALT crosstalk than a similar exposure experienced during adulthood. One of the other limitations of the current studies reviewed is that the intestinal immune response (GALT) and gut microbiota alterations were explored after exposure to one type of NP. However, humans are continually exposed to different foodborne NPs as well as to a multitude of other xenobiotics that may have synergistic or antagonistic effects on these functions. One of the challenges in the coming years will be to evaluate the effects on humans of this complex exposome, taking into account exposure to foodborne mineral particles with different physicochemical characteristics. For effective risk assessment, an understanding of the effects of this exposome extended to inorganic (nano) particles will be essential for prevention and remediation strategies and for facilitating the design of safe nanomaterials devoid of biocidal activity when used as food additives or food supplements.</p>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>Ag</term>
<def>
<p id="Par3">Silver</p>
</def>
</def-item>
<def-item>
<term>AhR</term>
<def>
<p id="Par4">Aryl hydrocarbon receptor</p>
</def>
</def-item>
<def-item>
<term>AMPs</term>
<def>
<p id="Par5">Antimicrobial peptides</p>
</def>
</def-item>
<def-item>
<term>bw</term>
<def>
<p id="Par6">Body weight</p>
</def>
</def-item>
<def-item>
<term>Card9</term>
<def>
<p id="Par7">Caspase recruitment domain 9</p>
</def>
</def-item>
<def-item>
<term>cfu</term>
<def>
<p id="Par8">Colony forming units</p>
</def>
</def-item>
<def-item>
<term>CRC</term>
<def>
<p id="Par9">Colorectal cancer</p>
</def>
</def-item>
<def-item>
<term>d</term>
<def>
<p id="Par10">Day</p>
</def>
</def-item>
<def-item>
<term>DCs</term>
<def>
<p id="Par11">Dendritic cells</p>
</def>
</def-item>
<def-item>
<term>DDR</term>
<def>
<p id="Par12">DNA damage response</p>
</def>
</def-item>
<def-item>
<term>EFSA</term>
<def>
<p id="Par13">European Food Safety Authority</p>
</def>
</def-item>
<def-item>
<term>F/B</term>
<def>
<p id="Par14">Firmicutes/Bacteroidetes</p>
</def>
</def-item>
<def-item>
<term>GALT</term>
<def>
<p id="Par15">Gut-associated lymphoid tissue</p>
</def>
</def-item>
<def-item>
<term>GF</term>
<def>
<p id="Par16">Germ-free</p>
</def>
</def-item>
<def-item>
<term>GI</term>
<def>
<p id="Par17">Gastrointestinal</p>
</def>
</def-item>
<def-item>
<term>GRAS</term>
<def>
<p id="Par18">Generally recognized as safe</p>
</def>
</def-item>
<def-item>
<term>IBD</term>
<def>
<p id="Par19">Inflammatory bowel diseases</p>
</def>
</def-item>
<def-item>
<term>IECs</term>
<def>
<p id="Par20">Intestinal epithelial cells</p>
</def>
</def-item>
<def-item>
<term>IELs</term>
<def>
<p id="Par21">Intraepithelial lymphocytes</p>
</def>
</def-item>
<def-item>
<term>IFN-γ</term>
<def>
<p id="Par22">Interferon-gamma</p>
</def>
</def-item>
<def-item>
<term>IgA</term>
<def>
<p id="Par23">Immunoglobulin A</p>
</def>
</def-item>
<def-item>
<term>IL</term>
<def>
<p id="Par24">Interleukin</p>
</def>
</def-item>
<def-item>
<term>ILCs</term>
<def>
<p id="Par25">Innate lymphoid cells</p>
</def>
</def-item>
<def-item>
<term>LP</term>
<def>
<p id="Par26">Lamina propria</p>
</def>
</def-item>
<def-item>
<term>M cells</term>
<def>
<p id="Par27">Microfold cells</p>
</def>
</def-item>
<def-item>
<term>MET-1</term>
<def>
<p id="Par28">Microbial ecosystem therapeutic-1</p>
</def>
</def-item>
<def-item>
<term>MLNs</term>
<def>
<p id="Par29">Mesenteric lymph nodes</p>
</def>
</def-item>
<def-item>
<term>NPs</term>
<def>
<p id="Par30">Nanoparticles</p>
</def>
</def-item>
<def-item>
<term>PPs</term>
<def>
<p id="Par31">Peyer’s patches</p>
</def>
</def-item>
<def-item>
<term>Reg3</term>
<def>
<p id="Par32">Regenerating islet-derived 3</p>
</def>
</def-item>
<def-item>
<term>ROS</term>
<def>
<p id="Par33">Reactive oxygen species</p>
</def>
</def-item>
<def-item>
<term>SCFAs</term>
<def>
<p id="Par34">Short-chain fatty acids</p>
</def>
</def-item>
<def-item>
<term>SFB</term>
<def>
<p id="Par35">Segmented filamentous bacteria</p>
</def>
</def-item>
<def-item>
<term>Si</term>
<def>
<p id="Par36">Silicon</p>
</def>
</def-item>
<def-item>
<term>SiO<sub>2</sub></term>
<def>
<p id="Par37">Silicon dioxide</p>
</def>
</def-item>
<def-item>
<term>Th</term>
<def>
<p id="Par38">T helper</p>
</def>
</def-item>
<def-item>
<term>Ti</term>
<def>
<p id="Par39">Titanium</p>
</def>
</def-item>
<def-item>
<term>TiO<sub>2</sub></term>
<def>
<p id="Par40">Titanium dioxide</p>
</def>
</def-item>
<def-item>
<term>Tlr5</term>
<def>
<p id="Par41">Toll-like receptor 5</p>
</def>
</def-item>
<def-item>
<term>TNF-α</term>
<def>
<p id="Par42">Tumour necrosis factor alpha</p>
</def>
</def-item>
<def-item>
<term>Treg</term>
<def>
<p id="Par43">Regulatory T-cell</p>
</def>
</def-item>
<def-item>
<term>WT</term>
<def>
<p id="Par44">Wild-type</p>
</def>
</def-item>
<def-item>
<term>ZnO</term>
<def>
<p id="Par45">Zinc oxide</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Publisher’s Note</bold>
</p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>All contributors who provided help during the research have been listed.</p>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>BL, NMB and EH. Designed the study and contributed to all the sections. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="funding-information">
<title>Funding</title>
<p>This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p>
</notes>
<notes notes-type="data-availability">
<title>Availability of data and materials</title>
<p>Not applicable.</p>
</notes>
<notes id="FPar1">
<title>Ethics approval and consent to participate</title>
<p id="Par69">Not applicable.</p>
</notes>
<notes id="FPar2">
<title>Consent for publication</title>
<p id="Par70">Not applicable.</p>
</notes>
<notes id="FPar3" notes-type="COI-statement">
<title>Competing interests</title>
<p id="Par71">The authors declare that they have no competing interests.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mädler</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Toxic potential of materials at the nanolevel</article-title>
<source/>Science.
          <year>2006</year>
<volume>311</volume>
<fpage>622</fpage>
<lpage>627</lpage>
<pub-id pub-id-type="pmid">16456071</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Nel</surname>
<given-names>AE</given-names>
</name>
</person-group>
<article-title>Potential health simpact of nanoparticles</article-title>
<source/>Annu Rev Public Health.
          <year>2009</year>
<volume>30</volume>
<fpage>137</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="pmid">19705557</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weir</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Westerhoff</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fabricius</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hristovski</surname>
<given-names>K</given-names>
</name>
<name>
<surname>von Goetz</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Titanium dioxide nanoparticles in food and personal care products</article-title>
<source/>Environ Sci Technol.
          <year>2012</year>
<volume>46</volume>
<fpage>2242</fpage>
<lpage>2250</lpage>
<pub-id pub-id-type="pmid">22260395</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaudhry</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Scotter</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Blackburn</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Boxall</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Castle</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Applications and implications of nanotechnologies for the food sector</article-title>
<source/>Food Addit Contam Part A Chem Anal Control Expo Risk Assess.
          <year>2008</year>
<volume>25</volume>
<fpage>241</fpage>
<lpage>258</lpage>
<pub-id pub-id-type="pmid">18311618</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srinivas</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Philbert</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vu</surname>
<given-names>TQ</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Kokini</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Saltos</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Nanotechnology research: applications in nutritional sciences</article-title>
<source/>J Nutr.
          <year>2010</year>
<volume>140</volume>
<fpage>119</fpage>
<lpage>124</lpage>
<pub-id pub-id-type="pmid">19939997</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Kweon</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Um</surname>
<given-names>JH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Risk assessment principle for engineered nanotechnology in food and drug</article-title>
<source/>Toxicol Res.
          <year>2012</year>
<volume>28</volume>
<fpage>73</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="pmid">24278592</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mercier-Bonin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Despax</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Raynaud</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Houdeau</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Mucus and microbiota as emerging players in gut nanotoxicology: The example of dietary silver and titanium dioxide nanoparticles</article-title>
<source/>Crit Rev Food Sci Nutr.
          <year>2018</year>
<volume>58</volume>
<fpage>1023</fpage>
<lpage>1032</lpage>
<pub-id pub-id-type="pmid">27740849</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Radziwill-Bienkowska</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Talbot</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kamphuis</surname>
<given-names>JBJB</given-names>
</name>
<name>
<surname>Robert</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Cartier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fourquaux</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Toxicity of Food-Grade TiO2 to Commensal Intestinal and Transient Food-Borne Bacteria: New Insights Using Nano-SIMS and Synchrotron UV Fluorescence Imaging</article-title>
<source/>Front Microbiol.
          <year>2018</year>
<volume>9</volume>
<fpage>794</fpage>
<pub-id pub-id-type="pmid">29740421</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Talbot</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Radziwill-Bienkowska</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Kamphuis</surname>
<given-names>JBJB</given-names>
</name>
<name>
<surname>Steenkeste</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bettini</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Robert</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Food-grade TiO2 is trapped by intestinal mucus in vitro but does not impair mucin O-glycosylation and short-chain fatty acid synthesis in vivo: implications for gut barrier protection</article-title>
<source/>J Nanobiotechnology.
          <year>2018</year>
<volume>16</volume>
<fpage>53</fpage>
<pub-id pub-id-type="pmid">29921300</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rooks</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Garrett</surname>
<given-names>WS</given-names>
</name>
</person-group>
<article-title>Gut microbiota, metabolites and host immunity</article-title>
<source/>Nat Rev Immunol.
          <year>2016</year>
<volume>16</volume>
<fpage>341</fpage>
<lpage>352</lpage>
<pub-id pub-id-type="pmid">27231050</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tomas</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wrzosek</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bouznad</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bouet</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mayeur</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Noordine</surname>
<given-names>M-LL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Primocolonization is associated with colonic epithelial maturation during conventionalization</article-title>
<source/>FASEB J.
          <year>2013</year>
<volume>27</volume>
<fpage>645</fpage>
<lpage>655</lpage>
<pub-id pub-id-type="pmid">23118025</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Natividad</surname>
<given-names>JMM</given-names>
</name>
<name>
<surname>Verdu</surname>
<given-names>EF</given-names>
</name>
</person-group>
<article-title>Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications</article-title>
<source/>Pharmacol Res.
          <year>2013</year>
<volume>69</volume>
<fpage>42</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="pmid">23089410</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belkaid</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hand</surname>
<given-names>TW</given-names>
</name>
</person-group>
<article-title>Role of the microbiota in immunity and inflammation</article-title>
<source/>Cell.
          <year>2014</year>
<volume>157</volume>
<fpage>121</fpage>
<lpage>141</lpage>
<pub-id pub-id-type="pmid">24679531</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belkaid</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>OJ</given-names>
</name>
</person-group>
<article-title>Homeostatic Immunity and the Microbiota</article-title>
<source/>Immunity.
          <year>2017</year>
<volume>46</volume>
<fpage>562</fpage>
<lpage>576</lpage>
<pub-id pub-id-type="pmid">28423337</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ni</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Albenberg</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tomov</surname>
<given-names>VT</given-names>
</name>
</person-group>
<article-title>Gut microbiota and IBD: causation or correlation?</article-title>
<source/>Nat Rev Gastroenterol Hepatol.
          <year>2017</year>
<volume>14</volume>
<fpage>573</fpage>
<lpage>584</lpage>
<pub-id pub-id-type="pmid">28743984</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verdu</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Galipeau</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Jabri</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Novel players in coeliac disease pathogenesis: role of the gut microbiota</article-title>
<source/>Nat Rev Gastroenterol Hepatol.
          <year>2015</year>
<volume>12</volume>
<fpage>497</fpage>
<lpage>506</lpage>
<pub-id pub-id-type="pmid">26055247</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richard</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Liguori</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lamas</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Brandi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>da Costa</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>TW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mucosa-associated microbiota dysbiosis in colitis associated cancer</article-title>
<source/>Gut Microbes.
          <year>2018</year>
<volume>9</volume>
<fpage>131</fpage>
<lpage>142</lpage>
<pub-id pub-id-type="pmid">28914591</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meijnikman</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Gerdes</surname>
<given-names>VE</given-names>
</name>
<name>
<surname>Nieuwdorp</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Herrema</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans</article-title>
<source/>Endocr Rev.
          <year>2018</year>
<volume>39</volume>
<fpage>133</fpage>
<lpage>153</lpage>
<pub-id pub-id-type="pmid">29309555</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosenfeld</surname>
<given-names>CS</given-names>
</name>
</person-group>
<article-title>Microbiome Disturbances and Autism Spectrum Disorders</article-title>
<source/>Drug Metab Dispos.
          <year>2015</year>
<volume>43</volume>
<fpage>1557</fpage>
<lpage>1571</lpage>
<pub-id pub-id-type="pmid">25852213</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration</article-title>
<source/>J Physiol (Lond).
          <year>2017</year>
<volume>595</volume>
<fpage>489</fpage>
<lpage>503</lpage>
<pub-id pub-id-type="pmid">27641441</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Minemura</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Gut microbiota and liver diseases</article-title>
<source/>World J Gastroenterol.
          <year>2015</year>
<volume>21</volume>
<fpage>1691</fpage>
<lpage>1702</lpage>
<pub-id pub-id-type="pmid">25684933</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<mixed-citation publication-type="other">EFSA ANS Panel. Scientific opinion on the re-evaluation of silver (E 174) as food additive. EFSA J EFSA Journal; 2016;14:4364.</mixed-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peters</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>van Bemmel</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Herrera-Rivera</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Helsper</surname>
<given-names>HP</given-names>
</name>
<name>
<surname>Marvin</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Weigel</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization of titanium dioxide nanoparticles in food products: analytical methods to define nanoparticles</article-title>
<source/>J Agric Food Chem.
          <year>2014</year>
<volume>62</volume>
<fpage>6285</fpage>
<lpage>6293</lpage>
<pub-id pub-id-type="pmid">24933406</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Doudrick</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hristovski</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Herckes</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Westerhoff</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization of food-grade titanium dioxide: the presence of nanosized particles</article-title>
<source/>Environ Sci Technol.
          <year>2014</year>
<volume>48</volume>
<fpage>6391</fpage>
<lpage>6400</lpage>
<pub-id pub-id-type="pmid">24754874</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>EFSA ANS Panel</collab>
</person-group>
<article-title>Re-evaluation of titanium dioxide (E 171) as a food additive</article-title>
<source/>EFSA J
          <year>2016</year>
<volume>14</volume>
<fpage>4545</fpage>
<lpage>4583</lpage>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dekkers</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Krystek</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Lankveld</surname>
<given-names>DPP</given-names>
</name>
<name>
<surname>Bokkers</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>van Hoeven-Arentzen</surname>
<given-names>PH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Presence and risks of nanosilica in food products</article-title>
<source/>Nanotoxicology.
          <year>2011</year>
<volume>5</volume>
<fpage>393</fpage>
<lpage>405</lpage>
<pub-id pub-id-type="pmid">20868236</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peters</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Oomen</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Rivera</surname>
<given-names>ZE</given-names>
</name>
<name>
<surname>Oegema</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tromp</surname>
<given-names>PC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Presence of nano-sized silica during in vitro digestion of foods containing silica as a food additive</article-title>
<source/>ACS Nano.
          <year>2012</year>
<volume>6</volume>
<fpage>2441</fpage>
<lpage>2451</lpage>
<pub-id pub-id-type="pmid">22364219</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>EFSA ANS Panel</collab>
</person-group>
<article-title>Re-evaluation of silicon dioxide (E 551) as food additive</article-title>
<source/>EFSA J
          <year>2018</year>
<volume>16</volume>
<fpage>5070</fpage>
<lpage>5088</lpage>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A combined toxicity study of zinc oxide nanoparticles and vitamin C in food additives</article-title>
<source/>Nanoscale.
          <year>2014</year>
<volume>6</volume>
<fpage>15333</fpage>
<lpage>15342</lpage>
<pub-id pub-id-type="pmid">25387158</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huttenhower</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gevers</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Abubucker</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Badger</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chinwalla</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structure, function and diversity of the healthy human microbiome</article-title>
<source/>Nature.
          <year>2012</year>
<volume>486</volume>
<fpage>207</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="pmid">22699609</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Raes</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Arumugam</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Burgdorf</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Manichanh</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A human gut microbial gene catalogue established by metagenomic sequencing</article-title>
<source/>Nature.
          <year>2010</year>
<volume>464</volume>
<fpage>59</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="pmid">20203603</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eckburg</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Bik</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Bernstein</surname>
<given-names>CN</given-names>
</name>
<name>
<surname>Purdom</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dethlefsen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sargent</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diversity of the human intestinal microbial flora</article-title>
<source/>Science.
          <year>2005</year>
<volume>308</volume>
<fpage>1635</fpage>
<lpage>1638</lpage>
<pub-id pub-id-type="pmid">15831718</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stilling</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>Microbial genes, brain &amp; behaviour - epigenetic regulation of the gut-brain axis</article-title>
<source/>Genes Brain Behav.
          <year>2014</year>
<volume>13</volume>
<fpage>69</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="pmid">24286462</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gill</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Pop</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Deboy</surname>
<given-names>RT</given-names>
</name>
<name>
<surname>Eckburg</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Turnbaugh</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Samuel</surname>
<given-names>BS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Metagenomic analysis of the human distal gut microbiome</article-title>
<source/>Science.
          <year>2006</year>
<volume>312</volume>
<fpage>1355</fpage>
<lpage>1359</lpage>
<pub-id pub-id-type="pmid">16741115</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Hara</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Shanahan</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>The gut flora as a forgotten organ</article-title>
<source/>EMBO Rep.
          <year>2006</year>
<volume>7</volume>
<fpage>688</fpage>
<lpage>693</lpage>
<pub-id pub-id-type="pmid">16819463</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<mixed-citation publication-type="other">Amedei A, Boem F. I’ve Gut A Feeling: Microbiota Impacting the Conceptual and Experimental Perspectives of Personalized Medicine. Int J Mol Sci. 2018;19.</mixed-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baquero</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Nombela</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>The microbiome as a human organ</article-title>
<source/>Clin Microbiol Infect.
          <year>2012</year>
<volume>18</volume>
<issue>Suppl 4</issue>
<fpage>2</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="pmid">22647038</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marchesi</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Fava</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hermes</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Hirschfield</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Hold</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The gut microbiota and host health: a new clinical frontier</article-title>
<source/>Gut.
          <year>2016</year>
<volume>65</volume>
<fpage>330</fpage>
<lpage>339</lpage>
<pub-id pub-id-type="pmid">26338727</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clarke</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Stilling</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Stanton</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
</person-group>
<article-title>Minireview: Gut microbiota: the neglected endocrine organ</article-title>
<source/>Mol Endocrinol.
          <year>2014</year>
<volume>28</volume>
<fpage>1221</fpage>
<lpage>1238</lpage>
<pub-id pub-id-type="pmid">24892638</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>K</given-names>
</name>
<name>
<surname>McCoy</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Macpherson</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota</article-title>
<source/>Semin Immunol.
          <year>2007</year>
<volume>19</volume>
<fpage>59</fpage>
<lpage>69</lpage>
<pub-id pub-id-type="pmid">17118672</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lamas</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Michel</surname>
<given-names>M-LL</given-names>
</name>
<name>
<surname>Waldschmitt</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Pham</surname>
<given-names>H-PP</given-names>
</name>
<name>
<surname>Zacharioudaki</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Dupraz</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Card9 mediates susceptibility to intestinal pathogens through microbiota modulation and control of bacterial virulence</article-title>
<source/>Gut.
          <year>2018</year>
<volume>67</volume>
<fpage>1836</fpage>
<lpage>1844</lpage>
<pub-id pub-id-type="pmid">28790160</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moens</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Veldhoen</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Epithelial barrier biology: good fences make good neighbours</article-title>
<source/>Immunology.
          <year>2012</year>
<volume>135</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">22044254</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamada</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Seo</surname>
<given-names>S-UU</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>GY</given-names>
</name>
<name>
<surname>Núñez</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Role of the gut microbiota in immunity and inflammatory disease</article-title>
<source/>Nat Rev Immunol.
          <year>2013</year>
<volume>13</volume>
<fpage>321</fpage>
<lpage>335</lpage>
<pub-id pub-id-type="pmid">23618829</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicholson</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kinross</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Burcelin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Host-gut microbiota metabolic interactions</article-title>
<source/>Science.
          <year>2012</year>
<volume>336</volume>
<fpage>1262</fpage>
<lpage>1267</lpage>
<pub-id pub-id-type="pmid">22674330</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hara</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Physiological concentrations of short-chain fatty acids immediately suppress colonic epithelial permeability</article-title>
<source/>Br J Nutr.
          <year>2008</year>
<volume>100</volume>
<fpage>297</fpage>
<lpage>305</lpage>
<pub-id pub-id-type="pmid">18346306</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z-RR</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Holzman</surname>
<given-names>IR</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers</article-title>
<source/>J Nutr.
          <year>2009</year>
<volume>139</volume>
<fpage>1619</fpage>
<lpage>1625</lpage>
<pub-id pub-id-type="pmid">19625695</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Pu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Aryl Hydrocarbon Receptor Activation in Intestinal Obstruction Ameliorates Intestinal Barrier Dysfunction Via Suppression of MLCK-MLC Phosphorylation Pathway</article-title>
<source/>Shock.
          <year>2016</year>
<volume>46</volume>
<fpage>319</fpage>
<lpage>328</lpage>
<pub-id pub-id-type="pmid">26939041</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>ABRAMS</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>BAUER</surname>
<given-names>H</given-names>
</name>
<name>
<surname>SPRINZ</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Influence of the normal flora on mucosal morphology and cellular renewal in the ileum. A comparison of germ-free and conventional mice</article-title>
<source/>Lab Invest.
          <year>1963</year>
<volume>12</volume>
<fpage>355</fpage>
<lpage>364</lpage>
<pub-id pub-id-type="pmid">14010768</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reinhardt</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bergentall</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Greiner</surname>
<given-names>TU</given-names>
</name>
<name>
<surname>Schaffner</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ostergren-Lundén</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>LC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling</article-title>
<source/>Nature.
          <year>2012</year>
<volume>483</volume>
<fpage>627</fpage>
<lpage>631</lpage>
<pub-id pub-id-type="pmid">22407318</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banasaz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Norin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Holma</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Midtvedt</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Increased enterocyte production in gnotobiotic rats mono-associated with <italic>Lactobacillus rhamnosus</italic> GG</article-title>
<source/>Appl Environ Microbiol.
          <year>2002</year>
<volume>68</volume>
<fpage>3031</fpage>
<lpage>3034</lpage>
<pub-id pub-id-type="pmid">12039764</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alam</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Midtvedt</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Uribe</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Differential cell kinetics in the ileum and colon of germfree rats</article-title>
<source/>Scand J Gastroenterol.
          <year>1994</year>
<volume>29</volume>
<fpage>445</fpage>
<lpage>451</lpage>
<pub-id pub-id-type="pmid">8036460</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shirkey</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Siggers</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Goldade</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Drew</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Laarveld</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of commensal bacteria on intestinal morphology and expression of proinflammatory cytokines in the gnotobiotic pig</article-title>
<source/>Exp Biol Med (Maywood).
          <year>2006</year>
<volume>231</volume>
<fpage>1333</fpage>
<lpage>1345</lpage>
<pub-id pub-id-type="pmid">16946402</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willing</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Van Kessel</surname>
<given-names>AG</given-names>
</name>
</person-group>
<article-title>Enterocyte proliferation and apoptosis in the caudal small intestine is influenced by the composition of colonizing commensal bacteria in the neonatal gnotobiotic pig</article-title>
<source/>J Anim Sci.
          <year>2007</year>
<volume>85</volume>
<fpage>3256</fpage>
<lpage>3266</lpage>
<pub-id pub-id-type="pmid">17785595</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Danielsen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hornshøj</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Siggers</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>van Kessel</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Bendixen</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Effects of bacterial colonization on the porcine intestinal proteome</article-title>
<source/>J Proteome Res.
          <year>2007</year>
<volume>6</volume>
<fpage>2596</fpage>
<lpage>2604</lpage>
<pub-id pub-id-type="pmid">17542629</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kozakova</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kolinska</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lojda</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Rehakova</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Sinkora</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zakostelecka</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effect of bacterial monoassociation on brush-border enzyme activities in ex-germ-free piglets: comparison of commensal and pathogenic <italic>Escherichia coli</italic> strains</article-title>
<source/>Microbes Infect.
          <year>2006</year>
<volume>8</volume>
<fpage>2629</fpage>
<lpage>2639</lpage>
<pub-id pub-id-type="pmid">16949322</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ardita</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>YM</given-names>
</name>
<name>
<surname>Mercante</surname>
<given-names>JW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species</article-title>
<source/>EMBO J.
          <year>2013</year>
<volume>32</volume>
<fpage>3017</fpage>
<lpage>3028</lpage>
<pub-id pub-id-type="pmid">24141879</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swanson</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Samarin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vijay-Kumar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kundu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Murthy</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Enteric commensal bacteria potentiate epithelial restitution via reactive oxygen species-mediated inactivation of focal adhesion kinase phosphatases</article-title>
<source/>Proc Natl Acad Sci USA.
          <year>2011</year>
<volume>108</volume>
<fpage>8803</fpage>
<lpage>8808</lpage>
<pub-id pub-id-type="pmid">21555563</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stockinger</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Di Meglio</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gialitakis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Duarte</surname>
<given-names>JHH</given-names>
</name>
</person-group>
<article-title>The aryl hydrocarbon receptor: multitasking in the immune system</article-title>
<source/>Annu Rev Immunol.
          <year>2014</year>
<volume>32</volume>
<fpage>403</fpage>
<lpage>432</lpage>
<pub-id pub-id-type="pmid">24655296</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>de</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Kendall</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Emam</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>Colonic health: fermentation and short chain fatty acids</article-title>
<source/>J Clin Gastroenterol
          <year>2006</year>
<volume>40</volume>
<fpage>235</fpage>
<lpage>243</lpage>
<pub-id pub-id-type="pmid">16633129</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Comalada</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bailón</surname>
<given-names>E</given-names>
</name>
<name>
<surname>de Haro</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Lara-Villoslada</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Xaus</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zarzuelo</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype</article-title>
<source/>J Cancer Res Clin Oncol.
          <year>2006</year>
<volume>132</volume>
<fpage>487</fpage>
<lpage>497</lpage>
<pub-id pub-id-type="pmid">16788843</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orchel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dzierzewicz</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Parfiniewicz</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Weglarz</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wilczok</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Butyrate-induced differentiation of colon cancer cells is PKC and JNK dependent</article-title>
<source/>Dig Dis Sci.
          <year>2005</year>
<volume>50</volume>
<fpage>490</fpage>
<lpage>498</lpage>
<pub-id pub-id-type="pmid">15810631</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<mixed-citation publication-type="other">Foster JA, Lyte M, Meyer E, Cryan JF. Gut Microbiota and Brain Function: An Evolving Field in Neuroscience. Int J Neuropsychopharmacol. 2016;19.</mixed-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Llorente</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schnabl</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>The gut microbiota and liver disease</article-title>
<source/>Cell Mol Gastroenterol Hepatol.
          <year>2015</year>
<volume>1</volume>
<fpage>275</fpage>
<lpage>284</lpage>
<pub-id pub-id-type="pmid">26090511</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mazagova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Anfora</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Wissmueller</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lesley</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Miyamoto</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice</article-title>
<source/>FASEB J.
          <year>2015</year>
<volume>29</volume>
<fpage>1043</fpage>
<lpage>1055</lpage>
<pub-id pub-id-type="pmid">25466902</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
</person-group>
<article-title>Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour</article-title>
<source/>Nat Rev Neurosci.
          <year>2012</year>
<volume>13</volume>
<fpage>701</fpage>
<lpage>712</lpage>
<pub-id pub-id-type="pmid">22968153</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desbonnet</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Shanahan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>Microbiota is essential for social development in the mouse</article-title>
<source/>Mol Psychiatry.
          <year>2014</year>
<volume>19</volume>
<fpage>146</fpage>
<lpage>148</lpage>
<pub-id pub-id-type="pmid">23689536</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luczynski</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Whelan</surname>
<given-names>SOO</given-names>
</name>
<name>
<surname>O’Sullivan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Shanahan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Adult microbiota-deficient mice have distinct dendritic morphological changes: differential effects in the amygdala and hippocampus</article-title>
<source/>Eur J Neurosci.
          <year>2016</year>
<volume>44</volume>
<fpage>2654</fpage>
<lpage>2666</lpage>
<pub-id pub-id-type="pmid">27256072</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoban</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Stilling</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Shanahan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Claesson</surname>
<given-names>MJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Regulation of prefrontal cortex myelination by the microbiota</article-title>
<source/>Transl Psychiatry.
          <year>2016</year>
<volume>6</volume>
<fpage>e774</fpage>
<pub-id pub-id-type="pmid">27045844</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braniste</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Al-Asmakh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kowal</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Anuar</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Abbaspour</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tóth</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The gut microbiota influences blood-brain barrier permeability in mice</article-title>
<source/>Sci Transl Med
          <year>2014</year>
<volume>6</volume>
<fpage>263ra158</fpage>
<pub-id pub-id-type="pmid">25411471</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erny</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hrabě de Angelis</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Jaitin</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wieghofer</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Staszewski</surname>
<given-names>O</given-names>
</name>
<name>
<surname>David</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Host microbiota constantly control maturation and function of microglia in the CNS</article-title>
<source/>Nat Neurosci.
          <year>2015</year>
<volume>18</volume>
<fpage>965</fpage>
<lpage>977</lpage>
<pub-id pub-id-type="pmid">26030851</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sudo</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Chida</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Aiba</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sonoda</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Oyama</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X-NN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice</article-title>
<source/>J Physiol (Lond).
          <year>2004</year>
<volume>558</volume>
<fpage>263</fpage>
<lpage>275</lpage>
<pub-id pub-id-type="pmid">15133062</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buffington</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Di Prisco</surname>
<given-names>GV</given-names>
</name>
<name>
<surname>Auchtung</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Ajami</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Petrosino</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Costa-Mattioli</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring</article-title>
<source/>Cell.
          <year>2016</year>
<volume>165</volume>
<fpage>1762</fpage>
<lpage>1775</lpage>
<pub-id pub-id-type="pmid">27315483</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zelante</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Iannitti</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Cunha</surname>
<given-names>C</given-names>
</name>
<name>
<surname>De Luca</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Giovannini</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pieraccini</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22</article-title>
<source/>Immunity.
          <year>2013</year>
<volume>39</volume>
<fpage>372</fpage>
<lpage>385</lpage>
<pub-id pub-id-type="pmid">23973224</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lamas</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Richard</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Leducq</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Pham</surname>
<given-names>H-PP</given-names>
</name>
<name>
<surname>Michel</surname>
<given-names>M-LL</given-names>
</name>
<name>
<surname>Da Costa</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands</article-title>
<source/>Nat Med.
          <year>2016</year>
<volume>22</volume>
<fpage>598</fpage>
<lpage>605</lpage>
<pub-id pub-id-type="pmid">27158904</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rothhammer</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Mascanfroni</surname>
<given-names>ID</given-names>
</name>
<name>
<surname>Bunse</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Takenaka</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Kenison</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Mayo</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor</article-title>
<source/>Nat Med.
          <year>2016</year>
<volume>22</volume>
<fpage>586</fpage>
<lpage>597</lpage>
<pub-id pub-id-type="pmid">27158906</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<mixed-citation publication-type="other">Beaumont M, Neyrinck AM, Olivares M, Rodriguez J, de RSA, Roumain M, et al. The gut microbiota metabolite indole alleviates liver inflammation in mice. FASEB J. 2018:fj201800544.</mixed-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakakibara</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yamauchi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Oshima</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tsukamoto</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kadowaki</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Acetic acid activates hepatic AMPK and reduces hyperglycemia in diabetic KK-A(y) mice</article-title>
<source/>Biochem Biophys Res Commun.
          <year>2006</year>
<volume>344</volume>
<fpage>597</fpage>
<lpage>604</lpage>
<pub-id pub-id-type="pmid">16630552</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Endo</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Niioka</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<fpage>e63388</fpage>
<pub-id pub-id-type="pmid">23696823</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Kivit</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tobin</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Forsyth</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Keshavarzian</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Landay</surname>
<given-names>AL</given-names>
</name>
</person-group>
<article-title>Regulation of Intestinal Immune Responses through TLR Activation: Implications for Pro- and Prebiotics</article-title>
<source/>Front Immunol.
          <year>2014</year>
<volume>5</volume>
<fpage>60</fpage>
<pub-id pub-id-type="pmid">24600450</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delgado-Rizo</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Martínez-Guzmán</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Iñiguez-Gutierrez</surname>
<given-names>L</given-names>
</name>
<name>
<surname>García-Orozco</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Alvarado-Navarro</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fafutis-Morris</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Neutrophil Extracellular Traps and Its Implications in Inflammation: An Overview</article-title>
<source/>Front Immunol.
          <year>2017</year>
<volume>8</volume>
<fpage>81</fpage>
<pub-id pub-id-type="pmid">28220120</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<mixed-citation publication-type="other">Cassard A-MM, Gérard P, Perlemuter G. Microbiota, Liver Diseases, and Alcohol. Microbiol Spectr. 2017;5.</mixed-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macpherson</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Uhr</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria</article-title>
<source/>Science.
          <year>2004</year>
<volume>303</volume>
<fpage>1662</fpage>
<lpage>1665</lpage>
<pub-id pub-id-type="pmid">15016999</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coombes</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Siddiqui</surname>
<given-names>KRR</given-names>
</name>
<name>
<surname>Arancibia-Cárcamo</surname>
<given-names>CV</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>C-MM</given-names>
</name>
<name>
<surname>Belkaid</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism</article-title>
<source/>J Exp Med.
          <year>2007</year>
<volume>204</volume>
<fpage>1757</fpage>
<lpage>1764</lpage>
<pub-id pub-id-type="pmid">17620361</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>LeBien</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Tedder</surname>
<given-names>TF</given-names>
</name>
</person-group>
<article-title>B lymphocytes: how they develop and function</article-title>
<source/>Blood.
          <year>2008</year>
<volume>112</volume>
<fpage>1570</fpage>
<lpage>1580</lpage>
<pub-id pub-id-type="pmid">18725575</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<mixed-citation publication-type="other">Ohno H. Intestinal M cells. J Biochem. 2016;159:151–160.</mixed-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sommer</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bäckhed</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>The gut microbiota--masters of host development and physiology</article-title>
<source/>Nat Rev Microbiol.
          <year>2013</year>
<volume>11</volume>
<fpage>227</fpage>
<lpage>238</lpage>
<pub-id pub-id-type="pmid">23435359</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chung</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Pamp</surname>
<given-names>SJJ</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Surana</surname>
<given-names>NK</given-names>
</name>
<name>
<surname>Edelman</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Troy</surname>
<given-names>EB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut immune maturation depends on colonization with a host-specific microbiota</article-title>
<source/>Cell.
          <year>2012</year>
<volume>149</volume>
<fpage>1578</fpage>
<lpage>1593</lpage>
<pub-id pub-id-type="pmid">22726443</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaboriau-Routhiau</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Rakotobe</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lécuyer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mulder</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bridonneau</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses</article-title>
<source/>Immunity.
          <year>2009</year>
<volume>31</volume>
<fpage>677</fpage>
<lpage>689</lpage>
<pub-id pub-id-type="pmid">19833089</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ivanov</surname>
<given-names>II</given-names>
</name>
<name>
<surname>Atarashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Manel</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Brodie</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Shima</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Karaoz</surname>
<given-names>U</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Induction of intestinal Th17 cells by segmented filamentous bacteria</article-title>
<source/>Cell.
          <year>2009</year>
<volume>139</volume>
<fpage>485</fpage>
<lpage>498</lpage>
<pub-id pub-id-type="pmid">19836068</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Telesford</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Ochoa-Reparaz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pant</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kircher</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Christy</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A commensal symbiotic factor derived from <italic>Bacteroides fragilis</italic> promotes human CD39(+)Foxp3(+) T cells and Treg function</article-title>
<source/>Gut Microbes.
          <year>2015</year>
<volume>6</volume>
<fpage>234</fpage>
<lpage>242</lpage>
<pub-id pub-id-type="pmid">26230152</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Round</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Mazmanian</surname>
<given-names>SK</given-names>
</name>
</person-group>
<article-title>Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota</article-title>
<source/>Proc Natl Acad Sci USA.
          <year>2010</year>
<volume>107</volume>
<fpage>12204</fpage>
<lpage>12209</lpage>
<pub-id pub-id-type="pmid">20566854</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sokol</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Pigneur</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Watterlot</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lakhdari</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Bermúdez-Humarán</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Gratadoux</surname>
<given-names>J-JJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients</article-title>
<source/>Proc Natl Acad Sci USA.
          <year>2008</year>
<volume>105</volume>
<fpage>16731</fpage>
<lpage>16736</lpage>
<pub-id pub-id-type="pmid">18936492</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quévrain</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Maubert</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Michon</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chain</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Marquant</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tailhades</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease</article-title>
<source/>Gut.
          <year>2016</year>
<volume>65</volume>
<fpage>415</fpage>
<lpage>425</lpage>
<pub-id pub-id-type="pmid">26045134</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breyner</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Michon</surname>
<given-names>C</given-names>
</name>
<name>
<surname>de</surname>
<given-names>SCS</given-names>
</name>
<name>
<surname>Vilas Boas</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Chain</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Azevedo</surname>
<given-names>VA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbial Anti-Inflammatory Molecule (MAM) from Faecalibacterium prausnitzii Shows a Protective Effect on DNBS and DSS-Induced Colitis Model in Mice through Inhibition of NF-κB Pathway. Frontiers in microbiology</article-title>
<source/>Front Microbiol
          <year>2017</year>
<volume>8</volume>
<fpage>114</fpage>
<pub-id pub-id-type="pmid">28203226</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levy</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Thaiss</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Elinav</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Metabolites: messengers between the microbiota and the immune system</article-title>
<source/>Genes Dev.
          <year>2016</year>
<volume>30</volume>
<fpage>1589</fpage>
<lpage>1597</lpage>
<pub-id pub-id-type="pmid">27474437</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donohoe</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Garge</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>W</given-names>
</name>
<name>
<surname>O’Connell</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Bunger</surname>
<given-names>MK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon</article-title>
<source/>Cell Metab.
          <year>2011</year>
<volume>13</volume>
<fpage>517</fpage>
<lpage>526</lpage>
<pub-id pub-id-type="pmid">21531334</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corrêa-Oliveira</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fachi</surname>
<given-names>JLL</given-names>
</name>
<name>
<surname>Vieira</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>FT</given-names>
</name>
<name>
<surname>Vinolo</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Regulation of immune cell function by short-chain fatty acids</article-title>
<source/>Clin Transl Immunology.
          <year>2016</year>
<volume>5</volume>
<fpage>e73</fpage>
<pub-id pub-id-type="pmid">27195116</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gurav</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sivaprakasam</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bhutia</surname>
<given-names>YD</given-names>
</name>
<name>
<surname>Boettger</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ganapathy</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Slc5a8, a Na+−coupled high-affinity transporter for short-chain fatty acids, is a conditional tumour suppressor in colon that protects against colitis and colon cancer under low-fibre dietary conditions</article-title>
<source/>Biochem J.
          <year>2015</year>
<volume>469</volume>
<fpage>267</fpage>
<lpage>278</lpage>
<pub-id pub-id-type="pmid">25984582</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lamas</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Natividad</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Sokol</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Aryl hydrocarbon receptor and intestinal immunity</article-title>
<source/>Mucosal Immunol.
          <year>2018</year>
<volume>11</volume>
<fpage>1024</fpage>
<lpage>1038</lpage>
<pub-id pub-id-type="pmid">29626198</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agus</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Planchais</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sokol</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease</article-title>
<source/>Cell Host Microbe.
          <year>2018</year>
<volume>23</volume>
<fpage>716</fpage>
<lpage>724</lpage>
<pub-id pub-id-type="pmid">29902437</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>HU</given-names>
</name>
<name>
<surname>McPherson</surname>
<given-names>ZE</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Korecka</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pettersson</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Host-microbiome interactions: the aryl hydrocarbon receptor and the central nervous system</article-title>
<source/>J Mol Med.
          <year>2017</year>
<volume>95</volume>
<fpage>29</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="pmid">27858116</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGee</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Storey</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Clipson</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Doyle</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Soil microbial community responses to contamination with silver, aluminium oxide and silicon dioxide nanoparticles</article-title>
<source/>Ecotoxicology.
          <year>2017</year>
<volume>26</volume>
<fpage>449</fpage>
<lpage>458</lpage>
<pub-id pub-id-type="pmid">28197855</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Timmusk</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Seisenbaeva</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Behers</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Titania (TiO2) nanoparticles enhance the performance of growth-promoting rhizobacteria</article-title>
<source/>Sci Rep.
          <year>2018</year>
<volume>8</volume>
<fpage>617</fpage>
<pub-id pub-id-type="pmid">29330479</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oral administration of rutile and anatase TiO 2 nanoparticles shifts mouse gut microbiota structure</article-title>
<source/>Nanoscale.
          <year>2018</year>
<volume>10</volume>
<fpage>7736</fpage>
<lpage>7745</lpage>
<pub-id pub-id-type="pmid">29658026</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Milner</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Boudreau</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Gokulan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cerniglia</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Khare</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Effects of subchronic exposure of silver nanoparticles on intestinal microbiota and gut-associated immune responses in the ileum of Sprague-Dawley rats</article-title>
<source/>Nanotoxicology.
          <year>2015</year>
<volume>9</volume>
<fpage>279</fpage>
<lpage>289</lpage>
<pub-id pub-id-type="pmid">24877679</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Javurek</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Suresh</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Spollen</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Ellersieck</surname>
<given-names>MR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut Dysbiosis and Neurobehavioral Alterations in Rats Exposed to Silver Nanoparticles</article-title>
<source/>Sci Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>2822</fpage>
<pub-id pub-id-type="pmid">28588204</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The effects of orally administered Ag, TiO2 and SiO2 nanoparticles on gut microbiota composition and colitis induction in mice</article-title>
<source/>Nanoimpact.
          <year>2017</year>
<volume>8</volume>
<fpage>80</fpage>
<lpage>88</lpage>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van den Brule</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ambroise</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lecloux</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Levard</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Soulas</surname>
<given-names>R</given-names>
</name>
<name>
<surname>De Temmerman</surname>
<given-names>P-JJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dietary silver nanoparticles can disturb the gut microbiota in mice</article-title>
<source/>Part Fibre Toxicol.
          <year>2016</year>
<volume>13</volume>
<fpage>38</fpage>
<pub-id pub-id-type="pmid">27393559</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Dietary ZnO nanoparticles alters intestinal microbiota and inflammation response in weaned piglets</article-title>
<source/>Oncotarget.
          <year>2017</year>
<volume>8</volume>
<fpage>64878</fpage>
<lpage>64891</lpage>
<pub-id pub-id-type="pmid">29029398</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yausheva</surname>
<given-names>Е</given-names>
</name>
<name>
<surname>Miroshnikov</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sizova</surname>
<given-names>Е</given-names>
</name>
</person-group>
<article-title>Intestinal microbiome of broiler chickens after use of nanoparticles and metal salts</article-title>
<source/>Environ Sci Pollut R.
          <year>2018</year>
<volume>25</volume>
<fpage>18109</fpage>
<lpage>18120</lpage>
</element-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Zinc Oxide Nanoparticles Influence Microflora in Ileal Digesta and Correlate Well with Blood Metabolites</article-title>
<source/>Front Microbiol.
          <year>2017</year>
<volume>8</volume>
<fpage>992</fpage>
<pub-id pub-id-type="pmid">28626453</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<mixed-citation publication-type="other">Das P, Julie A, Elaine O, Emma A-V, Virginia K. Nanosilver-Mediated Change in Human Intestinal Microbiota. J Nanomed Nanotechnol. 2014:05.</mixed-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dudefoi</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Moniz</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Allen-Vercoe</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ropers</surname>
<given-names>M-HH</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>VK</given-names>
</name>
</person-group>
<article-title>Impact of food grade and nano-TiO2 particles on a human intestinal community</article-title>
<source/>Food Chem Toxicol.
          <year>2017</year>
<volume>106</volume>
<fpage>242</fpage>
<lpage>249</lpage>
<pub-id pub-id-type="pmid">28564612</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hadrup</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Loeschner</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bergström</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wilcks</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Vogel</surname>
<given-names>U</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Subacute oral toxicity investigation of nanoparticulate and ionic silver in rats</article-title>
<source/>Arch Toxicol.
          <year>2012</year>
<volume>86</volume>
<fpage>543</fpage>
<lpage>551</lpage>
<pub-id pub-id-type="pmid">21969074</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilding</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Bassis</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Walacavage</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hashway</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Leroueil</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Morishita</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Repeated dose (28-day) administration of silver nanoparticles of varied size and coating does not significantly alter the indigenous murine gut microbiome</article-title>
<source/>Nanotoxicology.
          <year>2016</year>
<volume>10</volume>
<fpage>513</fpage>
<lpage>520</lpage>
<pub-id pub-id-type="pmid">26525505</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bettini</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Boutet-Robinet</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cartier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Coméra</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gaultier</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dupuy</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Food-grade TiO2 impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colon</article-title>
<source/>Sci Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>40373</fpage>
<pub-id pub-id-type="pmid">28106049</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Marcus</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Guysi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Metal Oxide Nanoparticles Induce Minimal Phenotypic Changes in a Model Colon Gut Microbiota</article-title>
<source/>Environ Eng Sci
          <year>2015</year>
<volume>32</volume>
<fpage>602</fpage>
<lpage>612</lpage>
</element-citation>
</ref>
<ref id="CR118">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kreyling</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Holzwarth</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Schleh</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kozempel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wenk</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Haberl</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Quantitative biokinetics of titanium dioxide nanoparticles after oral application in rats: Part 2</article-title>
<source/>Nanotoxicology.
          <year>2017</year>
<volume>11</volume>
<fpage>443</fpage>
<lpage>453</lpage>
<pub-id pub-id-type="pmid">28290734</pub-id>
</element-citation>
</ref>
<ref id="CR119">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Morton</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Jurkschat</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Harding</surname>
<given-names>A-HH</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Human in vivo and in vitro studies on gastrointestinal absorption of titanium dioxide nanoparticles</article-title>
<source/>Toxicol Lett.
          <year>2015</year>
<volume>233</volume>
<fpage>95</fpage>
<lpage>101</lpage>
<pub-id pub-id-type="pmid">25597860</pub-id>
</element-citation>
</ref>
<ref id="CR120">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>A</given-names>
</name>
<name>
<surname>He</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Coated zinc oxide improves intestinal immunity function and regulates microbiota composition in weaned piglets</article-title>
<source/>Br J Nutr.
          <year>2014</year>
<volume>111</volume>
<fpage>2123</fpage>
<lpage>2134</lpage>
<pub-id pub-id-type="pmid">24606984</pub-id>
</element-citation>
</ref>
<ref id="CR121">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsugita</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Morimoto</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Nakayama</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>SiO2 and TiO2 nanoparticles synergistically trigger macrophage inflammatory responses</article-title>
<source/>Part Fibre Toxicol.
          <year>2017</year>
<volume>14</volume>
<fpage>11</fpage>
<pub-id pub-id-type="pmid">28399878</pub-id>
</element-citation>
</ref>
<ref id="CR122">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schanen</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Karakoti</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Seal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Drake</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Self</surname>
<given-names>WT</given-names>
</name>
</person-group>
<article-title>Exposure to titanium dioxide nanomaterials provokes inflammation of an in vitro human immune construct</article-title>
<source/>ACS Nano.
          <year>2009</year>
<volume>3</volume>
<fpage>2523</fpage>
<lpage>2532</lpage>
<pub-id pub-id-type="pmid">19769402</pub-id>
</element-citation>
</ref>
<ref id="CR123">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winter</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Beer</surname>
<given-names>H-DD</given-names>
</name>
<name>
<surname>Hornung</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Krämer</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Schins</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Förster</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Activation of the inflammasome by amorphous silica and TiO2 nanoparticles in murine dendritic cells</article-title>
<source/>Nanotoxicology.
          <year>2011</year>
<volume>5</volume>
<fpage>326</fpage>
<lpage>340</lpage>
<pub-id pub-id-type="pmid">20846021</pub-id>
</element-citation>
</ref>
<ref id="CR124">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shah</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Hazardous Effects of Titanium Dioxide Nanoparticles in Ecosystem</article-title>
<source/>Bioinorg Chem Appl.
          <year>2017</year>
<volume>2017</volume>
<fpage>4101735</fpage>
<pub-id pub-id-type="pmid">28373829</pub-id>
</element-citation>
</ref>
<ref id="CR125">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Setyawati</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Tay</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Leong</surname>
<given-names>DT</given-names>
</name>
</person-group>
<article-title>Mechanistic Investigation of the Biological Effects of SiO<sub>2</sub>, TiO<sub>2</sub>, and ZnO Nanoparticles on Intestinal Cells</article-title>
<source/>Small.
          <year>2015</year>
<volume>11</volume>
<fpage>3458</fpage>
<lpage>3468</lpage>
<pub-id pub-id-type="pmid">25902938</pub-id>
</element-citation>
</ref>
<ref id="CR126">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lucarelli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gatti</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Savarino</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Quattroni</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Martinelli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Monari</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Innate defence functions of macrophages can be biased by nano-sized ceramic and metallic particles</article-title>
<source/>Eur Cytokine Netw.
          <year>2004</year>
<volume>15</volume>
<fpage>339</fpage>
<lpage>346</lpage>
<pub-id pub-id-type="pmid">15627643</pub-id>
</element-citation>
</ref>
<ref id="CR127">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mano</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Kanehira</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Taniguchi</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Comparison of cellular uptake and inflammatory response via toll-like receptor 4 to lipopolysaccharide and titanium dioxide nanoparticles</article-title>
<source/>Int J Mol Sci.
          <year>2013</year>
<volume>14</volume>
<fpage>13154</fpage>
<lpage>13170</lpage>
<pub-id pub-id-type="pmid">23803652</pub-id>
</element-citation>
</ref>
<ref id="CR128">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kanehira</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Taniguchi</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Role of toll-like receptors 3, 4 and 7 in cellular uptake and response to titanium dioxide nanoparticles</article-title>
<source/>Sci Technol Adv Mater.
          <year>2013</year>
<volume>14</volume>
<fpage>015008</fpage>
<pub-id pub-id-type="pmid">27877566</pub-id>
</element-citation>
</ref>
<ref id="CR129">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andersson-Willman</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gehrmann</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Cansu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Buerki-Thurnherr</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Krug</surname>
<given-names>HF</given-names>
</name>
<name>
<surname>Gabrielsson</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of subtoxic concentrations of TiO2 and ZnO nanoparticles on human lymphocytes, dendritic cells and exosome production</article-title>
<source/>Toxicol Appl Pharmacol.
          <year>2012</year>
<volume>264</volume>
<fpage>94</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="pmid">22842014</pub-id>
</element-citation>
</ref>
<ref id="CR130">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palomäki</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Karisola</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Pylkkänen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Savolainen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Alenius</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Engineered nanomaterials cause cytotoxicity and activation on mouse antigen presenting cells</article-title>
<source/>Toxicology.
          <year>2010</year>
<volume>267</volume>
<fpage>125</fpage>
<lpage>131</lpage>
<pub-id pub-id-type="pmid">19897006</pub-id>
</element-citation>
</ref>
<ref id="CR131">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The induction of maturation on dendritic cells by TiO2 and Fe (3) O (4)@TiO (2) nanoparticles via NF-κB signaling pathway</article-title>
<source/>Mater Sci Eng C Mater Biol Appl.
          <year>2014</year>
<volume>39</volume>
<fpage>305</fpage>
<lpage>314</lpage>
<pub-id pub-id-type="pmid">24863229</pub-id>
</element-citation>
</ref>
<ref id="CR132">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vandebriel</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Vermeulen</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>van</surname>
<given-names>ELB</given-names>
</name>
<name>
<surname>de</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Verhagen</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>de la</surname>
<given-names>F-BLJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The crystal structure of titanium dioxide nanoparticles influences immune activity in vitro and in vivo</article-title>
<source/>Part Fibre Toxicol
          <year>2018</year>
<volume>15</volume>
<fpage>9</fpage>
<pub-id pub-id-type="pmid">29382351</pub-id>
</element-citation>
</ref>
<ref id="CR133">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Batt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Milward</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chapple</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Addison</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>TiO2 nanoparticles can selectively bind CXCL8 impacting on neutrophil chemotaxis</article-title>
<source/>Eur Cell Mater.
          <year>2018</year>
<volume>35</volume>
<fpage>13</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="pmid">29350745</pub-id>
</element-citation>
</ref>
<ref id="CR134">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feltis</surname>
<given-names>BN</given-names>
</name>
<name>
<surname>Elbaz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Mackay</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Turney</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Lopata</surname>
<given-names>AL</given-names>
</name>
</person-group>
<article-title>Characterizing the inhibitory action of zinc oxide nanoparticles on allergic-type mast cell activation</article-title>
<source/>Mol Immunol.
          <year>2015</year>
<volume>66</volume>
<fpage>139</fpage>
<lpage>146</lpage>
<pub-id pub-id-type="pmid">25771180</pub-id>
</element-citation>
</ref>
<ref id="CR135">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Mendoza</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Raghavendra</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Podila</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Contribution of engineered nanomaterials physicochemical properties to mast cell degranulation</article-title>
<source/>Sci Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>43570</fpage>
<pub-id pub-id-type="pmid">28262689</pub-id>
</element-citation>
</ref>
<ref id="CR136">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Babin</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Antoine</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Goncalves</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Girard</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>TiO2, CeO2 and ZnO nanoparticles and modulation of the degranulation process in human neutrophils</article-title>
<source/>Toxicol Lett.
          <year>2013</year>
<volume>221</volume>
<fpage>57</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="pmid">23726862</pub-id>
</element-citation>
</ref>
<ref id="CR137">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sabziparvar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Saeedi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nouri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Najafi Bozorgi</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Alizadeh</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Attar</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Investigating the Interaction of Silicon Dioxide Nanoparticles with Human Hemoglobin and Lymphocyte Cells by Biophysical, Computational, and Cellular Studies</article-title>
<source/>J Phys Chem B.
          <year>2018</year>
<volume>122</volume>
<fpage>4278</fpage>
<lpage>4288</lpage>
<pub-id pub-id-type="pmid">29537841</pub-id>
</element-citation>
</ref>
<ref id="CR138">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>J-S</given-names>
</name>
</person-group>
<article-title>Induction of Functional Changes of Dendritic Cells by Silica Nanoparticles</article-title>
<source/>Immune Netw.
          <year>2012</year>
<volume>12</volume>
<fpage>104</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="pmid">22916046</pub-id>
</element-citation>
</ref>
<ref id="CR139">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winkler</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Kornprobst</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wick</surname>
<given-names>P</given-names>
</name>
<name>
<surname>von Moos</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Trantakis</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Schraner</surname>
<given-names>EM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MyD88-dependent pro-interleukin-1β induction in dendritic cells exposed to food-grade synthetic amorphous silica</article-title>
<source/>Part Fibre Toxicol.
          <year>2017</year>
<volume>14</volume>
<fpage>21</fpage>
<pub-id pub-id-type="pmid">28645296</pub-id>
</element-citation>
</ref>
<ref id="CR140">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herd</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Bartlett</surname>
<given-names>KT</given-names>
</name>
<name>
<surname>Gustafson</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>McGill</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Ghandehari</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Macrophage silica nanoparticle response is phenotypically dependent</article-title>
<source/>Biomaterials.
          <year>2015</year>
<volume>53</volume>
<fpage>574</fpage>
<lpage>582</lpage>
<pub-id pub-id-type="pmid">25890753</pub-id>
</element-citation>
</ref>
<ref id="CR141">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirai</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yoshioka</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ichihashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tochigi</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Amorphous silica nanoparticles enhance cross-presentation in murine dendritic cells</article-title>
<source/>Biochem Biophys Res Commun.
          <year>2012</year>
<volume>427</volume>
<fpage>553</fpage>
<lpage>556</lpage>
<pub-id pub-id-type="pmid">23022188</pub-id>
</element-citation>
</ref>
<ref id="CR142">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desai</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Foresto-Neto</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Honarpisheh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Steiger</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nakazawa</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Popper</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Particles of different sizes and shapes induce neutrophil necroptosis followed by the release of neutrophil extracellular trap-like chromatin</article-title>
<source/>Sci Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>15003</fpage>
<pub-id pub-id-type="pmid">29101355</pub-id>
</element-citation>
</ref>
<ref id="CR143">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>C-CC</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>W-HH</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>M-HH</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>H-TT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Involvement of MyD88 in zinc oxide nanoparticle-induced lung inflammation</article-title>
<source/>Exp Toxicol Pathol.
          <year>2013</year>
<volume>65</volume>
<fpage>887</fpage>
<lpage>896</lpage>
<pub-id pub-id-type="pmid">23352990</pub-id>
</element-citation>
</ref>
<ref id="CR144">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Girard</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Human eosinophils are direct targets to nanoparticles: Zinc oxide nanoparticles (ZnO) delay apoptosis and increase the production of the pro-inflammatory cytokines IL-1β and IL-8</article-title>
<source/>Toxicol Lett.
          <year>2016</year>
<volume>259</volume>
<fpage>11</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="pmid">27452280</pub-id>
</element-citation>
</ref>
<ref id="CR145">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heng</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Khamis</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Assodani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evaluation of the cytotoxic and inflammatory potential of differentially shaped zinc oxide nanoparticles</article-title>
<source/>Arch Toxicol.
          <year>2011</year>
<volume>85</volume>
<fpage>1517</fpage>
<lpage>1528</lpage>
<pub-id pub-id-type="pmid">21656222</pub-id>
</element-citation>
</ref>
<ref id="CR146">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gümüş</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Berber</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Ada</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Aksoy</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>In vitro genotoxic effects of ZnO nanomaterials in human peripheral lymphocytes</article-title>
<source/>Cytotechnology.
          <year>2014</year>
<volume>66</volume>
<fpage>317</fpage>
<lpage>325</lpage>
<pub-id pub-id-type="pmid">23784729</pub-id>
</element-citation>
</ref>
<ref id="CR147">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>E-JJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>I-HH</given-names>
</name>
</person-group>
<article-title>Inflammasome formation and IL-1β release by human blood monocytes in response to silver nanoparticles</article-title>
<source/>Biomaterials.
          <year>2012</year>
<volume>33</volume>
<fpage>6858</fpage>
<lpage>6867</lpage>
<pub-id pub-id-type="pmid">22770526</pub-id>
</element-citation>
</ref>
<ref id="CR148">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghosh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Manivannan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sinha</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chakraborty</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mallick</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Bandyopadhyay</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>In vitro and in vivo genotoxicity of silver nanoparticles</article-title>
<source/>Mutat Res.
          <year>2012</year>
<volume>749</volume>
<fpage>60</fpage>
<lpage>69</lpage>
<pub-id pub-id-type="pmid">22960309</pub-id>
</element-citation>
</ref>
<ref id="CR149">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>E-JJ</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism</article-title>
<source/>Toxicol In Vitro.
          <year>2010</year>
<volume>24</volume>
<fpage>872</fpage>
<lpage>878</lpage>
<pub-id pub-id-type="pmid">19969064</pub-id>
</element-citation>
</ref>
<ref id="CR150">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aldossari</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Shannahan</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Podila</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Influence of physicochemical properties of silver nanoparticles on mast cell activation and degranulation</article-title>
<source/>Toxicol In Vitro.
          <year>2015</year>
<volume>29</volume>
<fpage>195</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="pmid">25458489</pub-id>
</element-citation>
</ref>
<ref id="CR151">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alsaleh</surname>
<given-names>NB</given-names>
</name>
<name>
<surname>Persaud</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Silver Nanoparticle-Directed Mast Cell Degranulation Is Mediated through Calcium and PI3K Signaling Independent of the High Affinity IgE Receptor</article-title>
<source/>PLoS One
          <year>2016</year>
<volume>11</volume>
<fpage>e0167366</fpage>
<pub-id pub-id-type="pmid">27907088</pub-id>
</element-citation>
</ref>
<ref id="CR152">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burcelin</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Gut microbiota and immune crosstalk in metabolic disease</article-title>
<source/>Mol Metab.
          <year>2016</year>
<volume>5</volume>
<fpage>771</fpage>
<lpage>781</lpage>
<pub-id pub-id-type="pmid">27617200</pub-id>
</element-citation>
</ref>
<ref id="CR153">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lazar</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Ditu</surname>
<given-names>L-MM</given-names>
</name>
<name>
<surname>Pircalabioru</surname>
<given-names>GG</given-names>
</name>
<name>
<surname>Gheorghe</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Curutiu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Holban</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Aspects of Gut Microbiota and Immune System Interactions in Infectious Diseases, Immunopathology, and Cancer</article-title>
<source/>Front Immunol.
          <year>2018</year>
<volume>9</volume>
<fpage>1830</fpage>
<pub-id pub-id-type="pmid">30158926</pub-id>
</element-citation>
</ref>
<ref id="CR154">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gatti</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Biocompatibility of micro- and nano-particles in the colon</article-title>
<source/>Part II. Biomaterials.
          <year>2004</year>
<volume>25</volume>
<fpage>385</fpage>
<lpage>392</lpage>
<pub-id pub-id-type="pmid">14585686</pub-id>
</element-citation>
</ref>
<ref id="CR155">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruiz</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Morón</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Atrott</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Spalinger</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Titanium dioxide nanoparticles exacerbate DSS-induced colitis: role of the NLRP3 inflammasome</article-title>
<source/>Gut
          <year>2016</year>
<volume>66</volume>
<fpage>gutjnl–2015–310297</fpage>
</element-citation>
</ref>
<ref id="CR156">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Powell</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Ainley</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Harvey</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Kendall</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Sankey</surname>
<given-names>EA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterisation of inorganic microparticles in pigment cells of human gut associated lymphoid tissue</article-title>
<source/>Gut.
          <year>1996</year>
<volume>38</volume>
<fpage>390</fpage>
<lpage>395</lpage>
<pub-id pub-id-type="pmid">8675092</pub-id>
</element-citation>
</ref>
<ref id="CR157">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hummel</surname>
<given-names>TZ</given-names>
</name>
<name>
<surname>Kindermann</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stokkers</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Benninga</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>ten Kate</surname>
<given-names>FJ</given-names>
</name>
</person-group>
<article-title>Exogenous pigment in Peyer patches of children suspected of having IBD</article-title>
<source/>J Pediatr Gastroenterol Nutr.
          <year>2014</year>
<volume>58</volume>
<fpage>477</fpage>
<lpage>480</lpage>
<pub-id pub-id-type="pmid">24164906</pub-id>
</element-citation>
</ref>
<ref id="CR158">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Janer</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mas del Molino</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fernández-Rosas</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fernández</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vázquez-Campos</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Cell uptake and oral absorption of titanium dioxide nanoparticles</article-title>
<source/>Toxicol Lett.
          <year>2014</year>
<volume>228</volume>
<fpage>103</fpage>
<lpage>110</lpage>
<pub-id pub-id-type="pmid">24793716</pub-id>
</element-citation>
</ref>
<ref id="CR159">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brun</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Barreau</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Veronesi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Fayard</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sorieul</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chanéac</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Titanium dioxide nanoparticle impact and translocation through ex vivo, in vivo and in vitro gut epithelia</article-title>
<source/>Part Fibre Toxicol.
          <year>2014</year>
<volume>11</volume>
<fpage>13</fpage>
<pub-id pub-id-type="pmid">24666995</pub-id>
</element-citation>
</ref>
<ref id="CR160">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loeschner</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hadrup</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Qvortrup</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Larsen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Vogel</surname>
<given-names>U</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate</article-title>
<source/>Part Fibre Toxicol.
          <year>2011</year>
<volume>8</volume>
<fpage>18</fpage>
<pub-id pub-id-type="pmid">21631937</pub-id>
</element-citation>
</ref>
<ref id="CR161">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nogueira</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>de Azevedo</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Dagli</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Toma</surname>
<given-names>SHH</given-names>
</name>
<name>
<surname>Leite</surname>
<given-names>AZZ</given-names>
</name>
<name>
<surname>Lordello</surname>
<given-names>ML</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Titanium dioxide induced inflammation in the small intestine</article-title>
<source/>World J Gastroenterol.
          <year>2012</year>
<volume>18</volume>
<fpage>4729</fpage>
<lpage>4735</lpage>
<pub-id pub-id-type="pmid">23002342</pub-id>
</element-citation>
</ref>
<ref id="CR162">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yoshino</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Amorphous nanosilica particles block induction of oral tolerance in mice</article-title>
<source/>J Immunotoxicol.
          <year>2016</year>
<volume>13</volume>
<fpage>723</fpage>
<lpage>728</lpage>
<pub-id pub-id-type="pmid">27086695</pub-id>
</element-citation>
</ref>
<ref id="CR163">
<label>163.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Blockade of oral tolerance to ovalbumin in mice by silver nanoparticles</article-title>
<source/>Nanomedicine (Lond).
          <year>2015</year>
<volume>10</volume>
<fpage>419</fpage>
<lpage>431</lpage>
<pub-id pub-id-type="pmid">25707976</pub-id>
</element-citation>
</ref>
<ref id="CR164">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chai</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ZnO nanoparticles act as supportive therapy in DSS-induced ulcerative colitis in mice by maintaining gut homeostasis and activating Nrf2 signaling</article-title>
<source/>Sci Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>43126</fpage>
<pub-id pub-id-type="pmid">28233796</pub-id>
</element-citation>
</ref>
<ref id="CR165">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration</article-title>
<source/>Toxicol Lett.
          <year>2007</year>
<volume>168</volume>
<fpage>176</fpage>
<lpage>185</lpage>
<pub-id pub-id-type="pmid">17197136</pub-id>
</element-citation>
</ref>
<ref id="CR166">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ze</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gui</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Nanosized TiO2-induced reproductive system dysfunction and its mechanism in female mice</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<fpage>e59378</fpage>
<pub-id pub-id-type="pmid">23565150</pub-id>
</element-citation>
</ref>
<ref id="CR167">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Ba</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Pu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Susceptibility of young and adult rats to the oral toxicity of titanium dioxide nanoparticles</article-title>
<source/>Small.
          <year>2013</year>
<volume>9</volume>
<fpage>1742</fpage>
<lpage>1752</lpage>
<pub-id pub-id-type="pmid">22945798</pub-id>
</element-citation>
</ref>
<ref id="CR168">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J-HH</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>C-SS</given-names>
</name>
<name>
<surname>Ignacio</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D-HH</given-names>
</name>
<name>
<surname>Sajo</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Maeng</surname>
<given-names>EH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immunotoxicity of silicon dioxide nanoparticles with different sizes and electrostatic charge</article-title>
<source/>Int J Nanomedicine.
          <year>2014</year>
<volume>9</volume>
<issue>Suppl 2</issue>
<fpage>183</fpage>
<lpage>193</lpage>
<pub-id pub-id-type="pmid">25565836</pub-id>
</element-citation>
</ref>
<ref id="CR169">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshida</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yoshioka</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Misato</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hirai</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intestinal absorption and biological effects of orally administered amorphous silica particles</article-title>
<source/>Nanoscale Res Lett.
          <year>2014</year>
<volume>9</volume>
<fpage>532</fpage>
<pub-id pub-id-type="pmid">25288919</pub-id>
</element-citation>
</ref>
<ref id="CR170">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>E-JJ</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles</article-title>
<source/>Environ Toxicol Pharmacol.
          <year>2010</year>
<volume>30</volume>
<fpage>162</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="pmid">21787647</pub-id>
</element-citation>
</ref>
<ref id="CR171">
<label>171.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vijay-Kumar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Aitken</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Cullender</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Mwangi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Srinivasan</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5</article-title>
<source/>Science.
          <year>2010</year>
<volume>328</volume>
<fpage>228</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="pmid">20203013</pub-id>
</element-citation>
</ref>
<ref id="CR172">
<label>172.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mucosal adherent bacterial dysbiosis in patients with colorectal adenomas</article-title>
<source/>Sci Rep.
          <year>2016</year>
<volume>6</volume>
<fpage>26337</fpage>
<pub-id pub-id-type="pmid">27194068</pub-id>
</element-citation>
</ref>
<ref id="CR173">
<label>173.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ley</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Turnbaugh</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>JI</given-names>
</name>
</person-group>
<article-title>Microbial ecology: human gut microbes associated with obesity</article-title>
<source/>Nature.
          <year>2006</year>
<volume>444</volume>
<fpage>1022</fpage>
<lpage>1023</lpage>
<pub-id pub-id-type="pmid">17183309</pub-id>
</element-citation>
</ref>
<ref id="CR174">
<label>174.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turnbaugh</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Ley</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Mahowald</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Magrini</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Mardis</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>JI</given-names>
</name>
</person-group>
<article-title>An obesity-associated gut microbiome with increased capacity for energy harvest</article-title>
<source/>Nature.
          <year>2006</year>
<volume>444</volume>
<fpage>1027</fpage>
<lpage>1031</lpage>
<pub-id pub-id-type="pmid">17183312</pub-id>
</element-citation>
</ref>
<ref id="CR175">
<label>175.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sokol</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Seksik</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Furet</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Firmesse</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Nion-Larmurier</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Beaugerie</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Low counts of Faecalibacterium prausnitzii in colitis microbiota</article-title>
<source/>Inflamm Bowel Dis.
          <year>2009</year>
<volume>15</volume>
<fpage>1183</fpage>
<lpage>1189</lpage>
<pub-id pub-id-type="pmid">19235886</pub-id>
</element-citation>
</ref>
<ref id="CR176">
<label>176.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mariat</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Firmesse</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Levenez</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Guimarăes</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Sokol</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Doré</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age</article-title>
<source/>BMC Microbiol.
          <year>2009</year>
<volume>9</volume>
<fpage>123</fpage>
<pub-id pub-id-type="pmid">19508720</pub-id>
</element-citation>
</ref>
<ref id="CR177">
<label>177.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voreades</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kozil</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Weir</surname>
<given-names>TL</given-names>
</name>
</person-group>
<article-title>Diet and the development of the human intestinal microbiome</article-title>
<source/>Front Microbiol.
          <year>2014</year>
<volume>5</volume>
<fpage>494</fpage>
<pub-id pub-id-type="pmid">25295033</pub-id>
</element-citation>
</ref>
<ref id="CR178">
<label>178.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Natividad</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Agus</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Planchais</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lamas</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Jarry</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impaired Aryl Hydrocarbon Receptor Ligand Production by the Gut Microbiota Is a Key Factor in Metabolic Syndrome</article-title>
<source/>Cell Metab
          <year>2018</year>
<volume>28</volume>
<fpage>737</fpage>
<lpage>749</lpage>
<pub-id pub-id-type="pmid">30057068</pub-id>
</element-citation>
</ref>
<ref id="CR179">
<label>179.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>LeBlanc</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Chain</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Martín</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bermúdez-Humarán</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Courau</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Langella</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria</article-title>
<source/>Microb Cell Fact.
          <year>2017</year>
<volume>16</volume>
<fpage>79</fpage>
<pub-id pub-id-type="pmid">28482838</pub-id>
</element-citation>
</ref>
<ref id="CR180">
<label>180.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pessione</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Lactic acid bacteria contribution to gut microbiota complexity: lights and shadows</article-title>
<source/>Front Cell Infect Microbiol.
          <year>2012</year>
<volume>2</volume>
<fpage>86</fpage>
<pub-id pub-id-type="pmid">22919677</pub-id>
</element-citation>
</ref>
<ref id="CR181">
<label>181.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rizzatti</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lopetuso</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Gibiino</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Binda</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gasbarrini</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Proteobacteria: A Common Factor in Human Diseases</article-title>
<source/>Biomed Res Int.
          <year>2017</year>
<volume>2017</volume>
<fpage>9351507</fpage>
<pub-id pub-id-type="pmid">29230419</pub-id>
</element-citation>
</ref>
<ref id="CR182">
<label>182.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shin</surname>
<given-names>N-RR</given-names>
</name>
<name>
<surname>Whon</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>J-WW</given-names>
</name>
</person-group>
<article-title>Proteobacteria: microbial signature of dysbiosis in gut microbiota</article-title>
<source/>Trends Biotechnol.
          <year>2015</year>
<volume>33</volume>
<fpage>496</fpage>
<lpage>503</lpage>
<pub-id pub-id-type="pmid">26210164</pub-id>
</element-citation>
</ref>
<ref id="CR183">
<label>183.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nishida</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fujimoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Fujii</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shioya</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Imaeda</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn’s Disease</article-title>
<source/>Digestion.
          <year>2016</year>
<volume>93</volume>
<fpage>59</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="pmid">26789999</pub-id>
</element-citation>
</ref>
<ref id="CR184">
<label>184.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frank</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>St Amand</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Feldman</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Boedeker</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Harpaz</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Pace</surname>
<given-names>NR</given-names>
</name>
</person-group>
<article-title>Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases</article-title>
<source/>Proc Natl Acad Sci USA.
          <year>2007</year>
<volume>104</volume>
<fpage>13780</fpage>
<lpage>13785</lpage>
<pub-id pub-id-type="pmid">17699621</pub-id>
</element-citation>
</ref>
<ref id="CR185">
<label>185.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willing</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Dicksved</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Halfvarson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Andersson</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Lucio</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes</article-title>
<source/>Gastroenterology
          <year>2010</year>
<volume>139</volume>
<fpage>1844</fpage>
<lpage>1854</lpage>
<pub-id pub-id-type="pmid">20816835</pub-id>
</element-citation>
</ref>
<ref id="CR186">
<label>186.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fei</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers</article-title>
<source/>ISME J.
          <year>2012</year>
<volume>6</volume>
<fpage>320</fpage>
<lpage>329</lpage>
<pub-id pub-id-type="pmid">21850056</pub-id>
</element-citation>
</ref>
<ref id="CR187">
<label>187.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turnbaugh</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Hamady</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yatsunenko</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cantarel</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ley</surname>
<given-names>RE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A core gut microbiome in obese and lean twins</article-title>
<source/>Nature.
          <year>2009</year>
<volume>457</volume>
<fpage>480</fpage>
<lpage>484</lpage>
<pub-id pub-id-type="pmid">19043404</pub-id>
</element-citation>
</ref>
<ref id="CR188">
<label>188.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forbes</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Van Domselaar</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bernstein</surname>
<given-names>CN</given-names>
</name>
</person-group>
<article-title>Microbiome Survey of the Inflamed and Noninflamed Gut at Different Compartments Within the Gastrointestinal Tract of Inflammatory Bowel Disease Patients</article-title>
<source/>Inflamm Bowel Dis.
          <year>2016</year>
<volume>22</volume>
<fpage>817</fpage>
<lpage>825</lpage>
<pub-id pub-id-type="pmid">26937623</pub-id>
</element-citation>
</ref>
<ref id="CR189">
<label>189.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Favier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Neut</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mizon</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cortot</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Colombel</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Mizon</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn’s disease</article-title>
<source/>Dig Dis Sci.
          <year>1997</year>
<volume>42</volume>
<fpage>817</fpage>
<lpage>822</lpage>
<pub-id pub-id-type="pmid">9125655</pub-id>
</element-citation>
</ref>
<ref id="CR190">
<label>190.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer</article-title>
<source/>PLoS One.
          <year>2012</year>
<volume>7</volume>
<fpage>e39743</fpage>
<pub-id pub-id-type="pmid">22761885</pub-id>
</element-citation>
</ref>
<ref id="CR191">
<label>191.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mira-Pascual</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cabrera-Rubio</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ocon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Costales</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Parra</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Suarez</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers</article-title>
<source/>J Gastroenterol.
          <year>2015</year>
<volume>50</volume>
<fpage>167</fpage>
<lpage>179</lpage>
<pub-id pub-id-type="pmid">24811328</pub-id>
</element-citation>
</ref>
<ref id="CR192">
<label>192.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwiertz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Taras</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Schäfer</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Beijer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bos</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Donus</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbiota and SCFA in lean and overweight healthy subjects</article-title>
<source/>Obesity (Silver Spring).
          <year>2010</year>
<volume>18</volume>
<fpage>190</fpage>
<lpage>195</lpage>
<pub-id pub-id-type="pmid">19498350</pub-id>
</element-citation>
</ref>
<ref id="CR193">
<label>193.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Chatelier</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Prifti</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hildebrand</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Falony</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Richness of human gut microbiome correlates with metabolic markers</article-title>
<source/>Nature.
          <year>2013</year>
<volume>500</volume>
<fpage>541</fpage>
<lpage>546</lpage>
<pub-id pub-id-type="pmid">23985870</pub-id>
</element-citation>
</ref>
<ref id="CR194">
<label>194.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gevers</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kugathasan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Denson</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Vázquez-Baeza</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Van Treuren</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The treatment-naive microbiome in new-onset Crohn’s disease</article-title>
<source/>Cell Host Microbe.
          <year>2014</year>
<volume>15</volume>
<fpage>382</fpage>
<lpage>392</lpage>
<pub-id pub-id-type="pmid">24629344</pub-id>
</element-citation>
</ref>
<ref id="CR195">
<label>195.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joossens</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Huys</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cnockaert</surname>
<given-names>M</given-names>
</name>
<name>
<surname>De Preter</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Verbeke</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rutgeerts</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives</article-title>
<source/>Gut.
          <year>2011</year>
<volume>60</volume>
<fpage>631</fpage>
<lpage>637</lpage>
<pub-id pub-id-type="pmid">21209126</pub-id>
</element-citation>
</ref>
<ref id="CR196">
<label>196.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>DiBaise</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Zuccolo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kudrna</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Braidotti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human gut microbiota in obesity and after gastric bypass</article-title>
<source/>Proc Natl Acad Sci USA.
          <year>2009</year>
<volume>106</volume>
<fpage>2365</fpage>
<lpage>2370</lpage>
<pub-id pub-id-type="pmid">19164560</pub-id>
</element-citation>
</ref>
<ref id="CR197">
<label>197.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kostic</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Gevers</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pedamallu</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Michaud</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Duke</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Earl</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genomic analysis identifies association of Fusobacterium with colorectal carcinoma</article-title>
<source/>Genome Res.
          <year>2012</year>
<volume>22</volume>
<fpage>292</fpage>
<lpage>298</lpage>
<pub-id pub-id-type="pmid">22009990</pub-id>
</element-citation>
</ref>
<ref id="CR198">
<label>198.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kasai</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sugimoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Moritani</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Oya</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing</article-title>
<source/>BMC Gastroenterol.
          <year>2015</year>
<volume>15</volume>
<fpage>100</fpage>
<pub-id pub-id-type="pmid">26261039</pub-id>
</element-citation>
</ref>
<ref id="CR199">
<label>199.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ley</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Bäckhed</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Turnbaugh</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lozupone</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>JI</given-names>
</name>
</person-group>
<article-title>Obesity alters gut microbial ecology</article-title>
<source/>Proc Natl Acad Sci USA.
          <year>2005</year>
<volume>102</volume>
<fpage>11070</fpage>
<lpage>11075</lpage>
<pub-id pub-id-type="pmid">16033867</pub-id>
</element-citation>
</ref>
<ref id="CR200">
<label>200.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hildebrandt</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sherrill-Mix</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Keilbaugh</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Hamady</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y-YY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High-fat diet determines the composition of the murine gut microbiome independently of obesity</article-title>
<source/>Gastroenterology
          <year>2009</year>
<volume>137</volume>
<fpage>1716</fpage>
<lpage>1724</lpage>
<pub-id pub-id-type="pmid">19706296</pub-id>
</element-citation>
</ref>
<ref id="CR201">
<label>201.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weir</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Manter</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Sheflin</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Barnett</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Heuberger</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>EP</given-names>
</name>
</person-group>
<article-title>Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults</article-title>
<source/>PLoS One.
          <year>2013</year>
<volume>8</volume>
<fpage>e70803</fpage>
<pub-id pub-id-type="pmid">23940645</pub-id>
</element-citation>
</ref>
<ref id="CR202">
<label>202.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ruiz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lanza</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Haange</surname>
<given-names>S-BB</given-names>
</name>
<name>
<surname>Oberbach</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Till</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbiota from the distal guts of lean and obese adolescents exhibit partial functional redundancy besides clear differences in community structure</article-title>
<source/>Environ Microbiol.
          <year>2013</year>
<volume>15</volume>
<fpage>211</fpage>
<lpage>226</lpage>
<pub-id pub-id-type="pmid">22891823</pub-id>
</element-citation>
</ref>
<ref id="CR203">
<label>203.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patil</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Dhotre</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Chavan</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Sultan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Lanjekar</surname>
<given-names>VB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular analysis of gut microbiota in obesity among Indian individuals</article-title>
<source/>J Biosci.
          <year>2012</year>
<volume>37</volume>
<fpage>647</fpage>
<lpage>657</lpage>
<pub-id pub-id-type="pmid">22922190</pub-id>
</element-citation>
</ref>
<ref id="CR204">
<label>204.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noor</surname>
<given-names>SO</given-names>
</name>
<name>
<surname>Ridgway</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Scovell</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kemsley</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Lund</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Jamieson</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota</article-title>
<source/>BMC Gastroenterol.
          <year>2010</year>
<volume>10</volume>
<fpage>134</fpage>
<pub-id pub-id-type="pmid">21073731</pub-id>
</element-citation>
</ref>
<ref id="CR205">
<label>205.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takaishi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Matsuki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nakazawa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Takada</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kado</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Asahara</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease</article-title>
<source/>Int J Med Microbiol.
          <year>2008</year>
<volume>298</volume>
<fpage>463</fpage>
<lpage>472</lpage>
<pub-id pub-id-type="pmid">17897884</pub-id>
</element-citation>
</ref>
<ref id="CR206">
<label>206.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verdam</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Fuentes</surname>
<given-names>S</given-names>
</name>
<name>
<surname>De</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Zoetendal</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Erbil</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Greve</surname>
<given-names>JW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human intestinal microbiota composition is associated with local and systemic inflammation in obesity</article-title>
<source/>Obesity (Silver Spring)
          <year>2013</year>
<volume>21</volume>
<fpage>E607</fpage>
<lpage>E615</lpage>
<pub-id pub-id-type="pmid">23526699</pub-id>
</element-citation>
</ref>
<ref id="CR207">
<label>207.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Alkhouri</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>RD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH</article-title>
<source/>Hepatology.
          <year>2013</year>
<volume>57</volume>
<fpage>601</fpage>
<lpage>609</lpage>
<pub-id pub-id-type="pmid">23055155</pub-id>
</element-citation>
</ref>
<ref id="CR208">
<label>208.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Durbán</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Abellán</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Jiménez-Hernández</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Latorre</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Moya</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Daily follow-up of bacterial communities in the human gut reveals stable composition and host-specific patterns of interaction</article-title>
<source/>FEMS Microbiol Ecol.
          <year>2012</year>
<volume>81</volume>
<fpage>427</fpage>
<lpage>437</lpage>
<pub-id pub-id-type="pmid">22443608</pub-id>
</element-citation>
</ref>
<ref id="CR209">
<label>209.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sokol</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Leducq</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Aschard</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Pham</surname>
<given-names>H-PP</given-names>
</name>
<name>
<surname>Jegou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Landman</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fungal microbiota dysbiosis in IBD</article-title>
<source/>Gut.
          <year>2017</year>
<volume>66</volume>
<fpage>1039</fpage>
<lpage>1048</lpage>
<pub-id pub-id-type="pmid">26843508</pub-id>
</element-citation>
</ref>
<ref id="CR210">
<label>210.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dysbiosis signature of fecal microbiota in colorectal cancer patients</article-title>
<source/>Microb Ecol.
          <year>2013</year>
<volume>66</volume>
<fpage>462</fpage>
<lpage>470</lpage>
<pub-id pub-id-type="pmid">23733170</pub-id>
</element-citation>
</ref>
<ref id="CR211">
<label>211.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Denman</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Dore</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Leclerc</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dysbiosis of fecal microbiota in Crohn’s disease patients as revealed by a custom phylogenetic microarray</article-title>
<source/>Inflamm Bowel Dis.
          <year>2010</year>
<volume>16</volume>
<fpage>2034</fpage>
<lpage>2042</lpage>
<pub-id pub-id-type="pmid">20848492</pub-id>
</element-citation>
</ref>
<ref id="CR212">
<label>212.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manichanh</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rigottier-Gois</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bonnaud</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gloux</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Pelletier</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Frangeul</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach</article-title>
<source/>Gut.
          <year>2006</year>
<volume>55</volume>
<fpage>205</fpage>
<lpage>211</lpage>
<pub-id pub-id-type="pmid">16188921</pub-id>
</element-citation>
</ref>
<ref id="CR213">
<label>213.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tims</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Derom</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Jonkers</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Vlietinck</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Saris</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Kleerebezem</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbiota conservation and BMI signatures in adult monozygotic twins</article-title>
<source/>ISME J.
          <year>2013</year>
<volume>7</volume>
<fpage>707</fpage>
<lpage>717</lpage>
<pub-id pub-id-type="pmid">23190729</pub-id>
</element-citation>
</ref>
<ref id="CR214">
<label>214.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furet</surname>
<given-names>J-PP</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>L-CC</given-names>
</name>
<name>
<surname>Tap</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Poitou</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Basdevant</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bouillot</surname>
<given-names>J-LL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers</article-title>
<source/>Diabetes.
          <year>2010</year>
<volume>59</volume>
<fpage>3049</fpage>
<lpage>3057</lpage>
<pub-id pub-id-type="pmid">20876719</pub-id>
</element-citation>
</ref>
<ref id="CR215">
<label>215.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer</article-title>
<source/>PLoS One.
          <year>2014</year>
<volume>9</volume>
<fpage>e90849</fpage>
<pub-id pub-id-type="pmid">24603888</pub-id>
</element-citation>
</ref>
<ref id="CR216">
<label>216.</label>
<mixed-citation publication-type="other">Sen T, Cawthon CR, Ihde BT, Hajnal A, DiLorenzo PM, La Serre CB de, et al. Diet-driven microbiota dysbiosis is associated with vagal remodeling and obesity. Physiol Behav. 2017;173:305–317.</mixed-citation>
</ref>
<ref id="CR217">
<label>217.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hall</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Yassour</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sauk</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Garner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Arthur</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients</article-title>
<source/>Genome Med.
          <year>2017</year>
<volume>9</volume>
<fpage>103</fpage>
<pub-id pub-id-type="pmid">29183332</pub-id>
</element-citation>
</ref>
<ref id="CR218">
<label>218.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Co-occurrence of driver and passenger bacteria in human colorectal cancer</article-title>
<source/>Gut Pathog.
          <year>2014</year>
<volume>6</volume>
<fpage>26</fpage>
<pub-id pub-id-type="pmid">24995042</pub-id>
</element-citation>
</ref>
<ref id="CR219">
<label>219.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seksik</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rigottier-Gois</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gramet</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sutren</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pochart</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Marteau</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alterations of the dominant faecal bacterial groups in patients with Crohn’s disease of the colon</article-title>
<source/>Gut.
          <year>2003</year>
<volume>52</volume>
<fpage>237</fpage>
<lpage>242</lpage>
<pub-id pub-id-type="pmid">12524406</pub-id>
</element-citation>
</ref>
<ref id="CR220">
<label>220.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chassaing</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Darfeuille-Michaud</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases</article-title>
<source/>Gastroenterology.
          <year>2011</year>
<volume>140</volume>
<fpage>1720</fpage>
<lpage>1728</lpage>
<pub-id pub-id-type="pmid">21530738</pub-id>
</element-citation>
</ref>
<ref id="CR221">
<label>221.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sokol</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lepage</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Seksik</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Doré</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Marteau</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active <italic>Escherichia coli</italic> in the microbiota of patients with ulcerative colitis</article-title>
<source/>J Clin Microbiol.
          <year>2006</year>
<volume>44</volume>
<fpage>3172</fpage>
<lpage>3177</lpage>
<pub-id pub-id-type="pmid">16954244</pub-id>
</element-citation>
</ref>
<ref id="CR222">
<label>222.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Mpofu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nayar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Enhanced <italic>Escherichia coli</italic> adherence and invasion in Crohn’s disease and colon cancer</article-title>
<source/>Gastroenterology.
          <year>2004</year>
<volume>127</volume>
<fpage>80</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="pmid">15236175</pub-id>
</element-citation>
</ref>
<ref id="CR223">
<label>223.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pickert</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Neufert</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Leppkes</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wittkopf</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Warntjen</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing</article-title>
<source/>J Exp Med.
          <year>2009</year>
<volume>206</volume>
<fpage>1465</fpage>
<lpage>1472</lpage>
<pub-id pub-id-type="pmid">19564350</pub-id>
</element-citation>
</ref>
<ref id="CR224">
<label>224.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sonnenberg</surname>
<given-names>GF</given-names>
</name>
<name>
<surname>Fouser</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Artis</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22</article-title>
<source/>Nat Immunol.
          <year>2011</year>
<volume>12</volume>
<fpage>383</fpage>
<lpage>390</lpage>
<pub-id pub-id-type="pmid">21502992</pub-id>
</element-citation>
</ref>
<ref id="CR225">
<label>225.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stelter</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Käppeli</surname>
<given-names>R</given-names>
</name>
<name>
<surname>König</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Krah</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hardt</surname>
<given-names>W-DD</given-names>
</name>
<name>
<surname>Stecher</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Salmonella-induced mucosal lectin RegIIIβ kills competing gut microbiota</article-title>
<source/>PLoS One.
          <year>2011</year>
<volume>6</volume>
<fpage>e20749</fpage>
<pub-id pub-id-type="pmid">21694778</pub-id>
</element-citation>
</ref>
<ref id="CR226">
<label>226.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ota</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Manzanillo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kates</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zavala-Solorio</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Eidenschenk</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes</article-title>
<source/>Nature.
          <year>2014</year>
<volume>514</volume>
<fpage>237</fpage>
<lpage>241</lpage>
<pub-id pub-id-type="pmid">25119041</pub-id>
</element-citation>
</ref>
<ref id="CR227">
<label>227.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geier</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Howarth</surname>
<given-names>GS</given-names>
</name>
</person-group>
<article-title>Probiotics, prebiotics and synbiotics: a role in chemoprevention for colorectal cancer?</article-title>
<source/>Cancer Biol Ther.
          <year>2006</year>
<volume>5</volume>
<fpage>1265</fpage>
<lpage>1269</lpage>
<pub-id pub-id-type="pmid">16969130</pub-id>
</element-citation>
</ref>
<ref id="CR228">
<label>228.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Metidji</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Omenetti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Crotta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nye</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Environmental Sensor AHR Protects from Inflammatory Damage by Maintaining Intestinal Stem Cell Homeostasis and Barrier Integrity</article-title>
<source/>Immunity
          <year>2018</year>
<volume>49</volume>
<fpage>353</fpage>
<lpage>362</lpage>
<pub-id pub-id-type="pmid">30119997</pub-id>
</element-citation>
</ref>
<ref id="CR229">
<label>229.</label>
<mixed-citation publication-type="other">Gronke K, Hernández PP, Zimmermann J, Klose CSNS, Kofoed-Branzk M, Guendel F, et al. Interleukin-22 protects intestinal stem cells against genotoxic stress. Nature. 2019.</mixed-citation>
</ref>
<ref id="CR230">
<label>230.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Urrutia-Ortega</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Garduño-Balderas</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Delgado-Buenrostro</surname>
<given-names>NL</given-names>
</name>
<name>
<surname>Freyre-Fonseca</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Flores-Flores</surname>
<given-names>JOO</given-names>
</name>
<name>
<surname>González-Robles</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Food-grade titanium dioxide exposure exacerbates tumor formation in colitis associated cancer model</article-title>
<source/>Food Chem Toxicol.
          <year>2016</year>
<volume>93</volume>
<fpage>20</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="pmid">27117919</pub-id>
</element-citation>
</ref>
<ref id="CR231">
<label>231.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Proquin</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jetten</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Jonkhout</surname>
<given-names>MCMC</given-names>
</name>
<name>
<surname>Garduño-Balderas</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Briedé</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>de Kok</surname>
<given-names>TM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gene expression profiling in colon of mice exposed to food additive titanium dioxide (E171)</article-title>
<source/>Food Chem Toxicol.
          <year>2018</year>
<volume>111</volume>
<fpage>153</fpage>
<lpage>165</lpage>
<pub-id pub-id-type="pmid">29128614</pub-id>
</element-citation>
</ref>
<ref id="CR232">
<label>232.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Proquin</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jetten</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Jonkhout</surname>
<given-names>MCMC</given-names>
</name>
<name>
<surname>Garduño-Balderas</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Briedé</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>de Kok</surname>
<given-names>TM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Transcriptomics analysis reveals new insights in E171-induced molecular alterations in a mouse model of colon cancer</article-title>
<source/>Sci Rep.
          <year>2018</year>
<volume>8</volume>
<fpage>9738</fpage>
<pub-id pub-id-type="pmid">29950665</pub-id>
</element-citation>
</ref>
<ref id="CR233">
<label>233.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shoaie</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Karlsson</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mardinoglu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nookaew</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bordel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Understanding the interactions between bacteria in the human gut through metabolic modeling</article-title>
<source/>Sci Rep.
          <year>2013</year>
<volume>3</volume>
<fpage>2532</fpage>
<pub-id pub-id-type="pmid">23982459</pub-id>
</element-citation>
</ref>
<ref id="CR234">
<label>234.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>HV</given-names>
</name>
<name>
<surname>Frassetto</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kowalik</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Nawrocki</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Kosinski</surname>
<given-names>JR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms</article-title>
<source/>PLoS One.
          <year>2012</year>
<volume>7</volume>
<fpage>e35240</fpage>
<pub-id pub-id-type="pmid">22506074</pub-id>
</element-citation>
</ref>
<ref id="CR235">
<label>235.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hartstra</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Bouter</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Bäckhed</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Nieuwdorp</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Insights into the role of the microbiome in obesity and type 2 diabetes</article-title>
<source/>Diab Care.
          <year>2015</year>
<volume>38</volume>
<fpage>159</fpage>
<lpage>165</lpage>
</element-citation>
</ref>
<ref id="CR236">
<label>236.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harris</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kassis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Major</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<article-title>Is the gut microbiota a new factor contributing to obesity and its metabolic disorders?</article-title>
<source/>J Obes.
          <year>2012</year>
<volume>2012</volume>
<fpage>879151</fpage>
<pub-id pub-id-type="pmid">22315672</pub-id>
</element-citation>
</ref>
<ref id="CR237">
<label>237.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zambell</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Fitch</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Fleming</surname>
<given-names>SE</given-names>
</name>
</person-group>
<article-title>Acetate and butyrate are the major substrates for de novo lipogenesis in rat colonic epithelial cells</article-title>
<source/>J Nutr.
          <year>2003</year>
<volume>133</volume>
<fpage>3509</fpage>
<lpage>3515</lpage>
<pub-id pub-id-type="pmid">14608066</pub-id>
</element-citation>
</ref>
<ref id="CR238">
<label>238.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiong</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Miyamoto</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Shibata</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Valasek</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Motoike</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kedzierski</surname>
<given-names>RM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41</article-title>
<source/>Proc Natl Acad Sci USA.
          <year>2004</year>
<volume>101</volume>
<fpage>1045</fpage>
<lpage>1050</lpage>
<pub-id pub-id-type="pmid">14722361</pub-id>
</element-citation>
</ref>
<ref id="CR239">
<label>239.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brahe</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Astrup</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Larsen</surname>
<given-names>LH</given-names>
</name>
</person-group>
<article-title>Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases?</article-title>
<source/>Obes Rev.
          <year>2013</year>
<volume>14</volume>
<fpage>950</fpage>
<lpage>959</lpage>
<pub-id pub-id-type="pmid">23947604</pub-id>
</element-citation>
</ref>
<ref id="CR240">
<label>240.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vrieze</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Van</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>Holleman</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Salojärvi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kootte</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Bartelsman</surname>
<given-names>JF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome</article-title>
<source/>Gastroenterology
          <year>2012</year>
<volume>143</volume>
<fpage>913</fpage>
<lpage>916</lpage>
<pub-id pub-id-type="pmid">22728514</pub-id>
</element-citation>
</ref>
<ref id="CR241">
<label>241.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheppach</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Sommer</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kirchner</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Paganelli</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Bartram</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Christl</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis</article-title>
<source/>Gastroenterology.
          <year>1992</year>
<volume>103</volume>
<fpage>51</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="pmid">1612357</pub-id>
</element-citation>
</ref>
<ref id="CR242">
<label>242.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vernia</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Monteleone</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Grandinetti</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Villotti</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Di Giulio</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Frieri</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis: randomized, double-blind, placebo-controlled pilot study</article-title>
<source/>Dig Dis Sci.
          <year>2000</year>
<volume>45</volume>
<fpage>976</fpage>
<lpage>981</lpage>
<pub-id pub-id-type="pmid">10795763</pub-id>
</element-citation>
</ref>
<ref id="CR243">
<label>243.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Sabatino</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Morera</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ciccocioppo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cazzola</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gotti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tinozzi</surname>
<given-names>FP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oral butyrate for mildly to moderately active Crohn’s disease</article-title>
<source/>Aliment Pharmacol Ther.
          <year>2005</year>
<volume>22</volume>
<fpage>789</fpage>
<lpage>794</lpage>
<pub-id pub-id-type="pmid">16225487</pub-id>
</element-citation>
</ref>
<ref id="CR244">
<label>244.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vernia</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Marcheggiano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Caprilli</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Frieri</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Corrao</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Valpiani</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Short-chain fatty acid topical treatment in distal ulcerative colitis</article-title>
<source/>Aliment Pharmacol Ther.
          <year>1995</year>
<volume>9</volume>
<fpage>309</fpage>
<lpage>313</lpage>
<pub-id pub-id-type="pmid">7654893</pub-id>
</element-citation>
</ref>
<ref id="CR245">
<label>245.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Robbins</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Nie</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer</article-title>
<source/>Int J Cancer.
          <year>2011</year>
<volume>128</volume>
<fpage>847</fpage>
<lpage>856</lpage>
<pub-id pub-id-type="pmid">20979106</pub-id>
</element-citation>
</ref>
<ref id="CR246">
<label>246.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Canani</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Costanzo</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Leone</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pedata</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Meli</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Calignano</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Potential beneficial effects of butyrate in intestinal and extraintestinal diseases</article-title>
<source/>World J Gastroenterol.
          <year>2011</year>
<volume>17</volume>
<fpage>1519</fpage>
<lpage>1528</lpage>
<pub-id pub-id-type="pmid">21472114</pub-id>
</element-citation>
</ref>
<ref id="CR247">
<label>247.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Keku TO</collab>
<name>
<surname>Dulal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Deveaux</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jovov</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>The gastrointestinal microbiota and colorectal cancer</article-title>
<source/>Am J Physiol Gastrointest Liver Physiol.
          <year>2015</year>
<volume>308</volume>
<fpage>G351</fpage>
<lpage>G363</lpage>
<pub-id pub-id-type="pmid">25540232</pub-id>
</element-citation>
</ref>
<ref id="CR248">
<label>248.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donohoe</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Holley</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Montgomery</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Whitmore</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Hillhouse</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner</article-title>
<source/>Cancer Discov.
          <year>2014</year>
<volume>4</volume>
<fpage>1387</fpage>
<lpage>1397</lpage>
<pub-id pub-id-type="pmid">25266735</pub-id>
</element-citation>
</ref>
<ref id="CR249">
<label>249.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Byndloss</surname>
<given-names>MX</given-names>
</name>
<name>
<surname>Olsan</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Rivera-Chávez</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Tiffany</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Cevallos</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Lokken</surname>
<given-names>KL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion</article-title>
<source/>Science.
          <year>2017</year>
<volume>357</volume>
<fpage>570</fpage>
<lpage>575</lpage>
<pub-id pub-id-type="pmid">28798125</pub-id>
</element-citation>
</ref>
<ref id="CR250">
<label>250.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fei</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice</article-title>
<source/>ISME J.
          <year>2013</year>
<volume>7</volume>
<fpage>880</fpage>
<lpage>884</lpage>
<pub-id pub-id-type="pmid">23235292</pub-id>
</element-citation>
</ref>
<ref id="CR251">
<label>251.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carvalho</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Koren</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Goodrich</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Johansson</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Nalbantoglu</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Aitken</surname>
<given-names>JD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice</article-title>
<source/>Cell Host Microbe.
          <year>2012</year>
<volume>12</volume>
<fpage>139</fpage>
<lpage>152</lpage>
<pub-id pub-id-type="pmid">22863420</pub-id>
</element-citation>
</ref>
<ref id="CR252">
<label>252.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maharshak</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Packey</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Ellermann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Manick</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Siddle</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Huh</surname>
<given-names>EY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Altered enteric microbiota ecology in interleukin 10-deficient mice during development and progression of intestinal inflammation</article-title>
<source/>Gut Microbes.
          <year>2013</year>
<volume>4</volume>
<fpage>316</fpage>
<lpage>324</lpage>
<pub-id pub-id-type="pmid">23822920</pub-id>
</element-citation>
</ref>
<ref id="CR253">
<label>253.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garrett</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Gallini</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Yatsunenko</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Michaud</surname>
<given-names>M</given-names>
</name>
<name>
<surname>DuBois</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Delaney</surname>
<given-names>ML</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis</article-title>
<source/>Cell Host Microbe.
          <year>2010</year>
<volume>8</volume>
<fpage>292</fpage>
<lpage>300</lpage>
<pub-id pub-id-type="pmid">20833380</pub-id>
</element-citation>
</ref>
<ref id="CR254">
<label>254.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garrett</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Lord</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Punit</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lugo-Villarino</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mazmanian</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system</article-title>
<source/>Cell.
          <year>2007</year>
<volume>131</volume>
<fpage>33</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="pmid">17923086</pub-id>
</element-citation>
</ref>
<ref id="CR255">
<label>255.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rooks</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Veiga</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wardwell-Scott</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Tickle</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Segata</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Michaud</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission</article-title>
<source/>ISME J.
          <year>2014</year>
<volume>8</volume>
<fpage>1403</fpage>
<lpage>1417</lpage>
<pub-id pub-id-type="pmid">24500617</pub-id>
</element-citation>
</ref>
<ref id="CR256">
<label>256.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arthur</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Perez-Chanona</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mühlbauer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tomkovich</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Uronis</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>T-JJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intestinal inflammation targets cancer-inducing activity of the microbiota</article-title>
<source/>Science.
          <year>2012</year>
<volume>338</volume>
<fpage>120</fpage>
<lpage>123</lpage>
<pub-id pub-id-type="pmid">22903521</pub-id>
</element-citation>
</ref>
<ref id="CR257">
<label>257.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arthur</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Gharaibeh</surname>
<given-names>RZ</given-names>
</name>
<name>
<surname>Mühlbauer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Perez-Chanona</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Uronis</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>McCafferty</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer</article-title>
<source/>Nat Commun.
          <year>2014</year>
<volume>5</volume>
<fpage>4724</fpage>
<pub-id pub-id-type="pmid">25182170</pub-id>
</element-citation>
</ref>
<ref id="CR258">
<label>258.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suez</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Korem</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zeevi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zilberman-Schapira</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Thaiss</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Maza</surname>
<given-names>O</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Artificial sweeteners induce glucose intolerance by altering the gut microbiota</article-title>
<source/>Nature.
          <year>2014</year>
<volume>514</volume>
<fpage>181</fpage>
<lpage>186</lpage>
<pub-id pub-id-type="pmid">25231862</pub-id>
</element-citation>
</ref>
<ref id="CR259">
<label>259.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chassaing</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Koren</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Goodrich</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Poole</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Srinivasan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ley</surname>
<given-names>RE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome</article-title>
<source/>Nature.
          <year>2015</year>
<volume>519</volume>
<fpage>92</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="pmid">25731162</pub-id>
</element-citation>
</ref>
<ref id="CR260">
<label>260.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Organophosphorus pesticide chlorpyrifos intake promotes obesity and insulin resistance through impacting gut and gut microbiota</article-title>
<source/>Microbiome.
          <year>2019</year>
<volume>7</volume>
<fpage>19</fpage>
<pub-id pub-id-type="pmid">30744700</pub-id>
</element-citation>
</ref>
<ref id="CR261">
<label>261.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodriguez-Palacios</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Harding</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Menghini</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Himmelman</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Retuerto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nickerson</surname>
<given-names>KP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn’s Disease-Like Ileitis</article-title>
<source/>Inflamm Bowel Dis.
          <year>2018</year>
<volume>24</volume>
<fpage>1005</fpage>
<lpage>1020</lpage>
<pub-id pub-id-type="pmid">29554272</pub-id>
</element-citation>
</ref>
<ref id="CR262">
<label>262.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Viennois</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Merlin</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gewirtz</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Chassaing</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon Carcinogenesis</article-title>
<source/>Cancer Res.
          <year>2017</year>
<volume>77</volume>
<fpage>27</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="pmid">27821485</pub-id>
</element-citation>
</ref>
<ref id="CR263">
<label>263.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ebabe Elle</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gaillet</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vidé</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Romain</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lauret</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rugani</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dietary exposure to silver nanoparticles in Sprague-Dawley rats: effects on oxidative stress and inflammation</article-title>
<source/>Food Chem Toxicol.
          <year>2013</year>
<volume>60</volume>
<fpage>297</fpage>
<lpage>301</lpage>
<pub-id pub-id-type="pmid">23933361</pub-id>
</element-citation>
</ref>
<ref id="CR264">
<label>264.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhuo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Luan</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effect of titanium dioxide nanoparticles on the cardiovascular system after oral administration</article-title>
<source/>Toxicol Lett.
          <year>2015</year>
<volume>239</volume>
<fpage>123</fpage>
<lpage>130</lpage>
<pub-id pub-id-type="pmid">26387441</pub-id>
</element-citation>
</ref>
<ref id="CR265">
<label>265.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A mechanistic study to increase understanding of titanium dioxide nanoparticles-increased plasma glucose in mice</article-title>
<source/>Food Chem Toxicol.
          <year>2016</year>
<volume>95</volume>
<fpage>175</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="pmid">27430421</pub-id>
</element-citation>
</ref>
<ref id="CR266">
<label>266.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>EFSA ANS Panel</collab>
</person-group>
<article-title>Guidance on risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain: Part 1, human and animal health</article-title>
<source/>EFSA J
          <year>2018</year>
<volume>16</volume>
<fpage>5327</fpage>
<lpage>5395</lpage>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>